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1. Introduction 
1.1 Gliding bacteria 
Motility is an important characteristic of bacteria that enables them to move towards 
or away from attractants or repellants, respectively. This facilitates bacteria to choose 
suitable conditions for their living. Bacterial motility is of three types: flagella, 
twitching and gliding. Among them, the gliding motility is fascinating because of its 
distinct mechanisms encountered in different bacteria (McBride, 2001, Jarrell and 
McBride, 2008). Bacteria which move by gliding on the surface have been isolated 
from almost all environment including soil, marine samples, sewage plants and 
hydrothermal vents. Till now, no similarity has been observed among these bacteria 
except their pattern of locomotion. In 2007, Nett and König clustered gliding bacteria 
based on their phylogenetic origin (Table 1-1). It was apparent from the grouping that 
only the phylum Chloroflexi exclusively contains gliding bacteria, whereas other phyla 
include both gliding and non-gliding species (Nett and König, 2007).  
Phylum Genera 
Chloroflexi Chloroflexus, Chloronema, Heliothrix, Oscillothrix, Herpetosiphon 
Cyanobacteria Chroococcus, Gloeocapsa, Synechocystis, Dermocarpella, Staniera, 
Myxosarcina, Pleurocapsa, Arthrospira, Geitlerinema, Leptolyngbya, 
Lyngbya, , Oscillatoria, Plankothrix, Pseudoanabaena, Spirulina, 
Symploca, Microcoleus, Trichodesmium, Tychonema, Anabaena, 
Cylindrospermum, Nodularia, Nostoc, Calothrix, Calothrix, Rivularia, 
Tolypothrix, Chlorogloeopsis, Fischerella 
Chlorobi Chloroherpeton 
Proteobacteria Thithrix, Achromatium, Beggiatoa, Leucothrix, Thiploca, Lysobacter, 
Myxococcus, Corallococcus, Pyxicoccus, Cystobacter, Archangium, 
Hyalangium, Melittangium, Stigmatella, Polyangium, Byssophaga, 
Chondromyces, Hapolangium, Jahnia, Sorangium, Nannocystis, 
Kofleria  
Firmicutes Heliobacterium, Mycoplasma, Filibacter 
Planctomycetes Isosphaera 
Bacteroidetes Marinilabila, Flavobacterium, Capnocytophaga, Cellulophaga, 
Gelidibacter, Psychroflexus, Tenacibaculum, Zobellia, Sphingobacterium, 
Pedobacter, Saprospira, Haliscomenobacte, Lewinella, Flexibacter, 
Cytophaga, Microscilla, Runella, Spirosoma, Sporocytophaga, 
Flexithrix, Persicobacter, Thermonema, Chtinophaga, Toxothrix 
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Table 1-1: Grouping of gliding bacteria based on their phylogenetic origin. Genera known as 
the producers of secondary metabolites are highlighted in bold. This table is reproduced from 
Nett and König, 2007. 
1.1.1 Secondary metabolites of gliding bacteria 
Gliding bacteria are a prolific source of natural products, the latter being extremely 
valuable in drug discovery research, where novel lead compounds are urgently 
needed (Newman and Cragg, 2012). Myxobacteria and cyanobacteria with their 
secondary metabolic profile comparable to that of the actinomycetes are the most 
promising groups of gliding bacteria in this respect. From myxobacteria, compounds 
with around 100 different core structures and 500 derivatives thereof have been 
isolated (Weissman and Müller, 2009; Weissman and Müller, 2010). In this context it 
is important to note, that a semi-synthetic derivative of the myxobacterial metabolite 
epothilone (Sorangium cellulosum), ixabepilone, has been approved for the treatment 
of metastatic breast cancer (Vahdat, 2008). Indeed, the drug was proven to be 
effective on cancer cells resistant to chemotherapy with other agents. Similar to 
myxobacteria, more than 800 compounds with a wide range of activities from 
cytotoxic to antimicrobial were isolated from cyanobacteria (Tan, 2007; Wagoner et 
al., 2007). Secondary metabolites with intriguing structures were isolated from other 
groups of gliding bacteria as well including some genera of the phylum Bacteroidetes 
(Nett and König, 2007). In the latter cases however, the proportion is low when 
compared to myxobacteria and cyanobacteria.  
Overall, the investigation of gliding bacteria resulted in the isolation of new 
metabolites with striking structural and biological properties (Figure 1-1). Many of the 
compounds that have been isolated belong to a class of compounds called 
polyketides and nonribosomal peptides.   
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Figure 1-1: Compounds from gliding bacteria with diverse activities and modes of action. 
Compounds inside the box are antibacterial compounds. Biological activity and mode of 
action are represented in italics. Only compounds, for which the biosynthetic gene clusters 
are known are depicted. PKS-Polyketide synthase, NRPS-Nonribosomal peptide synthetase, 
PKS/NRPS-hybrids; HLE-Human leukocyte elastase. 
1.2. Biosynthetic machineries producing nonribosomal peptides and 
polyketides  
Many secondary metabolites isolated from terrestrial and marine microorganisms are 
nonribosomal peptides and polyketides. These molecules are constructed by 
enzymes called megasynthases, i.e nonribosomal peptide synthetases (NRPS) and 
polyketide synthases (PKS), respectively. Both of these machineries are organized in 
modules, with each module comprising catalytic centres, i.e. domain, to perform the 
respective function in order to assemble the peptide or polyketide. These domains 
function in a sequential manner starting up by selecting the specific substrates and 
subsequently loading them to the enzymatic assembly line via a thioester linkage. 
The loaded monomers in each module are then connected successively to form the 
final peptide or polyketide, which may, however be further modified by tailoring 
enzymes. The last module contains an additional domain called thioesterase (TE) for 
releasing the assembled product from the megasynthase (Fischbach and Walsh, 
2006; Walsh, 2004).  
To commence with the operation of megasynthases, the carrier protein (CP) domain 
that carries the substrate throughout the enzymatic assembly has to be first 
activated. The priming of the CPs, i.e peptidyl carrier protein (PCP) in NRPS and acyl 
carrier protein (ACP) in PKS from their inactive apo to their holo form is catalyzed by 
a phosphopantetheinyl transferase (PPTase) and acyl carrier protein synthase 
(AcpS), respectively. PPTases and AcpSs are distinct enzymes that transfer the 4’-
phosphopantetheine (PPant) group from coenzyme A (CoA) to the hydroxyl group of 
conserved serine residue in CPs leaving a terminal thiol group (Figure 1-2) (Dall’Aglio 
et al., 2011; Fischbach and Walsh, 2006). This thiol group would then covalently bind 
to the substrate via a thioester linkage (Figure 1-3-3) (Walsh et al., 1997). Due to the 
promiscuity of PPTases and AcpSs, other CoA analogs including acyl-CoAs that are 
ubiquitous in bacterial cells would act as their substrates rendering the 
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megasynthases inactive. In that scenario, a TE II domain hydrolyzes the acyl group 
thereby restoring the megasynthases for the activation by CoA to proceed further 
with biosynthesis (Heathcote et al., 2001; Schwarzer et al., 2002; Yeh et al., 2004). 
 
 
 
 
Figure 1-2: Enzymatic priming of carrier proteins (CP) to the active holo form. PPTase- 
phosphopantetheinyltransferase; AcpS- acyl-CoA protein synthase. The concise 
representation of holo-CP is in parenthesis are often used in this report. This figure is based 
on Fischbach and Wash, 2006; Schwarzer et al., 2003. 
1.3 Enzymology of NRPS 
Nonribosomal peptides synthesized by NRPS modular assembly lines vary from 
ribosomal peptides primarily in their building blocks and structural features. The 
building blocks of nonribosomal peptides include non-proteinogenic amino acids in 
addition to the 20 proteinogenic amino acids. As indicated by their biosynthetic 
function, an NRPS enzyme contains an initiation, one or more elongation and a 
single termination module (Finking and Marahiel, 2004). Each of these modules 
includes an adenylation (A) domain for specific recognition and adenylation of amino 
acids through the hydrolysis of ATP (Figure 1-3-1). This adenylated intermediate is 
then loaded on to the thiol moiety of the PPant prosthetic group of the PCP domain, 
which is located downstream to the A domain of the same module (Figure 1-3-2). 
Consecutively, the condensation (C) domain of the next module mediates C-N bond 
formation by Claisen condensation reaction between the upstream 
aminoacyl(peptidyl)-S-PCP and downstream aminoacyl-S-PCP. The resulting 
peptidyl-S-PCP intermediate is now ready for the next elongation step (Figure 1-3-3). 
After the last elongation step the release of the full length peptide from the enzyme is 
catalyzed by the TE domain (Figure 1-3-4) (Schwarzer et al., 2001). Altogether, an 
initiation module constitutes A and PCP domains, whereas elongation modules 
contain C, A and PCP domains. To terminate the biosynthesis, the last elongation 
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module, should contain a TE domain (termination module) (Fischbach and walsh, 
2006). 
 (1) Activation (adenylation) of the substrates 
 
 
 
 
 
 
 
 
 
 
(2) Loading of the activated substrates 
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(3) Extension of the chain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(4) Release of the peptide chain 
 
 
 
 
 
 
 
 
 
 
Figure 1-3: Basic steps (1-4) in the biosynthesis of nonribosomal peptides by an activated 
holo-NRPS. A, adenylation; PCP, peptidyl carrier protein; C, condensation; TE, thioesterase. 
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R, amino acid side chain; ATP, adenosine triphosphate; Module-1 is the initiation module, 
module-2 is the elongation module and module-3 is the termination module. Domains 
involved in each step are written in black. The order of condensation reactions are 
represented in roman numbers. This figure is adapted from Fischbach and Wash, 2006; 
Schwarzer et al., 2003. 
In addition to the minimal domains, i.e C, A, PCP and TE, NRPS might also contain 
cis acting accessory domains responsible for methylation, epimerization and 
cyclization providing immense structural diversity to nonribosomal peptides (Samel et 
al., 2008; Walsh et al., 2001). Depending on the nature of the methytransferase (MT) 
domain, the aminoacyl-S-PCP is either N- or C-methylated using the methyl group 
from the cofactor S-adenosylmethionine (SAM). Usually N-MT is located next to the 
A domain (Figure 1-4), whereas C-MT is located next to the PCP domain (Marahiel, 
2009; Schwarzer et al., 2003.).  
 
 
 
 
Figure 1-4: Reaction catalyzed by N-methyl transferase (N-MT). SAM-S, 
adenosylmethionine; C,  condensation; A, adenylation; PCP, peptidyl carrier protein; R, 
amino acid side chain. The N-MT domain, which is involved in methylation is written in black. 
This figure is adapted from Schwarzer et al., 2003. 
D-amino acids are prominent in nonribosomal peptides. In cyclosporine and 
microcystin synthetase, A domains selectively adenylate D-amino acids (Weber and 
Leitner, 1994). But in most of the NRPS, L-aminoacyl-S-PCP has to be epimerized 
by the action of specialized epimerization (E) domains. E domains that are located 
next to the PCP domain predominantly mediate the conversion of PCP-bound amino 
acid from their L-configuration to the D-isomer (Figure 1-5). In certain NRPS like 
arthrofactin synthetase, the C domain itself performs both the condensation and 
epimerization reactions (Balibar et al., 2005). This type of dual C domain can be 
readily distinguished from the conventional C domains based on their sequences. 
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Figure 1-5: Epimerization of PCP bound amino acid by epimerization (E) domain. C-
condensation; A-adenylation; PCP-peptidyl carrier protein; R- amino acid side chain. The E 
domain which is involved in epimerization is written in black. 
In addition to the above mentioned domains, another domain known as 
heterocyclization (HC) domain is of importance. Apart from the peptide bond 
formation this HC domain catalyzes the nucleophilic attack of a thiol group in cysteine 
or a hydroxyl group in serine and threonine with an upstream carbonyl group to form 
a cyclic adduct, followed by dehydration resulting in thiazoline or oxazoline rings, 
respectively (Schwarzer et al., 2003). This hydrolytically labile dihydroheterocyclic 
rings can be further oxidized by oxidation (Ox) domain to stable heterocycles, i.e. 
thiazole and oxazole rings (Figure 1-6) (Schwarzer et al., 2003).  
 
 
 
 
 
Figure 1-6: Heterocycle formation by susbsequent action of cyclization (HC) and oxidation 
(OX) domains. C, condensation; A, adenylation; PCP, peptidyl carrier protein; R,  amino acid 
side chain; FMN, flavin mononucleotide. This figure is adapted from Fischbach and Wash, 
2006; Schwarzer et al., 2003. 
1.4  Enzymology of PKS 
PKS function almost in the same way as NRPS, but they obviously differ in their 
substrates and domains (Walsh, 2007). In PKS systems, the acyltransferase (AT) 
PCP
S
O
NH2
R
PCP
S
O
NH2
R
EC A C A E
C An PCP HC An+1 PCP
SH S
O
OX
S N
FMN
RH2N
C An PCP HC An+1 PCP
SH S
O
NHHS
OX C An PCP HC An+1 PCP
SH
OX
O
R
H2N
-H2O
S
O
S N
RH2N
Module n+1 Module n Module n Module n+1 Module n Module n+1 
Introduction 
10 
 
domain selects a carboxy acid as substrate (Figure 1-7-1) and loads it on to the acyl 
carrier protein (ACP) domain (Figure 1-7-2). The ketosynthase (KS) domain mediates 
the C-C bond formation by decarboxylative condensation between the upstream acyl-
S-ACP and the downstream ACP bound carboxy acid (Figure 1-7-3). The KS domain 
mediated elongation proceeds until it reaches the TE domain, which releases the 
product from the enzyme (Figure 1-7-4) (Hertweck, 2009; Staunton and Weissman 
2001).  
Unlike the A domains in NRPS, the AT domain selects acyl-CoAs directly from the 
cells for polyketide biosynthesis. The AT domain in the loading module always prefer 
monocarboxylic acids such as acetyl-CoA and propionyl-CoA as their substrates. 
Other unusual substrates include aromatic and branched monocarboxylic acids. But 
in certain loading AT domains, dicarboxylic acids such as malonyl-CoA can also be 
selected. In such cases, the KS variant KSQ decarboxylates malonyl-S-ACP yielding 
acetyl-S-ACP. A KSQ domain which has glutamine instead of the active site cysteine 
cannot perform the condensation reaction typical for a KS domain. Therefore, KSQ is 
needed only in an initiating module that loads dicarboxylic acids (Ikeda et al., 2001; 
Ligon et al., 2002; Silakowski et al., 1999; Silakowski et al.., 2001). The AT domains 
of the extending modules always prefer dicarboxylic acids such as malonyl-CoA, 
methyl malonyl-CoA and ethyl malonyl-CoA as needed for the polyketide backbone. 
Some AT domains prefer ACP-linked extender units like aminomalonyl-S-ACP, 
hydroxymalonyl-S-ACP and its derivative methoxymalonyl-S-ACP (Chan et al., 2006) 
instead. In this case, enzymes required for the biosynthesis of this ACP-bound 
unusual intermediates is often found encoded within the gene cluster. 
(1) Recognition and binding of the substrates by AT domains 
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(2) Substrate loading on to the ACP domain 
 
 
 
 
 
 
 
 
 
 
 
 
(3) Chain extension 
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(4) Release of the polyketide chain 
 
 
 
 
 
 
 
Figure 1-7: Basic steps (1-4) in the biosynthesis of polyketides by an activated holo-PKS. 
AT-acyl transferase; ACP, acyl carrier protein; KS, ketosynthase; TE, thioesterase; CoA, 
coenzyme; Module-1 is the initiation module, module-2 is the elongation module and module-
3 is the termination module. Domains involved in each step are written in black. The order of 
extensions is represented in roman numbers. This figure is adapted from Fischbach and 
Wash, 2006. 
Similar to the NRPS, PKS modules may also contain cis acting tailoring domains to 
diversify the polyketide structures (Walsh, 2007). The three catalytic domains 
ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER) may act 
sequentially or partially resulting in completely or partially reduced ketide units 
(Fischbach and Walsh, 2006).  The KR domain initially reduces β-ketoacyl-S-ACP 
obtained from the elongation step to β-hydroxyacyl-S-ACP. This can be followed by 
dehydration of β-hydroxyacyl-S-ACP by the DH domain to yield a α,β-enoyl-S-ACP. 
This alkene is then saturated completely by the action of an ER domain (Figure 1-8) 
(Hertweck, 2009).  
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Figure 1-8: β-carbon modifications in polyketides by partial reductions or complete reduction. 
Subsequent to the formation of β-ketoacyl-S-ACP, ketoreductase (KR) reduces β- keto to a 
hydroxy group. In the next step, dehydratase (DH) eliminates water from the β-hydroxy 
function to form the α,β-enoyl-S-ACP, which is then completely reduced by a enoyl reductase 
(ER) domain. AT, acyl transferase; ACP, acyl carrier protein; KS, ketosynthase; Domains 
involved in each step are written in black. 
Methyl branching at Cα is common and it is either due to the addition of methyl 
malonyl-CoA as an extender unit or the action of MT as discussed in NRPS. There 
are also polyketides, like myxovirescin, which are branched at the β position. This β-
branching is catalyzed by distinct enzymes called hydroxymethylglutaryl-CoA 
synthase (HMG-CoA synthase) and enoyl-CoA hydratases (ECH) (Gulder et al., 
2011). HMG-CoA synthase mediates the attack of acetyl-S-ACP with β-ketoacyl-S-
ACP intermediate. This is followed by the consecutive action of dehydration and 
decarboxylation by two ECHs resulting in Δ2-prenyl-S-ACP (Figure 1-9). 
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Figure 1-9: Branching at the β carbon (highlighted in oval) catalyzed by the action of 
hydroxymethyl glutaryl-CoA synthase (HMG) and enoyl-CoA hydratases (ECH). ACP, acyl 
carrier protein; KS-ketosynthase; A, growing polyketide chain. This figure is adapted from 
Gulder et al., 2011. 
1.5 PKS/NRPS hybrids 
Hybrid gene clusters containing both PKS and NRPS modules involved in the 
biosynthesis of nonribosomal peptide-polyketide hybrid molecules are quite common 
and sometimes even more predominant than discrete PKS and NRPS gene clusters 
(Du and Shen, 2001). In such PKS/NRPS hybrid gene clusters, the PKS and NRPS 
template might be encoded either in the same ORF or in different ORFs. At the 
NRPS-PKS interface, the KS domain must be able to mediate C-C bond formation 
between upstream peptidyl-S-PCP and downstream acyl-S-ACP (Figure 1-10A). 
Similarly at the PKS/NRPS interface, the C domain must be able to catalyze C-N 
bond formation between upstream β-ketoacyl-S-ACP and downstream aminoacyl-S-
PCP (Figure 1-10B). This aberrant shift in the biosynthesis from PKS to NRPS and 
vice versa requires proper intermodular interaction through linkers for the transfer of 
the growing chain in the assembly line (Li et al., 2010; Richter et al., 2008). There are 
exceptions however, e.g. in the biosynthesis of the PKS/NRPS hybrid molecule 
coranatine, PKS and NRPS modules do not interact. Instead, the peptide and the 
polyketide scaffold are fused by the action of discrete enzyme (Bender et al., 1998; 
Rangaswamy et al., 1998a; Rangaswamy et al., 1998b). 
(A) NRPS/PKS                                               (B) PKS/NRPS 
 
 
 
 
 
Figure 1-10: NRPS and PKS mixed hybrid systems. A, adenylation; PCP, peptidyl carrier 
protein; KS, ketosynthase; AT, acyltransferase; ACP, acyl carrier protein. 
(A) NRPS/PKS hybrid locus where KS mediates decarboxylative condensation between 
upstream aminoacyl-S-PCP and the downstream acyl-S-ACP. 
PKS PKS PKS PKS NRPS NRPS NRPS NRPS 
A2 PCP
S
O
R1
NH2
S
O
KS AT2 ACP
O
HO
R2
C A2 PCP
S
O
R2
NH2
S
O
AT2 ACPA2 PCP
SH S
O
KS AT2 ACP
O
R2
NH2
R1
-CO2
C A2 PCP
S
O
R2
NH
SH
AT2 ACP
O
-H2O
Introduction 
15 
 
(B) PKS/NRPS hybrid locus where C mediates Claisen condensation between upstream 
acyl-S-ACP and downstream aminoacyl-S-PCP. 
1.6 Nonribosomal peptide and polyketide release mechanisms 
The release of a completely assembled chain from the biosynthetic machinery is 
catalyzed either by the action of TE or reductase (R) domains (Du and Lou, 2010; 
Kopp and Marahiel, 2007). In the TE mediated chain release mechanism, the full 
length peptidyl(acyl)-S-CP intermediate is transferred to the -OH group of the active 
site serine residue in TE (Fischerbach and Walsh, 2006). Depending on the nature of 
the TE the C-terminal carbonyl carbon of peptidyl(acyl)-O-TE intermediate is attacked 
either by an external or internal nucleophile resulting in linear or cyclic structures. 
Hydrolysis of peptidyl(acyl)-O-TE releases the assembled chain as a linear acid 
(Figure 1-11, Figure 1-12A). In an intramolecular cyclization reaction, a hydroxyl or 
an amino group of the peptidyl(acyl) chain acts as nucleophile yielding macrolactone 
or macrolactam rings, respectively (Figure 1-11, Figure 1-12B) (Kopp and Marahiel, 
2007). In addition to the above, TE domains observed in enterobactin and gramicidin 
synthetase catalyze cyclooligomerization of peptidyl(acyl) chains (Figure 1-12C) 
(Kratzschmar et al., 1989; Rusnak et al., 1991). TE domains that catalyze hydrolytic 
release or cyclization can be deciphered from the gene sequences, but TEs that 
catalyze oligomerization cannot be identified on the genetic level. Also the cyclization 
reaction is highly stereo- and regio-specific, which cannot be determined from the 
respective gene sequences (Kopp and Marahiel, 2007). 
 
 
 
 
 
Figure 1-11: General mechanism for the release of a chain from the megasynthase 
catalyzed by thioesterase (TE). X represents either of the nucleophiles OH or NH2; R 
represents acyl(peptidyl) chain; CP, carrier proteins. This figure is adapted from Du and Lou, 
2010. 
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(B) Macrocyclization 
 
 
 
 
(C) Cyclooligomerization 
 
 
 
 
 
 
 
Figure 1-12: Examples of nonribosomal peptides and polyketides dissociated from their 
megasynthases by the action of TE through hydrolysis (A), macrocyclization (B) and 
cyclooligomerization (C). Terminal carbonyl thioestered to CP is highlighted in red, whereas 
the nucleophile that attacks the thioestered carbonyl is highlighted in blue. 
In the absence of a TE domain, a R domain may catalyze the reductive release of 
peptidyl(acyl)-S-CP as a linear aldehyde from the megasynthase (Figure 1-13A) 
(Kopp and Marahiel, 2007). As observed in myxochelin A, R domains might also act 
iteratively thereby reducing the aldehyde to an alcohol (Figure 1-13B) (Gaitatzis et 
al., 2001). Recently, a variant of the R domain called Dieckmann type R domain was 
identified in PKS/NRPS hybrid gene clusters such as tenellin and equisetin 
synthetase (Figure 1-13D). Instead of reduction, this variant catalyzes Dieckmann 
OO
O
O
OH
N
S
OH
Epothilone B 
Rifamycin 
H
N
O
HO
OHO
O
OCH3
O
O
OH OH
O
Enterobactin 
OH
OH
H
N
O
O
O
NH
OO
O
OH
OH
HN
O
O
O
HO
HO
(A) Hydrolysis 
Ambruticin J 
O
OH OH
HO
O
Introduction 
17 
 
cyclization (Figure 1-13C) (Sims and Schmidt, 2008). This variant can be 
distinguished from the R domain by its amino acid sequence and a conserved 
aspartate residue (D3803) (Liu and Walsh, 2009).  
(A) Reductive release                                                 (C) Dieckmann cyclization                 
 
 
 
 
(B) Example for reductive release                         (D) Example for Dieckmann cyclization 
 
 
 
 
Figure 1-13: Reductase (R) domain release mechanism. 
(A) Reductive release of the growing chain as an aldehyde or alcohol by the action of a 
reductase (R) domain. NADH-nicotinamide dinucleotide; NADPH-nicotinamide dinucleotide 
phosphate 
(B) Reductively released myxalamide A as an alcohol.  
(C) Release of the peptide-polyketide hybrid by R domain variant R* via Dieckmann 
cyclization. 
(D) Equisetin dissociated from equisetin synthetase via Dieckmann cyclization. 
These figures are adapted from Du and Lou, 2010. 
Biosynthetic gene clusters without TE or R domain were reported to mediate the 
chain release by alternate mechanisms. However, with the identification of more PKS 
and/or NRPS gene clusters without any specialized domains for release, new chain 
release mechanisms will continue to emerge (Du and Lou, 2010).  
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1.7 Post-assembly tailoring reactions 
Many of the nonribosomal peptides and polyketides undergo further modifications 
such as glycosylation, methylation, halogenation and oxidation after their release 
from the respective megasynthases (Figure 1-14) (Samel et al., 2008; Walsh et al., 
2001). These modifications often influence the bioactivity, selectivity and 
pharmacokinetic properties of the molecules (Kopp et al., 2007; Thibodeaux et al., 
2008). For instance, non chlorinated analogue of the antibiotic bahimycin showed 
drastic reduction in their activity (Bister et al., 2003).The genes encoding the 
enzymes glycosyltransferase (GT), MT, halogenase (H), monooxygenase (MO) for 
the modification reactions are often found within the gene cluster (Walsh, 2007). In 
rare cases like chivosazol synthetase, GT acts in trans from a remote location with 
respect to the gene cluster (Perlova et al., 2006). 
 
 
 
 
 
 
Figure 1-14: Examples for post-assembly modification reactions. The addition of a glycosyl 
group by the action of a gylcosyltransferase (GT) is highlighted in red, O-methylation by O-
MT is highlighted in violet, double bond and hydroxylation by the action of a monooxygenase 
is highlighted in pink.  
1.8 Primary structure determinants in NRPS and PKS 
1.8.1 NRPSs ‘A’ domains 
The A domain in NRPS modules determines the specific amino acid that has to be 
incorporated into the nonribosomal peptide. This domain activates the amino acid as 
aminoacyl-AMP for its loading on to the PPant arm of PCP domain. Detailed studies 
on the 3D structure of a phenylalanyl-AMP bound A domain, i.e PheA of gramicidin 
synthetase (GrsA) revealed ten residues at positions 235, 236, 239, 278, 299, 301, 
322, 330, 331 and 517 that are present in the conserved motifs A3 to A7 and A10 
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make direct contact to phenylalanine (Figure 1-15) (Conti et al., 1997; Lautru and 
Challis 2004). These ten residues that are critical for the substrate binding, control 
the entry of the specific substrate and are called as the ‘Stachelhaus code’ or 
‘nonribosomal code’. Sequence alignments of the characterized A domains with GrsA 
synthetase enabled the extraction of the Stachelhaus code pointing towards the 
respective substrates (Challis et al., 2000; Stachelhaus et al., 1999). This in turn 
facilitates the identification of substrates for an uncharacterized A domain from its 
Stachelhaus code. Domain identification and substrate prediction lays the foundation 
for predicting a nonribosomal peptide structure from the respective genes.  
(A)                                                          (B) 
 
Figure 1-15: Adenylation (A) domain: the structure determinant in NRPS. 
(A) Structure of the L-Phe-activating domain (PheA) of the gramicidin S synthetase GrsA, 
with an enlargement of the L-Phe-binding pocket showing the residues of PheA making 
contact with L-Phe. The side chains of these residues and the substrate L-Phe are rendered 
in ball and stick representation. This figure is reproduced from Lautru and Challis, 2004. 
(B) Two dimensional representation of L-Phe binding pocket in PheA of gramicidin S 
synthetase GrsA. Residue colours indicate its nature; red-acidic; blue-basic; yellow-neutral 
polar; gray-hydrophobic. This figure is reproduced from Challis et al., 2000. 
1.8.2 PKSs AT domains 
Unlike the A domains, the AT domains of PKS selectively catalyze the transfer of acyl 
groups from acyl-CoA to the PPant arms attached to the active site serine of the ACP 
domains (Hertweck, 2009). Extensive analysis of E. coli FAS AT and 6-
deoxyerythronolide B synthase (DEBS) AT crystal structures has identified four 
signature motifs that govern substrate specificity (Smith and Tsai, 2007; Tsai and 
Ames, 2009). The AT structure includes two domains: a larger core subdomain and a 
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smaller subdomain. The catalytically active serine (GHSXG) in motif-2 lies in the cleft 
formed between these two subdomains. Motif-1 and -3 which is 30 and 100 residues 
upstream and downstream  to the active site serine lies on both sides of the catalytic 
cleft (Figure 1-16). Therefore, changes in these motifs affect size and shape of the 
substrate binding pocket. As per mutational studies in DEBS AT domains the motif-3 
is dominant in determining the substrates. Furthermore, α-β-α motif-4, a 
hypervariable region at the C-terminus has been identified to be important in 
recognizing the specific substrate. But based on amino acid sequence in this region 
to date no possible prediction about the substrates was made yet (Smith and Tsai, 
2007; Tsai and Ames, 2009). However, consensus sequences in motif-1, -2 and -3 
have been categorized between the extender units, malonyl and methylmalonyl-CoA. 
But a general pattern in identifying AT domains selecting unusual extenders and 
different starters is not yet fully developed. Furthermore, in AT domains selecting 
dicarboxylic acids a conserved arginine at position 117 is necessary for interacting 
with the C3 carboxylate oxygen, whereas a nonpolar amino acid is usually observed 
at this position in case of monocarboxylic acid substrates (Smith and Tsai, 2007; Tsai 
and Ames, 2009). In contrast to the NRPS A domains, prediction of especially the 
unusual substrates from PKS AT domains is not straightforward and cannot be done 
with accuracy. 
(A)                                      (B) 
 
Figure 1-16: Acyl transferase (AT) domain, the structure determinant of PKS.  
(A) Overall fold of AT domains (large core subdomain (A) in grey, small subdomain (B) in 
black), and the four substrate motifs. Motif-1 in red, motif-2 in green, motif-3 with serine in 
purple, and motif-4 in blue. This figure is reproduced from Tsai and Ames, 2009. 
Motif Malonyl-CoA Methylmalonyl-CoA 
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(B) Consensus sequence of motif-1, -2 and -3 in malonyl- and methylmalonyl-specific AT 
domains.  
1.8.3 Stereochemistry of the natural product deduced from NRPS and PKS 
sequences 
NRPS and PKS generate molecules with a vast diversity concerning the structural 
template and its stereochemistry. Analogous to the prediction of structure backbones, 
the stereochemistry implemented by NRPS and PKS assembly lines can be 
predicted to a certain extent.  
1.8.3.1 Stereospecificity of C domains in NRPS 
In NRPS, D-amino acids are often formed by the action of E or dual C domains. 
However, the successful incorporation of these D-amino acids into the assembly is 
done by the stereo-specific C domains (Schwarzer et al., 2003). The C domain has 
two binding sites; one for the electrophilic donor, i.e upstream aminoacyl(peptidyl)-S-
PCP and the other for the nucleophilic acceptor, i.e downstream aminoacyl-S-PCP, 
respectively (Figure 1-17) (Finking and Marahiel, 2004). Since both binding sites 
exhibit strong stereoselectivity (L- or D-amino acid), conserved residues driving the 
stereospecificty of C domains are observed in these binding sites. Based on this, C 
domains that are specific for D configured upstream donor and L configured 
downstream acceptor are classified as DCL domain, whereas domains that are 
specific for L configured donor and acceptor are termed as LCL domains (Rausch et 
al., 2007). From around 300 C domain amino acid sequences, the residues that differ 
among LCL and 
DCL domains were proposed. Especially a moderately conserved 
motif LPxDxxRP is usually observed in LCL domain at the N-terminus (Rausch et al., 
2007). 
 
 
 
 
 
SS* R2
NH2H2N
R1
O O
DCL
A2
PCPPCP
E
SS* R3
NH2HN
R2
O O
A3
PCPPCP
A2
PCP
E
HS
O
R1
NH2
*
DCL
LCLA3
PCP
LCL
S
O
H2N
R3
*
Module-1 
Module-3 
Module-2 
Module-3 Module-2 Module-1 
Introduction 
22 
 
Figure 1-17: General mechanism of condensation (C) domains. The white pockets in the C 
domains are the acceptor and donor sites where the electrophilic donor and the nucleophilic 
acceptor, respectively accommodate for the condensation reaction. The acceptor site is 
marked with an asterisk. The prefix and suffix of the C domain, i.e LCL and 
DCL  indicates the 
specificity of the acceptor and donor sites, respectively for the L- or D- configured residue. A, 
adenylation; PCP, peptidyl carrier protein. This figure is adapted from Finking and Marahiel, 
2004. 
1.8.3.2 Stereospecificity of KR domains in PKS 
The significant feature of polyketides is the presence of methyl-, hydroxyl- and 
double bond stereogenic centres. The KR domain catalyzes the reduction of β-
ketoacyl-S-ACP with the aid of NADPH to β-hydroxyacyl-S-ACP generating either D-
hydroxy or L-hydroxy intermediates (Caffrey, 2003). This variation in hydroxyl 
stereochemistry is due to a difference in the binding orientation of the substrate to the 
KR active site. This change in orientation is guided by the change in the amino acid 
sequences. A KR which generates L-β-hydroxacyl-S-ACP has a conserved 
tryptophan residue. This type of KR is termed as A-type KR.  In the B-type KR, which 
generates D-β-hydroxacyl-S-ACP, a conserved leucine-aspartate-aspartate (LDD) 
motif is observed (Kwan and Schulz, 2011; Valenzano et al., 2009) (Figure1-18)  
In addition to hydroxyl stereochemistry, KR guides the epimerization of α-methyl 
substituents of β-ketoacyl-S-ACP. Based on tylosin synthase KR crystal structure, 
conserved residues are observed to participate in the epimerization of α-methyl 
group in β-ketoacyl-S-ACP intermediates (Kwan and Schulz, 2011; Valenzano et al., 
2009). Based on the configuration of α-methyl group, A- and B-type KRs are further 
subdivided into A1, A2, B2 and B2, where 1 refers to D-isomer and 2 refers to L- 
configuration.  
KRs without NADPH binding site are often considered inactive and thereby proposed 
to be skipped during biosynthesis. But in narbonolide synthase, one of the KR 
domains that lacks the NADPH binding motif, but with the catalytically active triad 
lysine-serine-tyrosine was observed to catalyze the epimerization of an α-methyl 
group (Figure-1.8A) (Zheng and Keatinge-Clay, 2011). This type of KRs without 
NADPH binding motif but able to perform the epimerization of α-methyl are termed as 
C2-type.The KRs that are inactive lacking in both NADPH binding site and catalytic 
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active residues are referred as C1-type KR (Figure-1.8B) (Zheng and Keatinge-Clay, 
2011). 
(A) 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
 
Figure 1-18:  Stereochemistry of ketoreductase (KR) domain. 
(A) Stereochemistries concerning α-methyl and β-hydroxy group imposed by KR domains.  
(B) Based on the conserved residues present, KRs catalyze the epimerization of ACP bound 
β-ketoacyl intermediates. Residues that differentiate A- and B-type KRs are highlighted in 
bold italics. This table is based on Zhen and Keatinge-Clay, 2011. 
 
 
KR-type Conserved residues 
KR-A1 Trp141 
KR-A2 Trp141, His146 
KR-B1 Leu93, Asp94, Asp95,Pro144, Asn 148 
KR-B2 Leu93, Asp94, Asp95,Pro144, Asn 148,Pro151 
KR-C1 None (Catalytic active residues are also absent) 
KR-C2 None but possess the catalytic active triad for KRs 
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1.8.3.3 Stereospecificity of ER domains in PKS 
The stereochemistry of an α-methyl moiety is also reflected in the amino acid 
sequences of ER domains. Swapping the domains combined with site directed 
mutagenesis studies showed conserved residues necessary for the epimerization of 
an α-methyl group (Table 1-2) (Kwan and Leadlay, 2010). Similar to KR, ERs with L- 
and D-configured α-methyl are termed as ER1 and ER2, respectively (Zheng and 
Keatinge-Clay, 2011). Thus, the stereochemistry of polyketides especially α-methyl 
groups is suggested to be determined by the combined action of KR and ER 
domains.   
ER-type Conserved residues 
ER1 Leu46, Ile47, Tyr52, Pro53 
ER2 Val46, Val47, Val52 
Table 1-2: Stereochemistries concerning the α-methyl groups imposed by an ER domain. 
This table is based on Zhen and Keatinge-Clay, 2011. 
The identification of domains, their substrates and the resulting stereochemistry 
would enable the prediction of the encoded putative structures. This would indeed 
also facilitate the identification of the respective biosynthetic genes from the structure 
investigated. The stereochemistry of chivosazol and etnangien was first in silico 
predicted, and later it was found to be indeed in agreement with the chemically 
elucidated structures (Menche et al., 2008; Perlova et al., 2006). 
1.9 Challenges in genes to structure prediction 
The structure prediction from genes is done by considering the ‘co-linearity’ between 
the number of modules and the number of building blocks. But the megasynthases 
are not always constructed in a straightforward way and vary in their organization 
and functionality (Haynes and Kallis, 2007; Mootz et al., 2002; Schwarzer et al, 
2003).  
The classical type NRPS displays a co-linearity between structure and modular 
assembly and is termed linear or type-A NRPS. This type-A NRPS is more common 
and the product normally predictable from the genes.  In enterobactin synthetase the 
TE domain catalyzes the iterative action of modules for the assembly of enterobactin, 
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i.e. oligomerization (Kratzschamer et al., 1989). These types of NRPSs are termed 
as iterative or type-B NRPS. Since the iterative mechanism guided by the TE domain 
is not yet predictable from the primary genetic structure, type-B NRPS cannot be 
identified from genes. Another, however rare type of NRPS exists, where domains 
are organized in a manner different from that of the linear or type-A NRPS. These are 
the non-linear or type-C NRPS (Haynes and Kallis, 2007; Mootz et al., 2002; 
Schwarzer et al, 2003). In type-C NRPS, the unusual arrangement of domains is 
readily identifiable from the genes, but the order of the reactions is not easy to 
predict. 
Similar to NRPS, ‘non-canonical’ PKSs were found and they are far more 
complicated than NRPSs (Hertweck 2009; Li and Müller, 2009). Type-I PKS with 
large multi-modular assemblies are subdivided into two types: Linear type-I PKS 
where the catalytic domains are used only once in a co-linear fashion, and iterative 
type-I PKS where the catalytic domains are used more than once (Fischbach and 
Walsh, 2006; Schumann and Hertweck, 2006). Since, the iterative action cannot be 
predicted form gene sequences, only very preliminary product structures of linear 
type-I PKS can be determined. In Type-II PKS, the required catalytic domains are 
encoded as discrete proteins. These proteins must interact to form a functional PKS 
enzyme complex, where the catalytic active sites are used either once or iteratively 
(Brachmann et al., 2007; Sandmann et al., 2007). As the order of extensions is hard 
to predict from the sequences, type II PKS can only be identified on the genetic level 
but not the structure of the product. Type-III PKS are small dimeric proteins that 
catalyze iterative condensations of malonyl-CoA and are independent of an ACP 
domain for the assembly (Moore and Hopke, 2001). Again the iterative action cannot 
be predicted from the sequence.  
1.10 The ‘era’ of genome mining 
The search for new compounds from natural resources employed for a long time a 
bioactivity or chemistry-guided approach, whereby bioassays or spectroscopic 
methods accompanied the isolation process. Once the structure of the pure 
metabolite was elucidated, its biosynthesis was delineated on the biochemical and 
often also on the genetic level. These investigations gave insight into the 
organisation of biosynthetic machineries like those for nonribosomal peptides and 
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polyketides. Comparative analyses of NRPS and PKS genes and enzymes of known 
compounds facilitated the identification of consensus motifs indicative for the 
enzymatic activity of the encoded protein, e.g. based on the so called Stachelhaus 
code it is possible to predict the substrate likely to be selected by the A domain of an 
NRPS module (Challis et al., 2000; Stachelhaus et al., 1999). 
In the 1990’s bacterial genome sequencing commenced, which gave, apart from a 
deeper insight into bacterial metabolism and possible antibiotic drug targets, a 
detailed understanding of natural products biosynthesis. These genomes together 
with the knowledge on biosynthetic genes added a new dimension to natural product 
research. The analysis of the genome of Streptomyces coelicholor A3(2) revealed 
the presence of biosynthetic genes over-representing the number of isolated 
compounds. In total 22 biosynthetic gene clusters were identified, however only four 
products namely prodiginines, actinorhodin, Calcium-dependent antibiotic (CDA) 
lipopeptide and a pigment  had been isolated before (Lautru et al., 2005). An NRPS 
system with genes required for the synthesis of a peptidic siderophore was the first 
structure predicted from this genome sequence (Challis and Ravel, 2000). The 
cultivation of S. coelicholor A3(2) in an iron depletion medium resulted in the isolation 
of this siderophore, which is a tetrapeptide named coelichelin(Lautru et al., 2005). 
This finding resulting from genome mining has accelerated the search for new 
biosynthetic pathways in other sequenced genomes, and resulted in new biosynthetic 
pathways not only in Streptomyces, but also in other taxa including cyanobacteria, 
myxobacteria, bacilli (Challis, 2008; Corre and Challis, 2009; Lanen and Shen, 2006; 
Winter et al., 2011) New biosynthetic gene clusters were even found in well studied 
groups of fungi and plants (Bergmann et al, 2007; Bok et al., 2006; Fazio et al., 
2004). 
1.11 Exploiting the power of genomes 
A prerequisite for searching genomes for biosynthetic genes are powerful genome 
mining tools, which in many cases also allow to predict the chemical nature of the 
product of an identified biosynthetic pathway (Corre and Chalis, 2007). There are 
several bioinformatic tools developed for the identification of modular genes from 
gene sequences including CLUSEAN (Weber et al., 2009), PKS/NRPS analysis 
(Bachmann and Ravel, 2005) and NRPS-PKS database (Yadav et al., 2003). Multiple 
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sequence alignment of the PKS AT domains enables the prediction of their 
respective substrates to a certain extent. Unlike AT domains, special programs like 
NRPSpredictor (Rausch et al., 2005) and NRPSpredictor2 (Rottig et al., 2011) has 
been developed to identify the A domain substrates. Using these tools, many gene 
clusters are identified from the genomes, but the corresponding metabolites for many 
of these gene clusters, then called cryptic gene clusters, are not yet isolated from the 
producer. Partly they were overlooked before, due to their presence in very low 
amounts, thereby escaping the traditional screening methods, or expression of the 
biosynthetic genes does not take place under laboratory conditions. 
There are different strategies, some of which are complementary, for the detection 
and isolation of the products of cryptic gene clusters (Figure 1-19).  A more traditional 
approach includes the variation of culture conditions (temperature, media, cultivation 
vessel etc.) in order to induce the expression of the desired biosynthetic pathway 
[called “One Strain Many Compounds Approach, OSMAC”] (Christian et al., 2005; 
Cueto et al., 2001). Compounds, whose proposed structure suggests special 
physiochemical properties, i.e. UV maxima, NMR resonance signals, may be 
detected by making use of these features (Zazopoulos et al., 2003). Feeding of one 
of the predicted building blocks, e.g. isotopically labeled (15N or 15N-13C) amino acids 
during cultivation has been shown to ease the isolation procedures by tracing the 
metabolites through selective NMR experiments. The latter was termed 
genomisotopic approach and has been utilized to isolate metabolites like orfamide 
(Gross et al., 2007). A further possibility is the inactivation of the respective gene 
cluster and subsequent comparison of the metabolic profile between the wild type 
and the mutant strains. This should clearly identify the respective compound. In case 
of silent gene clusters, the genes involved in the biosynthesis of a putative compound 
may be transformed from the parent strain and expressed in another, possibly 
optimized host (Wenzel and Müller, 2005). Still another alternative approach is in-
vitro reconstitution of the genes and their expression in a heterologous host 
(Synthetic biology) (Meier and Burkhart, 2009). Also, recombinant biosynthetic 
proteins can be incubated with their appropriate substrate and the resultant 
compound is then analyzed further (McClerren et al., 2006). A good option for silent 
gene clusters is also, to access the regulatory genes thereby activating the 
transcription of the biosynthetic gene cluster (Bok et al., 2006; Chiang et al., 2011).  
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Figure 1-19: Genome mining tools. OSMAC: One strain many compounds. The circular 
chromosome of H. aurantiacus DSM 785 is reproduced from Kiss et al., 2011. 
1.12 Genome mining in gliding bacteria 
Cyanobacteria have been researched intensely for the isolation of secondary 
metabolites and are still being considered as a potential source for new secondary 
metabolites. Genome mining of Trichodesmium erythraeum IMS101 revealed a 
biosynthetic gene cluster encoding for a novel ribosomal peptide. Subsequent 
cultivation of the bacterium resulted in the isolation of a cyclic peptide, trichamide 
(Figure 1-20). Indeed this was the first compound known from T. erythraeum (Sudek 
et al., 2006). In addition to this three PKS, two NRPS and a PKS/NRPS hybrid cryptic 
gene loci were identified from this genome (Kalaitzis et al., 2009).  Nostoc 
punctiforme PCC7120 with a genome of 9 Mb in size contributes 3.1% of its genome 
for the biosynthesis of polyketides and nonribosomal peptides (Kalatzis et al., 2009). 
Thus, N. punctiforme has been identified as the most prolific natural product producer 
among other sequenced cyanobacteria. In total, 23 PKS and/or NRPS gene loci were 
identified with a majority of them belonging to PKS/NRPS hybrid systems. A 
PKS/NRPS hybrid gene cluster has been reported to encode for nostopeptolide 
biosynthesis (Kalatzis et al., 2009). Anabaena variabilis ATCC29413 and Nostoc sp. 
PCC7120 each with a genome of 7 Mb has 2.2% and 1.3% PKS and NRPS genes. 
All 24 gene loci identified from An. variabilis ATCC29413 and Nostoc sp. PCC7120 
were unknown and thus they are cryptic gene clusters (Kalatzis et al., 2009; Donadio 
OSMAC 
In-vitro reconstitution 
Heterologous expression 
   Structural features 
Gene knockout 
Genomisotopic approach 
Manipulating regulatory 
genes 
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et al., 2007)). Synechocystis sp. PCC6803 which is genetically feasible and easily 
culturable has already been manipulated for its use as a heterologous host (Roberts 
et al., 2009). This recombinant strain is useful for the expression of cryptic gene 
clusters from other cyanobacteria. 
Myxobacteria are well known producers of unprecedented structues with biological 
properties (Wenzel and Müller, 2007; Wenzel and Müller, 2009a). The genome 
sequences of Myxococcus xanthus DK 1622, Sorangium cellulosum So ce 56 and 
Stigmatella aurantiaca DW4/3-1 and three Anaeromyxobacter species 
(Anaeromyxobacter dehalogenans 2CP-1, Anaeromyxobacter sp. K, 
Anaeromyxobacter sp. FW 109-5) were analysed in order to gain further insight into 
the potential metabolic profile of the respective bacterial strains (Wenzel and Müller, 
2009b). The genomes of Anaeromyxobacter species comprise approximately 5 Mb 
and were reported to be devoid of PKS and NRPS genes, and indeed so far no 
secondary metabolites are reported from the latter (Wenzel and Müller, 2009b). For 
So. cellulosum Soce56, M. xanthus DK1622 and Sg. aurantiaca DW4/3-1 
biosynthetic genes for specific natural products were already annotated (Gerth et al., 
2003; Schneiker et al., 2007; Silakowski et al., 2001; Pradella et al., 2002; Wenzel 
and Müller, 2009b). 
M. xanthus DK1622 which was not known for secondary metabolites (although 
natural products had been obtained from other M. xanthus strains), was the first 
myxobacterium to have its genome sequenced. A genome size of 9.14 Mb urged to 
scan it for the presence of biosynthetic genes, since large genomes correlate often 
with the potential for secondary metabolite production. The sequences revealed 
almost 8.6% of the genome to possibly be involved in the biosynthesis of secondary 
metabolites (Krug et al., 2008). Mining the genome for the presence of PKS and 
NRPS genes exposed 19 biosynthetic clusters, with a predominance of PKS/NRPS 
hybrid gene clusters. Five of these gene clusters were related to known 
myxobacterial metabolites, i.e. myxochelin A, myxovirescin, myxochromide, 
DKxanthenes and myxalamide. Recently, myxoprincomide a novel peptide/polyketide 
hybrid product was identified by gene inactivation studies (Figure-1.20). Due to the 
production of myxoprincomide in low amounts, the compound was successfully 
isolated from another producer strain (Cortina et a., 2011). 
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So. cellulosum 56 harbors the biggest genome amongst bacteria comprising about 
13Mb (Pradella et al., 2002). Since the genus Sorangium is noted for the production 
of secondary metabolites (Gerth et al., 2003), the remarkable genome size of So. 
cellulosum 56 is not surprising (Schneiker et al. 2007). The genome harbours four 
hybrid PKS/NRPS cluster, one of which being extraordinary huge in size (92.4 kb), 
and two NRPS as well as three PKS cluster. The products of three of these clusters 
were attributed to the compounds chivosazole A, myxochelin B and etnangien 
already isolated from So. cellulosum. The putative structures encoded by the rest of 
the cryptic gene clusters were already predicted and reported (Schneiker et al., 
2007). Furthermore, two type III PKS gene loci were reported from the genome. 
Flaviolin was already isolated by expressing of one of the type III PKS genes in 
Pseudomonas putida (Li and Müller, 2009) (Figure 1-20) 
Sg. aurantiaca DW4/3-1 with a genome of 10.3 Mb in size is known for the 
production of several metabolites namely, myxochelin B, myxochromide S1-S3, 
myxothiazol A, DKxanthenes, aurafuron and dawenol. In addition, the genome 
sequences revealed four NRPS, four PKS and four PKS/NRPS hybrid cryptic gene 
clusters. Except dawenol, other compounds were identified and isolated based on 
the genetic information (Kunze et al., 2005; Meiser et al., 2008; Wenzel and Müller, 
2009b) (Figure -1.20)  
Chitinophaga  pinensis DSM 2588, the first organism to be completely sequenced in 
the family Chitinophagacae harbors a genome of 9.1 Mb in size. From the genome 
sequence, a PKS gene cluster was reported to be responsible for the biosynthesis of 
novel polyketides, elansolid B1 and D (Teta et al., 2010) (Figure-1.20). Additionally, a 
cryptic NRPS gene cluster was also reported from the genome sequence (Teta et al., 
2010). 
Flavobacterium  johnsoniae from the phylum Bacteroidetes is noted for its ability to 
utilize chitin, cellulose and lignin. From the 6.1 Mb genome sequence of F. 
johnsoniae UW-101, an NRPS gene cluster spanning approximately 70.7 Kb was 
already described. A peptidic structure was predicted fitting the architechture of the 
14 NRPS modules but the peptide is not yet isolated (McBride et al., 2009). 
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Figure 1-20: Genes to products. Compounds identified from the genomes of gliding bacteria. 
Mode of identification or isolation from culture extracts are indicated in italics.  
Thus, with the advancement in genomics the genetically encoded biosynthetic 
potential of gliding bacteria becomes even more evident, and bacteria which have not 
been completely or not at all explored can be considered for chemical investigation 
based on genomic data. Especially the gene clusters encoding enzymes for the 
biosynthesis of nonribosomal peptides and polyketides are in most cases readily 
identified from genome sequences (Donadio et al., 2007).  
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2. Scope of the project 
The advancement in the computational tools and comprehensive knowledge in 
nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) modular 
genes has been instrumental in the identification of new biosynthetic gene clusters 
from genomes. These biosynthetic clusters are often cryptic, i.e. associated with as 
yet unknown compounds. Thus, this approach called “genome mining” can be 
applied for the discovery of natural products useful for drug development. 
Gliding bacteria, which are known for their complex life style, include the chemically 
prolific myxobacteria and cyanobacteria. Other bacterial taxa in this group are hardly 
investigated for their chemistry. Therefore, the first part of this project aimed to 
evaluate 18 completely sequenced gliding bacterial genomes from the phyla 
Chloroflexi, Firmicutes, Bacteroidetes, Planctomycetes, Chlorobi and Proteobacteria 
for the presence of PKS and NRPS genes.  
The focus of the second part of the study was a detailed investigation of the complete 
genome sequence of the chemically unexplored Herpetosiphon aurantiacus DSM 
785 for PKS and NRPS gene clusters. Information on sequences of cryptic gene 
clusters and their encoded putative structures were to be used to optimize the 
conditions for the isolation of secondary metabolites from this bacterium.  
In the last part of this study, PKS/NRPS gene locus-1 from H. aurantiacus was to be 
characterized in detail. Emphasis was to be put on the adenylation domains, an 
integral component of NRPS, which control the entry of amino acid building blocks. 
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3. Materials and methods 
3.1 Materials 
3.1.1 Chemicals and solvents 
Chemicals Manufacturer 
4-hydroxyphenylglycine Sigma Aldrich (Germany) 
Acetic acid 
KMF Laborchemie Handels GmbH (Darmstadt, 
Germany) 
Aceton-d 99.8% D Deutero GmbH (Kastellaun, Germany) 
Acetonitrile VWR International GmbH (Darmstadt, Germany) 
Agar Fluka Chemie GmbH (Buchs, Switzerland) 
Ammonium acetate Roth Chemie GmbH (Karlsruhe, Germany) 
Ammonium per sulfate Roth Chemie GmbH (Karlsruhe, Germany) 
Bacto™ Casitone Becton, Dickinson and Company (Franklin Lakes, NJ, 
USA) 
Bis-acrylamide Roth Chemie GmbH (Karlsruhe, Germany) 
Boric acid Roth Chemie GmbH (Karlsruhe, Germany) 
Brilliant Blau R 250 Roth Chemie GmbH (Karlsruhe, Germany) 
CaCl2 × 2 H2O Merck KGaA (Darmstadt, Germany) 
Chloroform Roth Chemie GmbH (Karlsruhe, Germany) 
DMSO Roth Chemie GmbH (Karlsruhe, Germany) 
dNTPs Promega GmbH (Mannheim, Germany) 
Ethanol 99,8% p.a. Roth Chemie GmbH (Karlsruhe, Germany) 
Ethidium bromide Roth Chemie GmbH (Karlsruhe, Germany) 
Ethyl acetate Julius Hoesch GmbH & Co. KG (Düren, Germany) 
Gel loading dye (6x) Fermentas GmbH (St. Leon Rot, Germany) 
Glycerol Roth Chemie GmbH (Karlsruhe, Germany) 
Imidazole Roth Chemie GmbH (Karlsruhe, Germany) 
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Isopropanol Roth Chemie GmbH (Karlsruhe, Germany) 
Isovanillic acid Alfa Aesar (Ward Hill, MA, USA) 
Methanol Merck KGaA (Darmstadt, Germany) 
MgCl2 × 6 H2O Merck KGaA (Darmstadt, Germany) 
MgSO4 x 7 H2O Merck KGaA (Darmstadt, Germany) 
Na2-EDTA Roth Chemie GmbH (Karlsruhe, Germany) 
Na-acetate Merck KGaA (Darmstadt, Germany) 
NaCl Merck KGaA (Darmstadt, Germany) 
NaOH Merck KGaA (Darmstadt, Germany) 
Ni-NTA agarose Qiagen GmbH (Hilden, Germany) 
peqGOLD Agarose PEQLAB Biotechnologie GMBH (Erlangen, Germany) 
Phenol Merck KGaA (Darmstadt, Germany) 
Polygoprep 60 Macherey-Nagel (Germany) 
Roti-Load1 4x Konz Roth Chemie GmbH (Karlsruhe, Germany) 
SDS Roth Chemie GmbH (Karlsruhe, Germany) 
Sephadex LH-20 Pharmacia Biotech (Sweden) 
Silica gel 60 Merck KgaA (Darmstadt, Germany) 
Sorbitol Roth Chemie GmbH (Karlsruhe, Germany) 
Trifluoracetic acid Roth Chemie GmbH (Karlsruhe, Germany) 
Tris Roth Chemie GmbH (Karlsruhe, Germany) 
Tris-HCl Roth Chemie GmbH (Karlsruhe, Germany) 
Tryptone Roth Chemie GmbH (Karlsruhe, Germany) 
Yeast extract Fluka Chemie GmbH (Buchs, Switzerland) 
Table 3-1: List of chemicals used in this work. 
Deuterated solvents used for NMR measurements were obtained from Deutero 
GmbH (Kastellaum, Germany). Acetone, chloroform, dichloromethane, ethyl acetate 
and methanol were distilled prior to use. Ultra-pure water for HPLC and molecular 
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biology experiments was obtained from Milli-Q Academic Water Purification System 
(Millipore GmbH, Germany). All amino acids used in this study were either from 
Merck KGaA (Darmstadt, Germany), Sigma Aldrich (Germany) or Roth Chemie 
GmbH (Karlsruhe, Germany). 
3.1.2 Antibiotics 
Antibiotic Manufacturer 
Ampicillin  Roth Chemie GmbH (Karlsruhe, Germany) 
Gentamycin  Fluka Chemie GmbH (Buchs, Switzerland)  
Kanamycin  Sigma-Aldrich Co. LLC (St. Louis, MO, USA)  
Streptomycin  Sigma-Aldrich Co. LLC (St. Louis, MO, USA)  
Table 3-2: List of antibiotics used in this study 
3.1.3 Enzymes 
Enzyme Manufacturer 
GoTaq Flexi DNA Polymerase  Promega (Mannheim, Germany)  
Pfu DNA Polymerase Fermentas GmbH (St. Leon-Rot, Germany) 
Lysozyme  Roth (Karlsruhe, Germany)  
Proteinase K  Roth (Karlsruhe, Germany)  
Restriction enzymes  Fermentas GmbH (St. Leon-Rot, Germany)  
RNase (DNase free)  Roth Promega (Mannheim, Germany)  
DNase Fermentas GmbH (St. Leon-Rot, Germany) 
T4 DNA-ligase  Fermentas GmbH (St. Leon-Rot, Germany)  
Table 3-3: List of enzymes used in this study 
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3.1.4 Kits and Standards 
Article Manufacturer 
DNA Clean & ConcentratorTM  
Zymo Research Corporation (Irvine, USA)  
Gene RulerTM 1kb plus DNA ladder  Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM 50bp DNA ladder  Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM DNA Ladder Mix  Fermentas GmbH (St. Leon-Rot, Germany)  
Gene RulerTM high range DNA ladder  Fermentas GmbH (St. Leon-Rot, Germany)  
PureYieldTM Plasmid Miniprep System  Promega (Mannheim, Germany)  
QIAGEN Plasmid Maxi Kit  Qiagen GmbH (Hilden, Germany)  
QIAGEN Plasmid Midi Kit  Qiagen GmbH (Hilden, Germany)  
QIAprep Spin Miniprep Kit  Qiagen GmbH (Hilden, Germany)  
QIAquick Gel Extraction Kit  Qiagen GmbH (Hilden, Germany)  
QIAquick PCR Purification Kit  Qiagen GmbH (Hilden, Germany)  
RevertAid H Minus First Strand cDNA 
Synthesis Kit  
Fermentas GmbH (St. Leon-Rot, Germany)  
Unstained Protein Standard Fermentas GmbH (St. Leon-Rot, Germany) 
Wizard SV Gel and PCR Clean-Up 
System  
Promega (Mannheim, Germany)  
Table 3-4: List of kits and standards used in this study 
3.1.5 Solutions for DNA Analysis 
Name Constituents and their amounts 
Buffer P1  50 mM Tris-HCl (pH 8), 10 mM EDTA, 100 μg/mL RNase A  
Buffer P2  200 mM NaOH, 1% SDS  
Buffer P3  3M potassium acetate (pH 5.5)  
Proteinase K 
solution  
1 g Proteinase K was added to 50 ml DNAase/RNAse free water, 
aliquoted and stored at -80°C.  
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RNase Solution  
500 mg RNase was dissolved in 25 ml water and heated for 15 min 
at 95°C. Aliquoted and stored at -80°C.  
TBE (10 x)  0.89 M Tris base, 0.02 M EDTA, 0.87 M boric acid, pH 8.3.  
TE buffer  10mM Tris-HCl (pH 8.0), 1mM EDTA  
Table 3-5: List of buffers and solutions prepared for DNA analysis 
3.1.6 Solutions for Protein Biochemistry 
Table 3-6: List of buffers and solutions prepared for protein analysis 
3.1.7 Media 
Medium Composition 
LB medium  10 g tryptone, 5 g yeast extract, 10 g NaCl in 1 L of water, pH 7.5  
LB agar  10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g Agar, in 1 L of water, 
pH 7.5  
2 x YT medium 16 g tryptone, 10 g yeast extract, 5g NaCl in 1 L of water, pH-7.5 
Name Constituents and their amounts 
Lysis buffer  50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0  
Wash buffer  50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0; for 
more stringent washing 40 mM, 60 mM and 100 mM  imidazole 
were applied  
Elution buffer  50 mM NaH2PO4, 300 mM NaCl, 300 mM imidazole, pH 8.0 
SDS-running buffer 
(10x Laemmli buffer) 
250 mM Tris, 2M glycine, 1% SDS, pH 8.9 
Coomassie staining 
solution  
1.0 g Coomassie Brilliant Blue R-250, 25 ml acetic acid, 200 ml 
methanol and the volume was adjusted to 500 ml with distilled 
water and stored at room temperature. Solution was used more 
than once. 
Coomassie 
destaining solution  
50 ml acetic acid, 150 ml methanol and the solution made up to 
500 ml with water.  
A Domain buffer  20 mM Tris-HCl (pH 7.5), 5% glycerol 
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Trace element  
Solution 
20 mg ZnCl2, 100 mg MnCl2 x 4H2O, 10 mg boric acid, 10 mg CuSO4, 
20 mg CoCl2, 5 mg SnCl2 x 2H2O, 5 mg LiCl, 20 mg KBr, 20 mg KI, 10 
mg Na2MoO4 x 2H2O and 5.2 g Na2-EDTA x 2H2Oin 1 L of water. The 
solution was sterilized by filtration. 
CY medium  3.0 g casiton, 1.36 g CaCl2 x 2 H2O; 1.0 g yeast extract in 1 L of 
water, pH 7.2; after autoclaving add 1 ml filter sterilised trace element 
solution and 1 ml vitamin B12 solution (0.5 mg/ml)  
VY/2 agar  50 ml sterilised baker’s yeast suspension (10%), 1.36 g CaCl2 x 2 
H2O, 15 g agar in 1 L of water, pH 7.2; after autoclaving add 1 ml filter 
sterilised vitamin B12 solution (0.5 mg/ml)  
MD1+G 3 g casitone, 0.7g CaCl2 x 2H2O, 2 g MgSO4 x 7H2O in I L of water. 
The autoclaved medium was then supplemented with 0.2 % glucose 
and sterile filtered cyanocobalamine (0.5 mg/L) and trace element 
solution (1 ml/L) 
HP74 10 g sodium glutamate, 2 g yeast extract, 2 g MgSO4 x 7H2O in 1  of 
water. The autoclaved medium was then supplemented with 1% 
glucose. 
Table 3-7: List of media used for cultivating bacteria in this study 
3.1.8 Organisms 
Organism Genotype Provider 
Herpetosiphon aurantiacus 
DSM 785  
wild type  DSMZ  
XL1-Blue E. coli cells  recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZΔM15 Tn10 
(Tetr)]  
Stratagene (La Jolla, CA, 
USA)  
BL21 (DE3)pLysS  F– ompT gal dcm lon 
hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 
sam7 nin5])  
Invitrogen Life Technologies 
Corporation (Karlsruhe, 
Germany)  
Rosette (DE3)  F- ompT hsdSB(rB
- mB
-) 
gal dcm λ(DE3) pRARE 
(CamR) 
Invitrogen Life Technologies 
Corporation (Karlsruhe, 
Germany)  
ArcticExpress (DE3)  E. coli B F– ompT hsdS 
(rB– mB–) dcm+ Tetr gal 
λ(DE3) endA Hte [cpn10 
cpn60 Gentr] [argU proL 
Strr]  
Agilent Technologies (Santa 
Clara, CA, USA)  
Table 3-8: List of bacteria used in this study 
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3.1.9 Vectors 
Vector  Resistance  Manufacturer  
pET28a(+)  kanamycin  Merck KGaA (Darmstadt, Germany)  
pGEM-T  ampicillin  Promega (Mannheim, Germany)  
pCDF-Duet Streptomycin Dr. Max Crüsemann, Institute for Organic Chemistry, Bonn 
Table 3-9: List of vectors used in this study 
3.1.10 Softwares and databases 
Genome sequences used for analysis in this study were accessed from GenBank 
(http://www.ncbi.nlm.nih.gov). These sequences were then scanned for the presence 
of PKS and NRPS genes (Jenke-Kodama and Dittmann, 2009) using Cluster 
Sequence Analyzer (CLUSEAN). A graphical representation of PKS and NRPS 
domain organization was obtained from amino acid sequences by freely available 
databases such as PKS/NRPS analysis (Bachmann and Ravel, 2009) and 
NRPS/PKS database (Ansari et al., 2004). The specificity of the A domains in an 
NRPS system was identified by a specialized tool called NRPS predictor (Rausch et 
a., 2005) and NRPSpredictor2 (Rottig et al., 2011). The specificity of AT domains 
were analysed based on Yadav et al., (2003) and Smith and Tsai (2007) by mulitiple 
sequence alignment using CLUSTALW (Goujon et al., 2010; Larkin et al., 2007)  with 
similar AT domains obtained from BLAST. All domains including the accessory 
domains were analyzed for their activity by identifiying the catalytically active 
residues in their amino acid sequences by BLAST and CLUSTALW. The nucleotide 
sequences used for cloning experiments were based on the amino acid regions 
specified by Pfam. 
Program 
resource 
Hyperlink Enzymes Ref 
CLUSEAN http://redmine.secondarymetabolites.org/p
rojects/clusean 
NRPS, 
PKS 
Weber et al., 2009 
PKS/NRPS 
analysis 
http://nrps.igs.umaryland.edu/nrps/ NRPS, 
PKS 
Bachmann and Ravel, 
2009 
NRPS/PKS 
database 
http://www.nii.res.in/searchall.html NRPS, 
PKS 
Ansari et al., 2004 
NRPSpredictor http://ab.inf.uni- NRPS Rausch et al., 2005; 
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NRPSPredictor2 
tuebingen.de/toolbox/index.php?view=do
mainpred 
http://nrps.informatik.uni-
tuebingen.de/Controller?cmd=SubmitJob 
Rottig et al., 2011. 
Table 3-10: List of tools used in this study to analyse the genome sequences for PKS and 
NRPS genes. 
3.1.11 Primers 
All primers used in this study were from Eurofins MWG Operon (Ebersberg, 
Germany) as salt free lyophilized water. Once received, the oligonucleotides were 
suspended in sterile water to a concentration of 100 pmol/µl and stored at -20°C. 
Gene locus Primer Sequence (5’-3’) 
Primers for gene expression analysis 
haur_1857 P1 GATCTGAGCAGCCAACAC 
CTGTCAGCACGGCTTTAG 
haur_1858-59 P2 TGTTATAGCACTGATGGCTG 
CTTTGTAATTGGCTGGTTTC 
haur_1860-61 P3 CTTAATTATTCAGGCCGATG 
AGCCACAATTTTATGTCGAG 
haur_1871 P4 CGCCGTGTTGCACTGCCAAT 
AGTTGAAGCTACGCCCGCGA 
haur_1887-88 P5 GCAAATCGCGCAGCATCGCA 
AAACGTGGTGCCCGCCCAAT 
haur_2089 P6 ACGACCAGCCATCAAAAATC 
ATGTCGCATACTTGCAGCAG 
haur_2091 P7 CCCGCTCCAACAATTGAC 
ATGGCTGGTCGATTGGAA 
haur_2108 P8 AGGCTTGCTCACCAAACG 
GATCAGGGCATTGCCAAC 
haur_0810 P9 CTATAACTCGGGCTTGATTG 
CACAATCACAATTTGCTCAC 
Primers for protein expression analysis 
haur_1858-A3 P10 ATTTATGGATCCGGGCTAGTTGGGCGCTTG 
TATATCTCGAGTTAGTGGGGCAACTGTTGGGC 
haur_1859-A4 P11 GATCGTCATATGAGCTACGCCGAGCTTGAT 
ATATTAGAATTCCACCGCCGCCGATTGCAC 
haur_1859-A5 P12 GATCGACATATGAGCTATGCCGAGCTGGAT 
GGCCGCGAATTCTACAACGATTTGCGCAAT 
haur_1857-A2-PCP2 P13 CTCGGGATCCATGCGAAGATTACTCCTTGGC 
GCGGCCGTATACAACATCTCTTTGATCG 
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haur_1858-A3-PCP3 P14 ATTTATGGATCCGGGCTAGTTGGGCGCTTG 
TGTGTCTCGAGTTAAATCGCTTGGGCCAAGCT 
haur_3130-PPT P15 CGTGGTTCCATATGATCCTATGTTCTATG 
AGCTAGCAAGCTTACTCAGCCAAGCCCAG 
haur_2109-mbtH P16 GCGAGTCATATGGTGCAAACAACAGATGAC 
AATTATCTCGAGCTAAGCCGATTGGTTGGC 
Table 3-11: List of primers used in this study. Junk sequences for the purpose of cloning are 
underlined and restriction sites are highlighted in bold. 
3.1.12 Constructed recombinant plasmids  
Construct Plasmid Description 
pLN-A3 pET28a(+)  Haur_1858-A3 amplified from H. aurantiacus 
genomic DNA by P10 primers.  
pLNA4 pET28a(+)  Haur_1859-A4 amplified from H. aurantiacus 
genomic DNA by P11 primers. 
pLNA5 pET28a(+) Haur_1859-A5 amplified from H. aurantiacus 
genomic DNA by P12 primers. 
pLNA3-PCP3 pET28a(+) Haur_1858-A3-PCP3 amplified from H. aurantiacus 
genomic DNA by P14 primers. 
pLNPPT pET28a(+) Haur_3130 amplified from H. aurantiacus genomic 
DNA by P15 primers. 
pLNA2-PCP2 pET28a(+) Haur_1857-A2-PCP2 amplified from H. aurantiacus 
genomic DNA by P13 primers. 
pLN-mbtH pCDF-Duet Haur_2109 amplified from H. aurantiacus genomic 
DNA by P16 primers. 
RP1-9 pGEM-T H. aurantiacus cDNA amplified with respective 
primer pairs P1-P9. 
Table 3-12: List of recombinant plasmids constructed in this study 
3.2 Microbiological methods 
3.2.1 Sterilization 
All microbiology and molecular biology experiments were carried out in a sterile 
environment. To accomplish this, materials and solutions were steam sterilized 
before use by autoclaving at 121°C for 20 min in Varioklav steam sterilizer. In case of 
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heat sensitive solutions such as antibiotics, IPTG and culture media supplements 
sterilization was performed by filtration using 0.22 µm membrane filters. 
3.2.2 Preserving stock cultures 
For long term storage of the Escherichia coli strains, 900 µl of overnight culture was 
mixed with 600 µl of 80% glycerol in a cryovial and stored at -80°C. Herpetosiphon 
aurantiacus DSM 785 stocks were prepared by adding 500 µl of 7 days old liquid 
culture with equal volume of 2% casitone in cryovials and stored at -80°C. 
3.2.3 Cultivation of E. coli 
E. coli cultures were grown aerobically in LB medium in the presence of required 
antibiotic (Table 3-2). Unless described, the cultures were incubated overnight at 
37°C and 180 rpm. The cell density was monitored by measuring the optical density 
at 600 nm (OD600) in UV mini 1240 UV/Vis spectro-photometer.  
3.2.4 Cultivation of H. aurantiacus 
H. aurantiacus was cultivated in order to screen the bacterium for the presence of 
secondary metabolites. To explore the metabolic profile of H. aurantiacus different 
media were used for cultivation. They include Casiton-Yeast (CY) based medium, 
MD1+G and HP74 medium. However, in all conditions agar block of .H. aurantiacus 
grown in VY/2 agar at 30°C for 7 days was used to cultivate 50 ml liquid pre-culture.  
The preculture, which was grown at 30°C and 140 rpm for 7 days, was used as 
inoculum for 1.5 L culture. The main culture was also allowed to grow for 7 days 
before extraction.    
To the main culture in CY medium, supplements were added at different time points 
to induce the production of secondary metabolites. In one set of culture in CY 
medium, 2 mM of filter sterilized tyrosine was added after 2 days. In other set of 
cultures in same medium, filter sterilized 3 mM 4-hydroxyphenylglycine was added. 
H. aurantiacus lyses dead E. coli cells for nutrition and therefore, 10 ml of dead E. 
coli cells was added to 1 L of 3 days old culture in same medium and incubated 
further for 4 days. The dead E. coli cells were made by autoclaving 50 ml suspension 
obtained from the lawn of live E. coli cells in LB agar plate.  
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3.3 Chemical methods 
3.3.1 Crude extraction of bacteria 
3.3.1.1 Cell pellet 
To the cell pellet, 100 ml methanol was added and stirred overnight at room 
temperature. The methanol extract was then centrifuged at 8000 rpm for 15 min at 
room temperature. The supernatant was evaporated under vacuum for further 
fractionation and screening. 
In other case, the cell pellet was lyophilized in freeze dryer. Lyophilized biomass was 
suspended in 200 ml of methanol and dichloromethane (2:1) mixture and stirred at 
room temperature for 30 min. The suspension was then centrifuged at 8000 rpm for 
15 min. The supernatant was collected and the cell pellet was extracted again 
exhaustively. The collected supernatant were pooled together and evaporated under 
vacuum for further procedures. 
3.3.1.2 Supernatant 
In the first method, the supernatant was extracted exhaustively with equal volume of 
either ethyl acetate or butanol by liquid–liquid partition. The organic phase was 
collected and evaporated under vacuum. The extract was then further fractionated 
and all the fractions were subjected to LC-MS for screening. 
The second method, which involves alternate acidification and neutralization, has 
been successful in isolating lipopeptides like laspartomycin and aspartocin (Borders 
et al., 2004). According to this procedure butanol phase was initially mixed with equal 
volume of H2O and adjusted to a pH-2 using 1N HCl. Then the acidified butanol 
phase was washed with water and mixed with equal volume of water. This mixture 
was neutralized to pH-7 and the aqueous phase was separated. This aqueous phase 
was again acidified to pH-2 and extracted with butanol. The aqueous phase was 
adjusted back to pH-7 and should contain lipopeptides free of impurities.  
Finally, the extraction procedure used for the isolation of lipopeptide surfactin (Ohno 
et al.,1995) was followed. As per this procedure, the supernatant was adjusted to pH-
2 using 2 N hydrochloric acid. The mixture was incubated overnight at 4°C to allow 
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any lipopeptides to precipitate. The precipitate was then collected by centrifuging at 
5000 rpm at 4°C for 45 min. The precipitate was extracted with 100 ml of methanol 
for 1 h. The methanol extract was centrifuged at 8,000 rpm at 4°C for 15 min and the 
supernatant was evaporated under vacuum. 
3.3.2 Chromatography 
The obtained crude extracts were further fractionated by different chromatographic 
techniques to isolate the pure compound. They include gel filtration chromatography, 
vacuum liquid chromatography (VLC), and high performance liquid chromatography 
(HPLC)  
3.3.2.1 Gel filtration  and vacuum liquid chromatography (VLC) 
Gel filtration chromatography was carried out in Sephadex LH-20 (0.018-0.111 mm, 
Pharmacia Biotech AB; size exclusion material), using MeOH as eluent. The column 
was wet packed with MeOH before applying the sample solution. Sample was also 
loaded by using wet method. 20 ml of each fraction was collected, evaporated at 
40°C in a rotary evapaorator. 
VLC was carried out using Silical gel 60 (0.040-0.063 mm, Merck 1.09385.1000) or 
silica gel 60 (0.063-0.200 mm, Merck 1.07734.2500) as the stationary phase for 
normal phase (NP), whereas polygoprep 60 C18 (0.05 mm, Macherey-Nagel 
711500.1000) for reverse phase-vacuum liquid chromatography (RP-VLC). The 
columns were wet-packed with stationary phase soaked in dichloromethane for NP-
VLC or in methanol for RP-VLC. Sample was loaded by wet method 
Dichloromethane, ethyl acetate, acetone and methanol were used as mobile phase in 
NP-VLC, whereas in RP-VLC gradient of water and methanol were used as mobile 
phase. Fractions were collected and evaporated at 40°C under reduced pressure on 
a rotary evaporator.  
Prepacked Bakerbond Spe C18 disposable extraction columns (J. T. Baker Inc. 
Phillipsburg, NJ, USA; Cas No. 71889-02-06) were used for the fractionation of 
samples. 
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3.3.2.2 High performance liquid chromatography (HPLC) 
HPLC was carried out in Waters system. The system was equipped with in-line 
degasser, 717 plus autosampler, 600 pump and 996 photodiode array detector. 
Columns used were either Knauer Eurospher-100 C18 (5 µm, 250 x 8 mm), Knauer 
Eurospher-100 C8 (5 µm, 250 x 8 mm) or similar columns. Milli-Q purified water, 
distilled methanol and HPLC grade acetonitrile were used as mobile phase. Typical 
flow rates were 1.0-2.5 mL/min.  
3.4 Analytical methods 
3.4.1 NMR spectroscopy 
NMR analyses of the extracts were either carried out on a Bruker Avance 300DPX 
spectrometer operating at 300 MHz for 1H and 75 MHz for 13C or Bruker Avance 500 
DPX spectrometer operating at 500 MHz for 1H and 125 MHz for 13C. The spectra 
were processed using XWIN NMR Version 3.1 software. Deuderated solvents were 
used to suspend the fractions for NMR measurement. 
3.4.2 Mass spectrometry 
LC-MS measurements were conducted by E. Eguereva, Institute for Pharmaceutical 
Biology, Bonn, Germany. The samples were dissolved in methanol (1 mg/mL) for 
injection into the system. Experiments were recorded in both positive (+Q1) and 
negative mode (-Q1) and analysed by Applied Biosystems/ MDS Sciex Analyst 
software. 
HR-MS of the crude extract was performed by Dr. M. Nett in Leibniz Institute for 
Natural Product Research and Infection Biology, Jena, Germany. The sample was 
dissolved in methanol (1.5 mg/ml). Experiment was recorded in both positive (+Q1) 
and negative (-Q1) modes.  
In-gel trypsin digestion of protein bands of interest from a native-PAGE and 
subsequent analysis of the mass and peptide fingerprint was carried out in Bruker 
MALDI TOF/TOF mass spectrometer by Dr. Sebastian Franken and Dr. Till 
Schäberle in Institute for Biochemistry and Molecular Biology, Bonn, Germany.  
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γ-18O4-ATP pyrophosphate exchange assays was measured using MALDI-TOF MS 
by Dr. Max Crüsemann, Institute for Organic Chemistry, Bonn. Mass spectra were 
acquired in negative ion mode over a range of 450 to 1200 m/z. Data acquisition and 
quantitative spectral analysis was conducted using Bruker Compass Data Analysis 
software. 1 µl of the assay mixture was used for the measurement. 
3.4.3 UV measurements 
UV spectra were recorded on a Perkin-Elmer Lambda 40 with UV WinLab Version 
2.80.03 software, using 1.0 cm quartz cells. 
3.5 Molecular biological methods  
3.5.1 Isolation of nucleic acids 
3.5.1.1 Chromosomal DNA 
Chromosomal DNA was isolated according to Neumann et al.,1992. Bacterial cells 
were harvested from 100 ml of culture by centrifuging at 8000 rpm for 10 min. All 
centrifugation steps were performed at 4°C. The cell pellet was resuspended in 5 ml 
SET buffer. To the suspension 0.5 ml SDS (10%), 275 µl lysozyme (100mg/ml) and 
275 µl proteinase K (20 mg/ml) was added and incubated for 2 hours at 55°C with 
intermittent mixing for every 15 minutes. 1.8 ml 5 M NaCl and an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added to the lysate and gently 
mixed by inverting several times. The aqueous phase was then separated from the 
organic phase by centrifuging at 8000 rpm for 10 minutes. To get rid of phenol 
residues in the aqueous phase, the same step was carried out with chloroform: 
isoamyl alcohol (24:1). 
The aqueous phase containing genomic DNA was mixed with 1/10 volume of 3 M 
sodium acetate (pH 5.2) and 2-2.5 volumes of ice-cold ethanol 98%. The mixture was 
incubated at 4°C for 1 h. The precipitated DNA was centrifuged at 8000 rpm at 4°C 
for 30 min. The supernatant was decanted and the DNA pellet was dried at 37°C. 
The DNA was redissolved in TE buffer (pH 8.0) containing RNase (20 µg/ml) and 
was incubated at 37°C for 30 min to degrade the RNA. The RNA free DNA was then 
stored at 4°C. 
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3.5.1.2 Plasmid DNA 
Plasmid DNA was routinely isolated by alkaline lysis methods (Birnboim and Dolly, 
1979). For the small scale experiments, 3 ml of overnight bacterial culture was used 
to isolate the plasmid DNA. The cells were harvested from the overnight culture by 
centrifuging at 13,000 rpm for 2 min. The supernatant was decanted and the cell 
pellet was resuspended in 350 µl of P1 buffer. To the suspension, 300 µl of P2 buffer 
was added and tube was mixed by inverting six times. Within 2 min, 300 µl of P3 
buffer was added and mixed by inverting six times. The suspension was then 
centrifuged at 13,000 rpm for 10 min. Approximately, 900 µl of the supernatant was 
then carefully transferred to a new eppendorf without disturbing the pellet. To the 
supernatant, equal volume of ice-cold 96% ethanol was added. This mixture was 
then centrifuged at 13,000 rpm for 30 min at 4°C. The supernatant was carefully 
discarded and the DNA pellet was washed in 70% ethanol. The mixture was again 
centrifuged for 30 min at 4°C. The supernatant was discarded and the DNA pellet 
was dried. The pellet was then resuspended in 30-50 µl of TE buffer or H2O and then 
stored at -20°C. 
 
For sequencing purposes, highly pure plasmid DNA was isolated using PlamidMini 
Kit from Promega (Mannheim). For large scale purification of plasmid DNA, QIAGEN 
Plasmid Midi kit was used as recommended by the manufacturer.  
3.5.1.3 RNA and DNase reaction 
Extreme care was taken during the RNA isolation to prevent its degradation from the 
ribonucleases. The work space and all the labwares were cleaned with 0.5 N NaOH 
before and during isolation to get rid of the ribonucleases. Sterile tips and eppendorf 
tubes were used while handling RNA.  
Total RNA was isolated using Macherey Nagel Nucleospin RNA II kit as per the 
protocol from the manufacturer. RNA was then checked for any traces of DNA which 
would otherwise lead to false positives in RT-PCR. DNA free RNA was ensured by 
doing a PCR (section-3.5.3.1 with 3µl of the template) with the gene specific primers 
designed for RT-PCR (section-3.5.3.2). Amplified PCR fragments indicated the 
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presence of DNA. The contaminating DNA in the identified RNA preps was then 
removed with DNase as follows. 
Reagent Volume (µl) 
RNA 40 
DNase reaction buffer 90 
DNase 10 
Table 3-13: DNase reaction mix 
The solution was then incubated at 37°C for 1 hr followed by inactivation at 65°C for 
10 min. 
3.5.2 Evaluation of nucleic acids 
3.5.2.1 Agarose gel electrophoresis 
Agarose gel electrophoresis is a common method used to separate DNA based on its 
molecular weight. Standard gels containing 1% electrophoresis grade agarose was 
used to separate the DNA fragments of size ranging from 200bp to 10Kbp. The 
electrophoresis was carried out with the running buffer (0.1X TBE) covering the gel. 
The DNA samples were mixed with 0.2 volumes of 6X loading dye, which makes 
easy to monitor the progress of the gel. 5-10 µl of 1Kbp DNA ladder was used as 
standard size indicator. Electrophoresis was done in Horizon-58 and Horizon-11.14 
gel chamber (Life Technologies, Karlsruhe, Germany) at a voltage ranged between 
80 to 100V. To visualize the DNA, the gel was stained with ethidium bromide solution 
(10µg/ml) for 2 minutes. Subsequently, non-intercalated ethidium bromide was 
washed out for 2 minutes in demineralized water. DNA bands were visible under UV 
(254nm) and documented using intasiX imager (Intas Science Imaging Instruments 
GmbH, Göttingen, Germany). 
3.5.2.2 DNA extraction from agarose gels 
DNA fragments separated in the agarose gel was extracted and purified using 
QIAquick gel extraction kit (Qiagen, Hilden, Germany) as per the manufacturer’s 
instructions. The purified DNA was eluted with 30-50 µl water and stored at -20°C. 
 
Materials and methods 
50 
 
3.5.2.3 Determination of nucleic acid concentration and purity 
The nucleic acids concentration was determined using UV mini 1240 UV/Vis 
spectrophotometer (Shimadzu, Kyoto, Japan). In principle as per the Lambert-Beer 
law, the amount of energy absorbed at a particular wavelength is a function of the 
concentration of the absorbing material.  Usually, the nucleic acids have the 
maximum absorbance at 260 nm. Apart from the nucleic acids, the impurities from 
the nucleic acid preps usually absorbs in the range of 200 nm to 320 nm. Therefore, 
the absorbance at 260 nm can be adjusted for background correction using the 
absorbance at 320 nm. Using these absorbance values and the dilution factor, the 
nucleic acid concentration was calculated using the following equation. 
      Nucleic acid concentration (µg)     =     (A260 – A320) X extinction coefficient X 
dilution factor 
A260                            Absorbance at 260 nm 
A320                            Absorbance at 320 nm 
  Extinction coefficient (A260 of 1.0)            50 µg/ml for DNA and 40 µg/ml for RNA 
 
Proteins in particular the aromatic amino acids absorb at 280nm. So, therefore the 
ratio of the absorbance at 260 nm and 280 nm can be used to determine the purity of 
the sample. A260 : A280 in the range of 1.7 to 2.0 represents highly pure nucleic acids. 
3.5.3 Amplification of nucleic acids 
3.5.3.1 Polymerase Chain Reaction (PCR) 
PCR is an in vitro technique used for the amplification of the gene of interest. In 
general, oligonucleotides (18-20 bp) termed as primer complementary to the regions 
flanking the gene of interest was designed. These primers then hybridize to the 
single stranded DNA and then subsequently elongated at the 3’ end of the primer. 
Reagent Volume  
5X Taq-buffer (green) 4.0µl 
dNTP mix (10mM) 0.4µl 
Forward primer (100pmol) 0.5µl 
Reverse primer (100pmol) 0.5µl 
DMSO 1.0µl 
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Template 1.0µl 
Taq DNA Polymerase(5 units/µl) 0.2µl 
H20 12.4µl 
Table 3-14: Standard PCR master mix with Taq DNA Polymerase 
Reagent Volume 
10X Pfu buffer with MgSO4 5.0µl 
dNTP mix (10mM) 1.0µl 
Forward primer (100pmol) 0.5µl 
Reverse primer (100pmol) 0.5µl 
DMSO 1.0µl 
Template 1.0µl 
Pfu DNA Polymerase(2.5 units/µl) 1.0µl 
H20 40.0µl 
Table 3-15: Standard PCR master mix with Pfu DNA Polymerase 
No Step Temperature Time No. of cycles 
1 Initial denaturation 95°C 3 min 1 
2 Denaturation 95°C 45 sec  
30 cycles 
 
3 Annealing Tm – 5°C 45 sec 
4 Extension 72°C X sec 
5 Final extension 72°C 15 min 1 
Table 3-16: Standard cycling protocol 
Tm is the melting point of the primers. The extension time depends on the polymerase 
enzyme and the length of the fragment to be amplified. Taq polymerase lacking in the 
proof reading ability is used for normal PCR amplifications. For Taq polymerase the 
extension time is 1 min/Kb. Pfu polymerase with its proofreading property is usually 
used for cloning purposes. The extension time is 2 min/Kb. 
3.5.3.2 Reverse Transcriptional-Polymerase Chain Reaction (RT-PCR) 
The expression of the specific genes in the bacterial genome was analysed using 
RT-PCR. The isolated RNA was used as a template for the cDNA synthesis using the 
forward primer of the designed gene specific primers. Reverse transcription of the 
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RNA was done using the RevertaidTM first strand cDNA synthesis kit. The reaction 
was carried out with revertaid reverse transcriptase, reverse transcriptase reaction 
buffer, riboblock RNase inhibitor, dNTP, RNA and the gene specific primers Table 
3-11) as per the instructions from the manufacturer. 
With 3µl of the synthesized cDNA as the template, PCR (section-3.5.3.1) was done 
using the respective gene specific primers. An amplified PCR fragment of the 
expected size was an indicator for the successful reverse transcription reaction. The 
RT-PCR reaction was then confirmed by sequencing.   
3.5.4 Enzymatic manipulation of DNA 
3.5.4.1 Restriction digestion of the DNA 
The PCR amplified DNA and the plasmid DNA was digested with the respective 
restriction endonucleases. The respective site for the restriction enzyme was defined 
by the recognition sequence in the DNA. 
All the restriction enzymes used in this research were from Fermentas. The double 
digestions were performed as per the instructions from the manufacturer.  
Reagent Plasmid DNA (170ng/µl) PCR product (60ng/µl) 
DNA 3 µl  10 µl  
10X Tango buffer 4 µl 6 µl 
Restriction enzyme I &II X µl X µl 
Nuclease-free water To 20 µl To 30µl 
Table 3-17: Standard restriction digestion reaction mix 
The volume of the enzyme varies with the combination of the enzymes used for 
digestion. No matter, the total volume of the restriction enzymes should be restricted 
to 10% of the total volume. This is important because the glycerol in the enzyme 
could interfere with the digestion reaction. The optimal temperature for all the 
restriction enzymes used was 37°C.The reactions were incubated at 37°C for 16 hrs. 
The specific fragment was then selected and purified form the agarose gel.   
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3.5.4.2 Ligation 
The restriction digested PCR product and the plasmid DNA was ligated using T4 
DNA ligase. The reaction was performed as per the manufacturer’s instruction.   
Reagent Volume 
Plasmid DNA (100ng/µl) 3 µl  
PCR product (50ng/µl) 7 µl  
10X T4 DNA ligase buffer 2 µl 
T4 DNA ligase (1U/µl) 1 µl 
Nuclease-free water 7 µl 
Table 3-18: Ligation reaction mix 
The reaction was incubated at 16°C for 16 hrs. The reaction was stopped by heating 
at 70°C for 5min. 
In addition, the PCR products generated from the synthesized cDNA was ligated into 
the pGEM-T vector for sequencing. The amplicons generated with Taq DNA 
polymerase have 3’ A- overhangs. So that, the A-tailed amplicons could be directly 
ligated with the T-Tailed pGEM-T vector by T4 DNA ligase without restriction 
digestion. The ligation was carried out as per the manufacturer’s instruction 
described earlier. Typically, 1:3 vector to insert ratio was maintained in the ligation 
reaction. 
3.5.5 Bacterial Transformation 
3.5.5.1 Preparation of chemically competent cells 
E. coli XL 1 blue competent cells were prepared according to the method described 
by Dagert and Ehrlich, 1974. A single colony from a fresh agar plate was inoculated 
into 3 ml LB medium. The inoculum was then incubated at 37°C overnight with 
shaking at 160 rpm. The overnight culture was then inoculated in fresh 70ml 2 X YT 
medium. The culture was cultivated at 37°C at 160 rpm until it reaches an OD600 of 
0.3-0.4. Bacterial cells were harvested by centrifuging at 5000 rpm for 10 min. All the 
centrifugation steps were carried out at 4°C. The bacterial cell pellet was then 
resuspended in 10 ml of ice-cold 70 mM CaCl2/20 mM MgSO4 solution. The 
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suspension was incubated in ice for 30 min and centrifuged at 5000 rpm for 10 min. 
The cell pellet was again resuspended in 3.5 ml ice-cold 70mM CaCl2/20 mM MgSO4 
and incubated in ice for another 30 min. To this solution 875µl sterile glycerol was 
mixed and aliquoted as 100 µl volumes in 1.5 ml eppendorf tubes.  For storage, 
these competent cells were shock frosted in liquid nitrogen and were stored at -20°C. 
3.5.5.2 Transforming chemically competent cells 
The frozen competent cells were thawed in ice for 5 min. To that 5µl of the plasmid 
DNA was added and incubated in ice for 30 min. Then the cells were heat shocked at 
42°C for 50 sec. The cells were then incubated again in ice for atleast 2 min. To the 
cold shocked cells 900µl of LB medium was added and incubated at 37°C with 
shaking at 160 rpm for 1 hr. The cells were then centrifuged at 13,000 rpm for 5 min. 
The cell pellet was then resuspended in 300 µl of fresh LB medium. 100 µl of the cell 
suspension was then plated on LB agar plate containing ampicillin (100 µg/ml) as the 
selection marker. The plate was then incubated overnight at 37°C. The positive 
transformants was then identified by restriction digestion (section-3.5.4.1), PCR 
(section-3.5.3.1) and sequencing. 
3.5.6 Recombinant protein expression 
3.5.6.1 Construction of recombinant plasmids for A domain expression 
To characterize the A domains in vitro, they should be isolated in enough amounts. 
To accomplish this, the A domains were heterologously expressed. For this the 
nucleotide sequences encoding the A domains were first identified by Pfam and 
BLAST. The identified gene of interest were PCR amplified from H. aurantiacus 
genomic DNA using proof reading Pfu DNA polymerase and primers with appropriate 
restriction sites for its insertion in to the pET-28a expression vector. To facilitate the 
expression of A domains, the PCR amplified product was cloned in to pET-28a 
expression vector. 
The newly generated construct was stabilized by transforming in to a non-expression 
host, E. coli X-1 blue cells. Kanamycin resistance cassette, which is present in pET-
28a vector, was used to screen the clones. The positive clones with the construct 
were identified using whole cell PCR. Moreover, the construct in the positive clones 
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was verified for any mutation by sequencing. This was followed by the transformation 
of the constructs isolated from the positive clones in to a suitable expression host.    
3.5.6.2 Heterologous expression  
In most part of this work E.coli based Rosetta (DE3) cells were used as the 
expression host. In special cases it is mentioned in results section. A single colony of 
the transformant was inoculated in 10 ml of LB medium containing 50 µg/ml of 
kanamycin as the selective marker. The culture was then shaked overnight at 37°C. 
On the next day, 1 L of LB medium containing 50 µg/ml of kanamycin was inoculated 
with 10 ml of the overnight culture. The culture was then shaked at 37°C till the 
culture reaches an OD600 of 0.5. After induction the culture was then shaked 
overnight at 16°C.  
3.5.7 Recombinant protein purification and evaluation 
3.5.7.1 Recombinant protein extraction 
The cells were harvested from the induced cultures by centrifugation at 4000 rpm for 
30 min at 4°C. The cell pellet was then resuspended in 5 ml of lysis buffer for native 
purification. 1 mg/ml of lysozyme was added to the suspension and incubated in ice 
for 30 min. The lysate was then sonicated for 6 X 10 sec each with a pause for 10 
sec at 200-300 W. The sonication was carried out in ice. The insoluble materials 
were pelleted by centrifugation at 8000 rpm for 30 min at 4°C. The supernatant was 
the soluble fraction and contains proteins in its native form. The soluble and the 
insoluble fractions were analysed by SDS-PAGE for the presence of the protein of 
interest. 
3.5.7.2 Recombinant protein purification 
The six consecutive histidine residues (6X His-tag) conveyed by pET28-a vector at 
N- and C-terminus of the over-expressed protein facilitated the protein purification 
using Ni-NTA resin. The 6X His tag acts as chelator and immobilizes the protein on 
nickel ion in Ni-NTA resin. 
1ml of Ni-NTA slurry (50% suspension) was added to the 1 ml polypropylene 
columns. The resin was washed with 5 CV of water to get rid of ethanol in the Ni-NTA 
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suspension. The column was equilibrated with 10 CV of lysis buffer. The proteins 
were always kept in ice. The soluble fraction was then added to the column and 
allowed to flow through. The process was repeated for at least two times. The 
fraction was then collected as flow through (FT). The column was then washed with 
10 CV of wash buffer with 20mM imidazole to get rid of any non-specific binding. The 
fraction was collected as W1. The column was washed again with 10 CV of wash 
buffer with 40mM Imidazole to ensure that the column is free of non-specific binding 
contaminants. The fraction was collected as W2. The protein was then eluted from 
the column with 4X1 ml of elution buffer. The fractions were then analysed by SDS-
PAGE. The eluates which are pure enough were then pooled together.  
3.5.7.3 Buffer exchange and concentration of recombinant proteins 
Imidazole interferes in further assay with the protein and hence the protein solution in 
imidazole was exchanged in A domain buffer using gravity-flow PD-10 desalting 
columns by GE Healthcare following the manufacturer’s protocol. Since the amount 
of expressed proteins were low, concentration of the protein solutions in A domain 
buffer was done using Amicon Millipore columns (10KDa, 30KDa, 100KDa- 
depending on the molecular weight of the protein) as per the instructions from the 
manufacturer. 
3.5.7.4 Polyacrylamide Gel Electrophoresis (PAGE) 
The overexpressed protein of interest from the lysate and purified eluates were 
identified based on their molecular weight by sodium dodecyl sulfate (SDS)-PAGE  
(Laemmli 1970). The protein fraction to be analyzed was mixed with sample buffer in 
a ration of 3:1 and boiled at 100°C for 5 min. Depending on the molecular weight of 
the desired protein, 15 µl of protein samples were loaded on to 10% or 12% SDS-
PAGE containing 1X Tris-glycine-SDS running buffer. To estimate the size of the 
protein, 10µl of unstained protein molecular weight standard was also loaded on to 
the SDS-PAGE. The electrophoretic run was performed in XCell SureLock MiniCell 
(Invitrogen Lifescience Technologies, Karlsruhe, Germany) at a constant voltage of 
150V as per the maufacturer’s instruction until the dye front reached the bottom of 
the gel. To visualize the separated proteins, the apparatus was disassembled and 
the gel was soaked in Coomassie staining solution for 30 min. Subsequently the 
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stained gel was soaked in destaining solution until the protein bands become visible 
and clear.  
 (A) Compounds for 4% stacking gel                (B) Compounds for 12% separating gel 
Table 3-19: Composition of SDS-PAGE 
The proteins for the MALDI-TOF-TOF measurements were separated in a native-
PAGE. Native or denaturing PAGE was carried out in the absence of SDS in gels, 
running and sample loading buffers.  
A) Compounds for 4% stacking gel                (B) Compounds for 10% separating gel 
 
 
(C) Sample buffer 
 
 
 
 
Table 3-20: Composition of native-PAGE 
 
0.5M Tris-HCl pH 6.0 1,250 µl 
Bis-acrylamide (30%) 675 µl 
10% SDS 25 µl 
Water 3,050 µl 
10% APS 25 µl 
TEMED 2.5 µl 
1M Tris-HCl pH 8.9 2,500 µl 
Bis-acrylamide (30%) 675 µl 
10% SDS 100 µl 
Water 3,050 µl 
10% APS 50 µl 
TEMED 2.5 µl 
0.5M Tris-HCl pH 6.0 1,010 µl 
Bis-acrylamide (30%) 404 µl 
Water 2,585 µl 
10% APS 40.4 µl 
TEMED 4.04 µl 
1M Tris-HCl pH 8.9 1,470 µl 
Bis-acrylamide (30%) 1.951 
Water 2,580 µl 
10% APS 21 µl 
TEMED 4.83 µl 
0.5 M Tris- HCl pH 6.0 217 µl 
Glycerol 508 µl 
Water 275 µl 
Bromophenolblue 50 µl 
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3.5.8 Biochemical analysis of recombinant proteins 
3.5.8.1 γ-18O4-ATP pyrophosphate exchange assay 
Adenylation proteins catalyze reversible activation of specific amino acids in the 
presence of ATP to form aminoacyl-adenylate and pyrophosphate (PPi).  
Conventionally this adenylation activity is monitored by a pyrophosphate exchange 
assay. Recently, a non-radioactive, mass spectrometry-based γ-18O4-ATP 
pyrophosphate exchange assay was developed in which the adenylation reaction 
was measured in reverse through the incorporation of  γ-16O4-ATP from the isotope 
labeled γ-18O4-ATP in the presence of excess PPi (Phelan et al., 2009). The rate of 
mass shifts in the presence of different amino acids enables to conclude the specific 
amino acid that could be activated by the adenylation proteins in vivo.  
The assay was carried out at in a total volume of 6 µl with 2µl of purified and 
concentrated protein, 2 µl of 3 mM amino acid containing 15 mM PPi in 20 mM Tris 
(pH-7.5) and 2µl of 3 mM γ-18O4-ATP containing 15mM MgCl2 in 20mM Tris (pH-7.5). 
The assay mixture was incubated for 2 hrs at room temperature. The reaction was 
then quenched by adding 6 µl of 9-aminoacridine. 1 µl of this reaction mixture was 
analyzed for the mass shifts using MALDI-TOF MS. MALDI-TOF MS experiments 
were performed by Dr. Max crüsemaan in co-operation with the mass department 
from the Organic chemistry Institute, Bonn. 
Data analysis 
The quantification of the adenylation reaction was determined by the shift in mass 
from ү-18O4 isotope labelled ATP (m/z=514) to 
16O4–ATP (m/z=506) using MALDI-
TOF MS. Moreover, the masses of their monosodium adducts m/z=536 and 
m/z=528, respectively were also identified. In addition to the exchange into 16O4–
ATP, other masses were also detected corresponding to the incomplete exchange 
18O3–ATP (m/z=512), 
18O2–ATP (m/z=510), 
18O1–ATP (m/z=508) and their 
corresponding sodium adducts m/z=534, m/z=532 and m/z=530, respectively. 
Percentage of exchange was calculated by the ratio of area of unlabelled ATP 
(m/z=506) to the sum of the area of all the ATP species including unlabelled 
(m/z=506), completely (m/z=514) and partially labeled (m/z=508, m/z=510 and 
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m/z=512) and their monosodium adducts (m/z=528, m/z=530, m/z=532, m/z=534 
and m/z=536). 
3.5.8.2 Phosphopantetheinylation of peptidyl carrier protein (PCP) 
The building blocks of nonribosomal peptides are attached to the 
phosphopantetheine arm of PCP in the NRPS. This phosphopantetheine arm on the 
PCP is derived from coenzyme A by the action of phosphopantetheinyl transferase 
(PPTase). This phosphopantetheinylation, which converts PCP from its inactive apo 
to holo form is crucial for the functioning of NRPS and can be identified in vitro by 
shift in the mass of 340.1 Da due to the phosphopantetheine arm. 
Heterologously expressed A-PCP didomain (1mg/ml) and PPTase (0.4 mg/ml) was 
incubated with 8 mM MgCl2 and 320 µM CoA for 1 hr at room temperature. 100 µl of 
the so formed holo- didomain was incubated with 5 µl of 0.1 M ATP and 1 mM of 
amino acid for the loading of specific amino acid activated by the A domain on to the 
PCP domain. The reaction was carried out for 30 min at room temperature before 
stopping it by adding equal volume of 10% formic acid. The proteins were then 
separated via native-PAGE for MALDI-TOF/TOF analysis. 
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4. Results 
4.1 Mining the genomes of gliding bacteria 
There are more than thirty accessible gliding bacterial genomes in NCBI, the majority 
of which belong to the phylum Bacteroidetes. Published cyanobacterial genomes 
were excessively analyzed for the PKS and NRPS genes (Kalaitzis et al., 2007; 
Donadio et al., 2007) and are thus not further considered. The focus here is instead 
put on other gliding bacteria belonging to the phylum Proteobacteria, 
Planctomycetes, Bacteroidetes and Chloroflexi. Genomes were analyzed for PKS 
and NRPS genes computationally using CLUSEAN (Weber et al., 2009), BLAST, 
Pfam, PKS/NRPS Analysis (Bachmann and Ravel, 2009), NRPS predictor (Rausch 
et al., 2005) and NRPS/PKS database (Ansari et al., 2004). The genome of H. 
aurantiacus DSM 785 from the phylum Chloroflexi is analysed in detail in order to 
predict the putative structures encoded by PKS and NRPS genes of their genome. 
4.1.1 Genomes of the phylum Proteobacteria 
This phylum includes the myxobacteria from which compounds with unprecedented 
structural and biological properties were reported (Wenzel et al., 2005). The genome 
sequences of Myxococcus xanthus DK 1622, Myxococcus fulvus HW-1, Sorangium 
cellulosum So ce 56 and Stigmatella aurantiaca DW4/3-1, three Anaeromyxobacter 
species (Anaeromyxobacter dehalogenans 2CP-1, Anaeromyxobacter sp. K, 
Anaeromyxobacter sp. FW 109-5) and of Haliangium ochraceum DSM 14365 were 
reported and allow to gain further insight into the potential metabolic profile of the 
respective bacterial strains. The genomes of Anaeromyxobacter species comprise 
approximately 5 Mb and were reported to be devoid of PKS and NRPS genes, and 
indeed so far no secondary metabolites are reported from the latter (Wenzel et al., 
2009). For So. cellulosum Soce56, M. xanthus DK1622 and Sg. aurantiaca DW4/3-1 
biosynthetic genes for specific natural products were already annotated and were 
thus not considered further on (Bode and Müller, 2006; Li and Müller, 2009; Wenzel 
and Müller, 2009b). The genomes of M. fulvus HW-1 (Li et al., 2011) and Ha. 
ochraceum DSM 14365 (Ivanova et al., 2010) which were sequenced completely and 
published recently are here analysed for the presence of PKS and NRPS genes. 
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4.1.1.1 Myxococcus fulvus HW-1 
M. fulvus HW-1 is a halotolerant myxobacterial strain isolated from a coastal sea-
water sample. The strain has a circular genome of 9 Mb in size (Li et al., 2011). 
Although potent antibiotics like myxopyronins, myxathiazol, myxovalargins and 
cytotoxic bithiazole metabolites are known for M. fulvus strains, none of these 
metabolites have to date been isolated from M. fulvus HW-1. In contrast, scanning 
the genome revealed a pool of PKS and NRPS genes, which however did not 
correspond to the above mentioned structural classes.  
Just like in other myxobacterial genomes, the PKS/NRPS hybrid gene loci are 
predominant over the discrete NRPS and PKS gene loci. From the genome 
sequence, nine PKS/NRPS hybrid gene loci were identified, whereas only six NRPS 
and two PKS gene loci were recognized (Table 4-1).  Two of the gene loci could be 
attributed to known structural classes, i.e. the Dxanthenes and myxochelin A. Thus, 
the PKS/NRPS gene locus-8 putatively encodes the biosynthetic enzymes for 
DKxanthenes (Figure 4-1, Table 4-1). It has the approximate size of 47.5 Kb 
including, as expected seven PKS and two NRPS modules. Till date, none of the 
DKxanthenes were yet isolated from the strain. 
(A)  
M. xanthus DK1622 
 
M. fulvus HW-1 
 
 (B) 
 
Figure 4-1: DKxanthenes in M. fulvus HW-1.  
(A) The DKxanthene biosynthetic gene loci from M. xanthus DK1622  and M. fulvus HW-1. 
Red, PKS genes; blue, NRPS genes; green, PKS/NRPS hybrid genes; grey, accessory 
genes; black, a hypothetical protein in different locations; pink, starter unit biosynthetic 
genes; orange, thioesterase. 
(B) Structure of DKxanthenes. 
R1/2  = H, CH3 
R3     = H, OH 
n    = 1-4 
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The NRPS gene locus-5 is highly homologous to the myxochelin A biosynthetic gene 
cluster (Gaitatzis et al., 2001; Silakowski et al., 2000). The locus includes the genes 
required for the synthesis of 2,3-dihydroxybenzoic acid (Kwon et al., 1996) and for 
iron transport and utilization (Silakowski et al., 2000). The respective A domain has 
the Stachelhaus code, DAEDIGTVVK, which is consistent with that of the A domain 
in myxochelin A. Therefore, the NRPS gene locus-5 in M. fulvus HW-1 is proposed to 
encode for the biosynthesis of myxochelin A. 
(A) M. xanthus DK1622 
 
    M. fulvus HW-1 
 
(B)  
 
 
Figure 4-2: Myxochelin in M. fulvus HW-1. 
(A) Myxochelin biosynthetic gene loci from Myxococcus xanthus DK1622 and Myxococcus 
fulvus HW-1. Red, NRPS gene; green, aminotransferase; grey, iron transport and utilization 
proteins, others, genes for the biosynthesis and loading of DHBA. 
(B) Structure of myxochelin A. 
Gene Gene locusa Sizeb 
(Kb) 
No. of modules Compound 
PKS NRPS 
PKS/NRPS-1 lilab_9160-lilab_9195 21.4 1+ACL 2 Unknown 
PKS/NRPS-2 lilab_21685-lilab_21695 11.8 1 1 Unknown 
PKS/NRPS-3 lilab_26120-lilab_26145 30.3 3 5 Unknown 
PKS/NRPS-4 lilab_26215-lilab_26265 71.8 1 19 Unknown 
PKS/NRPS-5 lilab_27065-lilab_27075 27.6 1 13 Unknown 
PKS/NRPS-6 lilab_28140-lilab_28150 28.8 1 8 Unknown 
PKS/NRPS-7 lilab_ 28580  -lilab_28585 22.6 1 6 Unknown 
HN NH
O O
OH
HO
OH
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PKS/NRPS-8 lilab_29600-lilab_29675 47.5 7 2 DKxanthenes 
PKS/NRPS-9 lilab_30100-lilab_30125 33.2 1 7 Unknown 
NRPS-1 lilab_0695-lilab_0700 17 - 5 Unknown 
NRPS-2 lilab_0720 4 - 1 Unknown 
NRPS-3 lilab_1140 4.4 - 1 Unknown 
NRPS-4 lilab_24940-lilab_24945 13.2 - 4 Unknown 
NRPS-5 lilab_26275-lilab_26330 20.2 - 1 Myxochelin A 
NRPS-6 lilab_30650 6.5 - 2 Unknown 
PKS-1 lilab_25050-lilab_25055 8 1 - Unknown 
PKS-2 lilab_26180-lilab_26200 10.9 2 - Unknown 
Table 4-1: PKS and/or NRPS gene loci from M. fulvus HW-1. a The gene loci are named 
according to GenBank, b Unannotated nucleotide sequences between each gene locus are 
also considered. ACL- acyl-CoA synthetase. 
4.1.1.2 Haliangium ochraceum DSM 14365 
Recently the 9.4 Mb genome of H. ochraceum DSM 14365 was completely 
sequenced and published (Ivanova et al., 2010). This was the first obligate marine 
myxobacterium to have its genome sequenced. Our scanning of the genome 
sequence revealed three PKS/NRPS hybrid gene loci, eight NRPS, and three PKS 
loci (Table 4-2). So far, none of these gene clusters can be attributed with certainty to 
a known natural product. However, there are some aspects that let us consider PKS 
gene locus-3 as the gene cluster encoding haliangicin biosynthetic enzymes. 
Haliangicin an antifungal compound is the only secondary metabolite isolated from 
Ha. ochraceum DSM 14365 (Fudou et al., 2001; Kundim et al., 2003). 
Putative haliangicin biosynthetic gene cluster 
Haliangicin is a polyunsaturated metabolite with an epoxide ring, a β-methoxy 
acrylate at one and an alkene moiety at the other end of the molecule (Figure 4-3A) 
[Fudou et al., 2001). Haliangicin occurs as cis and trans isomer at the epoxide 
portion of the molecule. In addition, there are geometrical isomers at the polyene 
moieties i.e. haliangicin B-D, which were also isolated as cis, trans mixtures (Figure 
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4-3-A) (Kundim et al., 2003). Concluded from the structure, the biosynthesis requires 
seven PKS elongation steps followed by post-PKS modification reactions like O-
methylation, epoxide ring and alkene formation. The methoxy groups at the terminal 
carboxyl group C1 and at the β-carbon (C3) are likely to be added by an O-MT. On 
the contrary, the methoxy substitution at C4 is most likely to be derived from the 
building block methoxy malonate. A striking feature is the methyl branching at C9. 
This type of β-methyl branching is incorporated by the action of HMG-CoA synthases 
(Gulder et al. 2011) and ECH enzymes. Considering these factors the genome was 
scanned for such PKS genes. PKS gene locus-3 has all the genes (Figure 4-3B) 
required for the synthesis of methoxy malonyl-CoA (Chan et al., 2006) (Figure 4-4) 
and the incorporation of β-methyl branching (Figure 4-5). Since the locus has merely 
six elongation modules, one of the PKS modules is most likely used iteratively. Since 
the biosynthetic genes are not strictly co-linear, the elucidation of the exact 
biosynthetic pathway requires feeding and gene inactivation studies. Especially the 
formation of terminal alkene would be an interesting feature to study further. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-3: Haliangicin in Ha. Ochaceum DSM 14365. 
(A) Structure of haliangicin. The table was adapted from Kundim et al and lists the isomers of 
haliangicin. a cis isomers were the minor components. 
(B) Proposed haliangicin biosynthetic gene cluster. PKS genes are shown in red. Genes 
involved in the synthesis of methoxymalonyl-CoA are shown in green. Putative genes 
involved in the HMG-CoA synthase reaction are shown in blue. However, a discrete gene 
Compound Geometry 
C2 C4 C6 Epoxidea 
Haliangicin E Z Z trans 
cis-Haliangicin E Z Z cis 
Haliangicin B 
(+ cis isomer) 
Zb Z Z trans 
(+cis)  
Haliangicin C 
(+ cis isomer) 
E Eb Z trans 
(+cis)  
Haliangicin D 
(+ cis isomer) 
E Eb Eb trans 
(+cis)  
Hoch_1169-Hoch_1187 
(A) 
OMe
OMe
CO2Me
O
1
3
4
(B) 
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encoding KS domain for the HMG-CoA synthase reaction is missing. MT gene is shown in 
violet. Other accessory genes are shown in grey. 
 
 
 
 
 
 
Figure 4-4: Biosynthesis of methoxymalonyl-CoA. Hoch 1174, glyceryl transferase 
(phosphatase); Hoch 1176, acyl carrier protein (ACP); Hoch 1175, acyl-CoA dehydrogenase; 
Hoch 1177, β-hydroxyacyl CoA dehydrogenase; Hoch 1183, O- methyltransferase. 
 
 
 
 
 
 
 
 
Figure 4-5: Beta branching mediated by Hoch 1180 (ACP), Hoch 1178 (KS), Hoch 1179 
(HMG-CoA synthase), Hoch 1181 (ECH) and Hoch 1169 (ECH). ACP, Acyl Carrier Protein; 
KS, Ketosynthase; HMG-CoA synthase, Hydroxymethyl glutaryl-Coenzyme A synthase; 
ECH, Enoyl-Coenzyme A hydratase. 
Siderophore-type metabolite 
Scanning of the genome sequence exposed the NRPS gene locus-4, which is 
bordered by genes required for the synthesis of 2,3-dihydroxybenzoic acid (DHBA) 
(Kwon et al., 1996), for iron transport and utilization. Thus, the assumption was made 
that NRPS gene locus-4 encodes siderophore biosynthetic enzymes. The 
biosynthetic pathway resembles that of myxochelin A (Figure 4-2) (Gaitatzis et al., 
2001; Silakowski et al., 2000). Based on the Stachelhaus code, the A domain was 
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predicted to activate lysine as for myxochelins. But, in contrast to the myxochelin A 
cluster, the gene locus includes a methyltransferase gene, hoch_2016. Therefore, it 
is predicted that the NRPS gene locus-4 of Ha. ochraceum DSM 14365 encodes for 
a methylated derivative of myxochelin A. Clearly, the isolation of the putative 
siderophore and structure elucidation is necessary to gain further proof. 
Gene Gene locus Size 
(Kb) 
No. of 
modules 
Compound/Comments 
PKS NRPS 
PKS/NRPS-1 hoch_0798-hoch_0799 21.7 4 1 Unknown 
PKS/NRPS-2 hoch_1746-hoch_1750 40 2 8 Unknown 
PKS/NRPS-3 hoch_2945-hoch_2957 59 8 2 Unknown 
NRPS-1 hoch_1077 12.3 - 4 Unknown 
NRPS-2 hoch_1312 3.7 - 1 Unknown 
NRPS-3 hoch_1365-hoch_1371 25.9 - 6 Unknown 
NRPS-4 hoch_2016-hoch_2022 11.4 - 1 Methylated myxochelin A 
(putative) 
NRPS-5 hoch_1694 4.06 - 1 Unknown 
NRPS-6 hoch_5720 1.5 - 1 Unnown 
NRPS-7 hoch_6170 3.2 - 1 Unnown 
NRPS-8 hoch_6298 2.7 - 1 Unknown 
PKS-1 hoch_0692-hoch_0693 6.4 1 - Unknown 
PKS-2 hoch_2966-hoch_2975 52.6 9 - Unknown 
PKS-3 hoch_1168-hoch_1187 46.1 6 - Haliangicin (putative) 
Table 4-2: PKS and/or NRPS hybrid gene loci from H. ochraceum DSM 14365 
4.1.2 Genome from the phylum Planctomycetes 
Isospahaera is the only genus in the phylum Planctomycetes to possess gliding 
motility. The sequences of the 5.5 Mb genome isolated from Isosphaera pallida 
ATCC 43644 (Göker et al., 2011) reveals only one PKS gene locus. This PKS gene 
locus from Isop 2002-Isop 2006 has a size of 17 Kb and includes genes encoding for 
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a 3-oxoacyl-ACP and a α/β hydrolase. The locus comprises a single PKS module 
split between two ORFs with tandem ACP domains. 
4.1.3 Genomes from the phylum Bacteroidetes 
With 12 genomes accessible in NCBI, the biosynthetic potential of Bacteroidetes 
seems not as prolific as that of the phylum Proteobacteria. Eight of the genomes 
were less than 5 Mb in size and thus they were unlikely to possess NRPS and PKS 
biosynthetic gene clusters. Spirosoma lingulae DSM 74 with a genome of around 8.1 
MB (Lail et al., 2010) could be expected to have many PKS and NRPS genes. 
However, no genes for PKS or NRPS metabolism could be identified from this 
genome. The 6.3 Mb genome of Cytophaga fermentans DSM 9555 was also lacking 
PKS and NRPS genes. The 6.1 Mb genome sequence of Flavobacterium johnsoniae 
UW-101 was already reported to harbor an NRPS gene cluster from Fjoh 2083-Fjoh 
2104 spanning approximately 70.7 Kb (McBride et al., 2009). However, the 
associated nonribosomal peptide product is not yet isolated. PKS and NRPS genes 
were identified from Chitinophaga pinensis DSM 2588 genome sequences (Rio et al., 
2010). Furthermore, the genome of Paedobacter heparinus DSM 2366 was reported 
(Han et al., 2009) and we analyzed for the PKS and NRPS biosynthetic genes.  
4.1.3.1 Chitinophaga pinensis DSM 2588  
Chitinophaga  pinensis DSM 2588 is the first organism to be completely sequenced 
in the family Chitinophagacae. The organism harbors a genome of 9.1 Mb in size 
(Rio et al., 2010). A trans AT-PKS gene cluster of 75.1 Kb had already been reported 
to encode for the biosynthesis of elansolid B1 and D (Figure 4-6) (Teta et al., 2010). In 
this context, it is interesting to note that Müller et al. described the isolation of 
elansolids A1/A2 , elansolid A3 and elansolids B1-B3 from a different Chitinophaga sp., 
i.e. C. sanctii (Dehn et al., 2011). From the C. pinensis DSM 2588 genome NRPS 
genes in the size of 98 Kb spanning from Cpin_5188- Cpin_5195 and a PKS/NRPS 
mixed genes in the size of 88 Kb spanning from Cpin_3399- Cpin_3421 were 
identified during the current study. These NRPS and PKS/NRPS biosynthetic gene 
loci could not be correlated with any known compounds.  
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Figure 4-6: Structures of elansolids isolated from C. pinensis DSM 2588. 
4.1.3.2 Paedobacter heparinus DSM 2366 
No metabolites have to date been isolated from members of this genus. The genome 
sequence of Paedobacter heparinus DSM 2366 (Han et al., 2009) harbors only one 
PKS/NRPS hybrid gene locus with a size of 12.5 Kb spanning from Phep 2032- Phe 
2034. The locus includes two NRPS and a single PKS module. As in the case of the 
myxothiazol A biosynthetic gene cluster (Wenzel and Müller, 2009b), downstream to 
the NRPS and PKS genes is the 4’-phosphopantetheinyl transferase gene. The 
respective gene product is necessary for the priming the biosynthetic enzymes. 
4.1.4 Genomes from the phylum Chloroflexi 
Till date, only four genomes from this phylum were sequenced completely. Out of 
these, three belong to the genus Chloroflexus (Ch. aurantiacus J-10-fl, Chloroflexus 
sp. Y-400-fl, Ch. aggregans DSM 9485) with the genome size of 5.3 Mb or smaller. 
Moreover, we could not identify PKS or NRPS genes in Chloroflexus genomes.  The 
fourth completed genome sequence is that of the bacterium Herpetosiphon 
aurantiacus DSM 785. 
4.1.4.1 Herpetosiphon aurantiacus DSM 785 
The genome of H. aurantiacus DSM 785 harbors two plasmids of 3.4 Kb and 1 Kb 
size, respectively and a single circular chromosome of 6.3 Mb. This circular 
chromosome is the largest among all members of the Chloroflexi. It was sequenced 
completely by the Joint Genome Institute, annotated and made publicly accessible in 
NCBI. Analysis for PKS and NRPS genes revealed five PKS/NRPS (Table 4-3) 
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hybrid, five NRPS and a single PKS gene locus from the circular chromosome. 
However, no PKS and NRPS genes were identified from the plasmids.  
With 6.3% of the genome contributing to the synthesis of PKS- and NRPS-derived 
compounds, the biosynthetic ability of this bacterium is comparable to that of other  
and well known secondary metabolite producers such as Streptomyces coelicolor 
(4.5%), S. avermitis (6.6%) and Pseudomonas fluorescens (5.7%) (Nett et al., 2009). 
But this sequenced bacterial strain is not known for the production of secondary 
metabolites yet, raising the question whether the gene clusters present are indeed 
expressed. In a related strain, however the compound siphonazole was obtained as 
the first secondary metabolite from bacteria of the genus Herpetosiphon (Nett et al., 
2006). No gene cluster related to the biosynthesis of siphonazole was identified from 
the H. aurantiacus DSM 785 genome sequence. 
Gene Gene locus Size 
(Kb) 
No. of modules Compound 
PKS NRPS 
PKS/NRPS-1 haur_1856-haur_1863 53.1 2+ACL 6 Unknown 
PKS/NRPS-2 haur_1871-haur_1888 71.9 1 11 Unknown 
PKS/NRPS-3 haur_2008 12.3 1 1 Unknown 
PKS/NRPS-4 haur_2406-haur_2419 35.9 1 3 Unknown 
PKS/NRPS-5 haur_3958-haur_3974 112.6 16 8 Unknown 
NRPS-1 haur_1571-haur_1574 10 - 3 Unknown 
NRPS-2 haur_1800-haur_1809 14 - 1 Myxochelin A  
NRPS-3 haur_2088-haur_2092 16 - 5 Unknown 
NRPS-4 haur_2104-haur_2109 18.5 - 4+ACL Unknown 
NRPS-5 haur_3124-3130 13.3 - 2 Unknown 
PKS-1 haur_0864-haur_0874 17.2 1 - Unknown 
Table 4-3: PKS and/or NRPS gene loci from H. aurantiacus DSM 785. ACL, acyl-CoA 
synthetase 
Results 
70 
 
Therefore, to explore the biosynthetic potential of H. aurantiacus DSM 785, the 
sequences of the five PKS/NRPS, five NRPS and PKS gene loci are explored here in 
detail to gain perspectives towards the strategies to isolate the respective 
compounds. 
4.1.4.1.1 PKS/NRPS gene locus-1 
The hybrid gene locus-1, comprising six NRPS and two PKS modules is organized in 
five ORFs, i.e haur_1857, haur_1858, haur_1859, haur_1860 and haur_1861 (Table 
4-4). One of the PKS modules was found to be the PKS/NRPS hybrid module-1 
(Haur_1857). All PKS and NRPS ORFs have a size of 34.6 Kb and are flanked by 
additional ORFs speculated to be involved in the biosynthesis and modification of the 
PKS/NRPS hybrid product. These are transcriptional regulators (Haur_1853 and 
Haur_1855) and an AMP-dependant synthetase and ligase (Haur_1856) in the 
upstream and a transporter (Haur_1862), a pyridoxal dependent (PLP) enzyme 
(Haur_1863) as well as ornithine cyclodeaminase (Haur_1864) in the downstream 
region (Table 4-4). 
Gene locus Modules Putative functions 
haur_1856  AMP-dependant synthetase and 
ligase  
haur_1857 Module-L 
Module-1 
Module-2 
ACPL 
KS1-AT1-PCP1-AMT1 
C2-A2-MT2-PCP2 
haur_1858 Module-3 C3-A3-PCP3-E3 
haur_1859 Module-4 
Module-5 
C4-A4-PCP4-E4 
C5-A5-PCP5 
haur_1860 Module-6 KS6-AT6-KR6-ACP6 
haur_1861 Module-7 
Module-8 
C7-A7-PCP7-E7 
C8-A8-PCP8-TE 
haur_1862  Pyridoxal-phosphate dependent 
enzyme 
haur_1863  Ornithine cyclodeaminase 
Table 4-4: List of genes in PKS/NRPS gene locus-1 and their putative functions. Suffices 
indicate the respective modules. L, Loading module; ACP, Acyl Carrier Protein; KS, 
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Ketosynthase; AT, Acyltransferase; AMT, Aminotransferase; C, Condesation; A, Adenylation; 
MT, Methyltransferase; PCP, Peptidyl Carrier Protein; E- Epimerization 
AMP-dependent synthetase and ligase 
AMP-dependent synthetases and ligases belong to the adenylate-forming family of 
enzymes (ANL), which includes acyl and aryl-CoA synthetases, A domains of NRPS 
and luciferase (Gulick 2009). ANL enzymes in general catalyze the activation of a 
carboxylate substrate at the expense of ATP to form an acyl adenylate intermediate. 
The ANL enzymes can be easily identified from the amino acid sequences based on 
the three conserved core motifs, i.e. motif-1 (A3)-L-A-Y-X-X-Y-T-S-G-S(T)-T-G-X-P-
K-G, motif-2 (A5)- Y-G(W)-P(X)-T(A)-E and motif-3  (A7)- Y(X)-R(K)-T(S)-G-D-L, all 
required for ATP binding (Gulick 2009). The alignment of Haur_1856 AMP dependent 
synthetase and ligase showed 48% identity to the AMP-forming acyl-CoA 
synthetases of Moorea producta 3L. Also, the Haur_1856 sequences contain the 
three conserved motifs for ATP binding (Figure 4-7). In addition, 34 residues 
downstream to motif I is a histidine residue typical for long chain acyl-CoA 
synthetases and luciferase. In the case of A domains, this typical amino acid is 
phenylalanine and in small chain acyl-CoA synthetases it is tryptophan (Gulick 2009). 
Thus, it is concluded that based on bioinformatic results AMP-dependent synthetase 
and ligase from PKS/NRPS gene locus-1 is adenylating a long chain carboxy acid. 
 
Figure 4-7: Characteristic motifs in acyl-CoA synthetases (highlighted in yellow). Alignment 
of AMP-dependent synthetase and ligase from PKS/NRPS gene locus-1 (Haur 1856) of 
Moorea producta (Acc no-ZP08428587.1), of HctA from Lyngbya majuscula (Acc no- 
AAY42393.1), of β-keto acyl synthase-AMP from Microcoleus chthonoplastes PCC 7420 
(Acc no- ZP05029386.1) and Long chain (LC) Fatty acid (FA)-CoA ligase from Cyanotheca 
sp (Acc no- ZP08976119.1). The histidine amino acid typical for acyl-CoA synthetases 
selecting long chain substrates is highlighted in orange. The consensus sequences from the 
literature are highlighted in bold. The numbers indicate the position of amino acids. 
 L A Y X X Y T S G S T G X P K G  H  Y G P T E  Y R T G D L  
          T           W X A   X K S     
Haur 1856 L A F L Q Y T S G S T S Q P R G 193 H 228 Y G L A E 339 L R T G D L 448 
M. producta L A F L Q Y T S G S T A A P K G 181 H 216 Y G M A E 328 L R T G D L 441 
HctA I A Y L Q Y T S G S T S T P K G 185 H 220 Y G L A E 332 L R T G D L 445 
Beta-ketoacyl L A F L Q Y T S G S T G T P K G 187 H 222 Y G M A E 335 L R T G D L 447 
LC-FA-CoA L A F L Q Y T S G S T G N P K G 175 H 210 Y G L A E 323 L R T G D L 446 
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Adenylation domains 
Non-ribosomal peptides possess diverse structures because of the multiple building 
blocks. These comprise not only the twenty proteinogenic amino acids but also other 
acids (Schwarzer et al., 2003). It is the A domain that accesses the specific substrate 
for loading to the respective NRPS module (Marahiel et al., 1997). The A domain 
amino acid sequences contain ten highly conserved core motifs (Konz and Marahiel, 
1999). These core motifs harbor the ten amino acid residues referred to as 
Stachelhaus code. They are found in between the core motifs-4 and -5, and in motif-
10, and together define the substrate of the respective A domain (Stachelhaus et al., 
1999, Challis et al., 2000). 
The hybrid gene locus-1 with six NRPS modules comprises six A domains, i.e A2–A8 
(Table 4-4). All the A domains contain the ten core motifs with a slight deviation 
(Figure 4-8A). The ten amino acid code extracted from in between the core motifs-4, 
5 and -10 were used to predict the substrate for each A domain. The Stachelhaus 
code, DIWELTADD deduced from the A2 domain amino acid sequence is 90% 
identical to that of the A domain predicted to activate 2,4-diaminobutyric acid in 
pyoverdine biosynthesis (Mossialos et al., 2002). The computational analysis of the 
A2 domain amino acid sequences in the NRPS predictor-2 showed a high score for 
the amino acid 4-hydroxyphenlyglycine (HPG) and its derivatives. Despite these 
results, the putative substrate activated by the A2 domain remains obscure. Except 
for A2, the substrate specificities of all A domains could be predicted using the 
Stachelhaus code (Figure 4-8B). Thus, A domain A3 activates asparagine, A4 
activates threonine, A5 activates serine, A7 activates ornithine and A8 activates 
glycine.  
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Gene locus A domain Stachelhaus code Predicted substrate 
haur_1857 A2 DIWELTADD* Unknown 
haur_1858 A3 DATKVGEVGK Asparagine 
haur_1859 A4 DFWNIGMVHK Threonine 
haur_1859 A5 DVWHFSLVDK Serine 
haur_1861 A7 DVGEIGSIDK Ornithine 
haur_1861 A8 DILQLGMVWK Glycine 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A2 Y S Y Q A L 45 F K A G A A Y L P L D 95 L A Y V I Y T S G S T G L P K G 179 F D I S 218 N A Y G P T E 308 
A3 I C Y T E L 51 L K A G A A Y L P L D 101 L A Y V I Y T S G S T G K P K G 179 F D A T 218 N E Y G P T E 313 
A4 L S Y A E L 56 L K A G A A Y V P L D 106 P A Y V I Y T S G S T G N P K G 179 F D F S 218 N M Y G I T E 318 
A5 Y S Y A E L 56 V K A G A A Y V P F D 106 A A Y M I Y T S G S T G K P K G 179 F D V S 218 N L Y G P T E 314 
A7 L S Y A Q L 52 L K A G A A Y L P L D 102 P A Y V I Y T S G S T G L P K G 180 F D V C 219 N S Y G V T E 318 
A8 L S Y A E L 48 L K A G G A Y V P L D 98 L A Y A I Y T S G S T G K P K G 179 F D I A 218 N M Y G P T E 310 
 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
A2 G E L Y V G G V G V G R G Y L 380 Y R T G D L 409 G R I D H Q V K V R G F R I E L G E I E 441 Q W D S V W A 497 I N T I G W 515 
A3 G E L Y I A G L G V G R G Y H 374 Y R S G D L 416 G R I D Q Q V K L H G F R I E L G E I E 448 L P H Y M L P 506 N G K V D R 525 
A4 G E L Y V G G A G V A Q G Y L 380 Y R S G D L 412 G R I D L Q V K I R G F R I E L G E I E 444 L P E Y M W P 511 N G K L D R 530 
A5 G E L L I G G L N L A R G Y A 373 Y R T G D L 402 G R N D F Q I K V R G I R V E L G E I E 434 L P E A M I P 488 N G K L N R 506 
A7 G E L Y L A G E R L A S A Y L 379 Y R T G D R 408 G R G D Q Q I K L R G F R I E L G E I E 440 V P E Y M L P 494 N G K V D R 512 
A8 G E L Y I A G T G V A R G Y H 372 Y R T G D L 401 G R I D Q Q V K I R G Y R I E L G E I E 433 L P R Y M L P 489 N G K I D R 507 
Motif-4 Motif-5 
(A) 
(B) 
Motif-2 Motif-3 Motif-1 
Motif-6 Motif-7 Motif-10 Motif-8 Motif-9 
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Figure 4-8: PKS/NRPS gene locus-1 adenylation (A) domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains from 
PKS/NRPS gene locus-1. The ten core motif sequences (Konz and Marahiel, 1999) are 
highlighted in bold and the respective motifs in the PKS/NRPS-1 A domains are highlighted 
in yellow. The numbers represent the amino acid positions in the respective proteins. 
Suffices indicate the respective modules. 
(B) The table lists the Stachelhaus codes extracted from the sequences of PKS/NRPS gene 
locus-1 A domains and their putative amino acid substrates. The asterisk indicates the 
missing amino acid. 
Acyltransferase domains  
In PKS megasynthetases the AT domain is the key element in determining the 
building blocks of the respective polyketide.  The active site motif-2 of the AT 
domains include the sequence GHSIG, where the serine is required for the catalytic 
activity of the AT.  In the PKS/NRPS gene locus-1 two AT domains, i.e AT1 and AT6 
(Table 4-4) are encoded, which both have this sequence motif (Figure 4-9). The two 
other conserved motifs, i.e. motif-1 and -3 that were identified in AT1 and AT6 
domains showed slight variation in their sequence but showed close homology to 
malonyl-CoA specific ATs (Smith and Tsai, 2007)(Figure 4-9). Therefore, both the AT 
domains was speculated to select malonyl-CoA as their substrates. 
 
 Z T X $ A Q  G H S X G  * A F H  
     T E        G  S   
AT1 D T R Y T Q 62 G H S I G 92 H G F H 191 
AT6 A T N V A Q 60 G H S I G 90 H A F H 187 
Figure 4-9: Characteristic motifs in the AT domains, AT1 and AT6 (highlighted in yellow) of 
PKS/NRPS gene locus-1. The catalytically active serine is highlighted in green. Malonyl-CoA 
specific AT consensus sequences from the literature (Smith and Tsai, 2007) are highlighted 
in bold. Z, hydrophilic amino acid; $, aromatic amino acid; X, branched hydrophobic amino 
acid; *, [HTVYGMIL]. The residues that deviates from the literature are highlighted in brown. 
The numbers represent the position of the amino acids. Suffices indicate the respective 
modules. 
 
 
Motif-1 Motif-2 Motif-3 
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Carrier protein (ACP-PCP) domains 
After the selection of the substrates by the respective AT or A domains, they are 
loaded to the 4’-phosphopantetheine arm attached to the serine residue of the carrier 
proteins, referred to as ACP in PKS and PCP in NRPS (Lai et al., 2006). Sequence 
alignment of the ACP and the PCP domains of the hybrid gene locus-1, i.e PCP2 to 
PCP8 and ACPL, ACP1 as well as ACP6 (Table 4-4) showed that the active site serine 
residue (Findlow et al., 2003) is conserved, suggesting that all the carrier protein 
domains are active (Figure 4-10). The other conserved sequences were also 
identified (Konz and Marahiel, 1999; Pawlik et al., 2007). 
  
 
          
 
 
Figure 4-10: Characteristic motifs in the PCP (A) and ACP (B) domains (highlighted in 
yellow) of PKS/NRPS gene locus-1. The PPant attaching serine residue is highlighted in 
green. Conserved sequences from the literature (Konz and Marahiel, 1999; Pawlik et al., 
2007) are highlighted in yellow. The numbers indicate the position of amino acid. Suffices 
indicate the respective modules. L- Loading module. 
Condensation domains 
The C domains are responsible for connecting all the loaded substrates in a 
sequential manner by a condensation reaction. This takes place between the 
upstream amino acyl or peptidyl-S-PCP with the downstream aminoacyl-S-PCP, 
resulting in amide bonds (Schwarzer et al., 2003). Albeit the C domains in NRPS and 
KS domains in PKS have analogous functions, the chemical mechanisms behind the 
connecting reactions are divergent (Fischbach et al., 2006).  
C domains include seven highly conserved core motifs (Konz and Marahiel, 1999). 
Alignment of the hybrid gene locus-1 C domains, i.e C2 - C8 (Table 4-4) showed that 
there were slight deviations in the conserved sequences in six of the seven core 
 D X F F X L G G H S L  
         D  I  
PCP2 Q S F F E L G G H S I 30 
PCP3 A N F F S L G G D S I 30 
PCP4 V N F F S L G G D S I 30 
PCP5 R P F F D L G G H S L 30 
PCP7 A N F F G L G G D S R 29 
PCP8 D H F L E H G G H S L 29 
 G X X S   
ACPL G L S S L 22 
ACP1 G A D S L 32 
ACP6 G G H S L 30 
(A)  PCP domains                                             (B) ACP domains 
(B)  ACP domains 
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motifs (Figure 4-11). Just like in the myxochelin biosynthetic gene cluster, the 
seventh motif could not be identified from the sequence (Silakowski et al., 2000). 
However, all the hybrid gene locus-1 C domains harbor the highly conserved H-H-X-
X-X-D-G region. This histidine motif is necessary for amide bond formation 
(Bergendahl et al., 2002; Konz and Marahiel, 1999) and its presence makes it likely 
that all C domains of the hybrid gene locus-1 are functional. One of the C domains, 
i.e C2 is preceeded by an aminotransferase (AMT1) domain (Table 4-4), and thus 
suggested to be a hybrid C domain (Rausch et al., 2007) catalyzing the condensation 
reaction between an upstream aminated polyketide and a downstream amino acyl-S-
PCP2. The C4, C5 and C8 domains are preceeded by E3, E4 and E7 domains, 
respectively and are expected to belong to the class of DCL domains (Table 4-4). 
These DCL domains catalyse the condensation reaction between an upstream D-
amino acyl or petidyl-S-PCP with a downstream L-amino acyl-S-PCP. The DCL 
domains i.e C4, C5 and C8 differs concerning some critical residues from those of the 
LCL domains. This allows to differentiate their respective function (Rausch et al., 
2007) (Figure 4-11).  
 
Figure 4-11: Characteristic motifs in the C domains of PKS/NRPS gene locus-1 are 
highlighted in yellow. The catalytically active residues are highlighted in green. The residues 
critical for the DCL domains are highlighted in violet and those of 
LCL domains are highlighted 
in blue (Rausch et al., 2007).  The conserved residues from the literature (Konz and 
 S X A Q X R L W X L    R H E X L R T X F  M H H X I S D G W S  
       M Y                        V   
C2 S E D Q Y H L W V L 16 P 29 R H E S L R T I I 61 V H H L L V D G W S 140 
C3 S F A Q Q R L W F L 14 A 26 R H E T L R T T F 58 L H H I I A D G W S 141 
C7 S F G Q E R L W F L 16 S 28 R H E I L R T S F 60 M H H T I A D G W S 144 
C4 S P M Q Q G M L F H 16 Q 28 R H T I L R S G F 60 F H H L L L D G W S 144 
C5 A P L Q V G M L Y H 16 Q 28 R H A V L R T A F 60 H H H L L L D G W S 144 
C8 T P L Q E G M L F H 16 Q 28 R H A V F R T A F 60 H H H L L L D G W S 142 
 Y X D F A V W       V G X F V N T L Q X R  N Q D Y P F E  
    Y          I       Q A    H        
C2 F R D Y L A W 175 V G I P 267 V G Y C G N L L P L R 296 N E D Y S L A 322 
C3 Y A D Y S E W 177 I G S P 273 I G F F V N T V V F K 302 N Q D V P F E 328 
C7 Y G D F A A W 180 I G T P 276 I G F F V N S L V M R 305 N Q D A P F A 331 
C4 Y R A Y I D W 179 F G A T 271 I G L C I N T L P I R 300 L Q Q H S A S 325 
C5 Y R D Y I A W 178 F G A T 270 V G L C I N S L P V R 298 C N D F A A T 324 
C8 Y R E Y L G W 177 F G L T 269 V G M F I N T L P C V 297 A Q Q Y A A S 323 
Motif-3 Motif-2 
Motif-6 Motif-5 Motif-4 
Motif-1 
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Marahiel, 1999) are highlighted in bold. The numbers indicate the position of amino acids. 
Suffices indicate the respective modules. 
Ketosynthase domains  
After loading the substrates to the respective ACP domains of PKS modules, the KS 
domain links all the substrates sequentially starting from the intitation module by 
Claisen condensation (Staunton and weissman, 2001; Hertweck, 2009). Since the 
two PKS modules, with KS1 and KS6 are elongating modules, both of them require 
KS domains for this activity. PKS module-6 (Haur_1860) is preceeded by an NRPS 
module (Haur_1859) (Table 4-4). Therefore, KS6 is likely to mediate Claisen 
condensation between an upstream peptidyl-S-PCP5 and a downstream malonyl-S-
ACP6. Sequence alignment of both the KS domains, i.e KS1 and KS6 showed that the 
catalytic triad ‘C/H/H’(Zhang et al., 2006) is conserved in KS1 and KS6 (Figure 4-12). 
The histidine residues are necessary for malonyl-CoA decarboxylation and the 
cysteine moiety is required for the condensation reaction between the resulting 
carbanion and the upstream acyl-S-ACP or peptidyl-S-PCP (Carlson et al., 2010; 
Pawlik et al.,2007).  
 
 
Figure 4-12: Catalytic cysteine/histidine/histidine motif (highlighted in green) extracted from 
the KS domains of PKS/NRPS gene locus-1. Consensus sequences from the literature 
(Zhang et al., 2006) are highlighted in bold. The numbers indicate the position of the amino 
acid. Suffices indicate the respective modules. 
Epimerization domains 
One of the unusual features of non-ribosomal peptides is the occasional presence of 
D-amino acids as part of the peptidic structure (Schwarzer et al., 2003). In NRPS 
megasynthetases, the epimerization reaction is performed by a so called E domain. 
In rare cases the C domain might also perform the epimerization reaction, often 
referred to as C/E dual domain (Vallet-Gely et al., 2009). Sequence alignments of the 
epimerization domains E3, E4 and E7 from the hybrid gene locus-1 (Table 4-4) 
showed that all seven core motifs (Konz and Marahiel, 1999) were conserved with 
only a slight variation (Figure 4-13).  
 C    H     H   
KS1 C S S 173 H G T 306 G H L 343 
KS6 C S T 175 H G T 311 G H L 348 
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Figure 4-13: Characteristic motifs in E domains (highlighted in yellow) of PKS/NRPS gene 
locus-1. Consensus sequences from the literature (Konz and Marahiel, 1999) are highlighted 
in bold. The numbers indicate the position of amino acids. Suffices indicate the respective 
modules. 
Methyltransferase domain  
N-methylation and C-methylation is one of the most common modification reactions 
in NRPS and PKS systems, and occurs at the thioester bound stage (Schwarzer et 
al., 2003, Hertweck, 2009). It is the methyltransferase (MT), which transfers the 
methyl group from S-adenosyl-methionine to the acceptor. All MTs are expected to 
possess the typical glycine rich S-adenosyl-methionine binding motif-1, (V/I/L)-(L/V)-
(D/E)-(V/I)-G-(G/C)-G-(T/P)-G (Konz and Marahiel, 1999). PKS/NRPS gene locus-1 
is encoding for one MT, i.e MT2 (Table 4-4). BLASTP of the MT2 domain protein 
sequence showed 41% identity to Nda A from Nodularia spumigena. The MT2 
domain amino acid sequence also contains additional five core motifs typical for N-
MT (Konz and Marahiel, 1999; Hacker et al., 2000). Except for motif-5 and motif-3 all 
other motifs are conserved, in MT2 with respect to reference sequences (Figure 
4-14).  
 P I Q X W F  H H X I S D G W S  D X L L X A X G  E G H G R E  
               V                   
E3 P M Q H W L 14 H H S I I D G V S 133 E L L I T G L A 239 E S H G R E 260 
E4 S I G H W L 14 H H L V I D G V S 138 D L L L T A L T 248 E S H G R F 269 
E7 P V Q H W F 26 H H W I I D G V S 146 N D L L L T A L 249 E S H G R F 275 
 R T V G W F T X X Y P Y P F E  P X X G X G Y G  F N Y L G Q  
            V                   R  
E3 R S L G W F T S L Y P V R L D 283 P Q A G A G Y G 313 F N Y L G Q 339 
E4 R S V G W F T S L Y P V A L D 292 P A G G Q S F G 322 F N Y L G Q 346 
E7 R T V G W L T S I Y P Q H V S 298 P D Q G L S Y G 328 F N Y L G Q 354 
Motif-4 Motif-1 Motif-2 Motif-3 
Motif-5 Motif-6 Motif-7 
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Figure 4-14: Conserved motifs for the N-MT (highlighted in yellow) domain MT2 of 
PKS/NRPS gene locus-1, NdaA from Nodularia spumigena (acc.no-AA064403.1), MycA from 
Anabaena sp. 1tu44S16 (acc no-ABW96246.1), Pro-D from Planktothrix rubescens (acc no-
ACG63858.1). The conserved motifs as described by Hacker et al., 2000 are referred to in 
roman numbers, whereas the motifs taken from Konz and Marahiel, 1999 are referred to in 
numeric. The numbers indicate the position of amino acids. Suffices indicate the respective 
modules. 
Ketoreductase domain 
Ketoreductases are NADPH dependant enzymes catalyzing the reduction of the β-
keto-group of the keto acyl-S-ACP to a hydroxyl group (Hertweck, 2009). The KR6 
domain is the only KR domain in the PKS/NRPS gene locus-1 (Table 4-4) and carries 
the NADP(H) binding site G-X-G-X-X-G(A)-X-X-X-A which is necessary for its activity 
(Bachmann and Ravel, 2009). The KR6 domain also includes the catalytic triad S-
136/Y-149/N-153 required for the catalytic activity (Pawlik et al., 2007) (Figure 4-15). 
Sequences of KR domains can also reveal the configuration of the chiral centre 
formed by the reduction reaction. However, the KR6 domain amino acid sequence 
lacks in both, the consensus motifs LDD, P-144 and N-148 required for the R-
  V L E I G X G X G  S Y V G L D P S  N S V V Q Y F P X X X Y L  
    D                    A           
MT2 I L E L G C G T G 81 S Y R G H D I A 100 N S V A Q Y F P S I D Y L 157 
NdaA  V L E I G S G T G 82 R Y C G T D I S 101 N S V V Q Y F P S I D Y L 158 
McyA  V L E I G C G T G 85 H Y W G T D I S 104 N S V V Q Y F P H I D Y L 161 
ProD1 V L E I G C G T G 82 S Y W G I D A A 101 N S V V Q Y F P N I D Y L 158 
ProD2 V L E I G C G T G 81 R Y W G T E L S 100 N S V I Q Y F P S I D Y L 157 
 A T N G H F L A A R A  
  
N E L S X Y R Y X A V  
      
V 
     
E X S X A R Q 
     
X 
  
G L D  
MT2 S L N P L L H A S I Q 36 N E L T R F R Y D V V 104 I S V S L A Q S G E L G 371 
NdaA P L L P A F H A D I V 36 N E L T R F R Y D V I 104 I D I S W S D A G A N G 370 
McyA Q L L E A F H T S V E 36 N E L T Q F R Y N V L 104 L V V S W S D S S V L G 377 
ProD1 P L L S A F H S S V Q 36 N E M T K F R Y D V V 104 I K I D F A - T D A L D 372 
ProD2 P L L E A F H T G I Q 192 N E M S K Y R Y D V V 260 V E I F S S - A D A L D 375 
Motif-3 Motif-2 Motif-V 
Motif-IV Motif-II/Y Motif-1 
Results 
80 
 
configuration with respect to the hydroxyl group (B type) and W-141 needed for the 
S-configuration with respect to the hydroxyl group (A type) (Caffrey., 2003). 
 
 
Figure 4-15: Characteristic motifs in the KR6 domain (highlighted in yellow) of PKS/NRPS 
gene locus-1. The catalytic active residues are highlighted in green. Consensus sequences 
from the literature (Bachmann and Ravel, 2009; Pawlik et al., 2007) are highlighted in bold. 
The numbers indicate the position of amino acid. The suffix indicates the respective module. 
Aminotransferase domain  
The PKS/NRPS hybrid module-1 includes a putative AMT1 domain, the encoding 
sequences for which are located between the PKS and NRPS part of modules- 1 and 
2 respectively in Haur_1857 (Table 4-4). Aminotransferases catalyse the transfer of 
an amino group from an amino acid to an α-keto acid in the presence of pyridoxal 
phosphate. Therefore, an AMT is expected to posses the conserved residues K-277 
for the binding of the pyridoxal phosphate cofactor, and both, E-220 and D-248 for 
interacting with the 3-OH and the N1 of pyriodixal phosphate (Naranjo et al., 2005) 
(Figure 4-16). Alignment of the AMT1 domain protein sequences with mycosubtilin 
synthetase A showed the presence of pyridoxal phosphate binding site sequences 
(Duitman et al., 1999) (Figure 4-16). Therefore, the AMT1 domain is suggested to 
aminate the ketoacyl-S-ACP1. 
AMT1 E 333 D 366 D L A T Y G K I V G G G M P I G V V A G R 407 
MycA  E 354 D 387 D L V T Y G K V I G G G Q P L G V V A G K 428 
BmyD  E 347 D 380 D L V T Y G K I I G G G Q P L G I V A G K 421 
iturin a syn a E 375 D 408 D L V T Y G K V I G G G L P I G I V G G K 449 
MicA  E 382 D 415 D I A T Y G K V I A G G M P I G V V A G K 456 
Figure 4-16: Conserved pyridoxal phosphate binding site sequences (Duitman et al., 1999) 
of AMT1 in PKS/NRPS gene locus-1, with functional AMT domains are highlighted in yellow. 
The residues typical for the binding of pyridoxal phosphate are highlighted in orange 
(Naranjo et al., 2005). The numbers indicate the position of amino acids. The suffix indicates 
the respective module. MycA from Desmospora sp. 8437 (Acc no-ZP08466280), BmyD from 
Bacillus subtilis (Acc no-AAN07012.1), iturin a synthetase a from Paenibacillus elgii B69 (Acc 
no-ZP09075091.1), MicA from Planktothrix rubescens NIVA-CA-98 (Acc no- CA048259.1). 
 G X G X X G X X X A  S  Y  N  
      A            
KR6 G N G G L G R Q I A 16 S 136 Y 149 N 153 
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Thioesterase domain 
Thioesterases belong to the family of α/β-hydrolases catalyzing the cleavage of 
thioesters. TE domains must have the conserved motif 1, i.e G-X-S-X-G, which is 
typical for hydrolytic enzymes (Rajakumari and Daum, 2009). In addition, TE amino 
acid sequences comprise a highly conserved aspartate residue, which is 25 residues 
downstream to the conserved motif 1. Another conserved region is motif-2, i.e G-X-H 
(Konz and Marahiel, 1999). The latter motif is at approximately 130 residues 
downstream to the aspartate residue. The catalytic triad S/D/H extracted from the 
above consensus motifs is necessary for the TE domain activity (Bruner et al., 2002). 
The C-terminus of the PKS/NRPS gene locus-1 (Table 4-4) encodes a TE domain as 
a part of haur_1861. Examining the amino acid sequences of this TE domain 
revealed the presence of the highly conserved catalytic triad with S, D and H motifs 
(Figure 4-17). Therefore, this TE domain was suggested to be active in releasing the 
fully assembled hybrid product from the megasynthetase. Moreover, the TE domain 
includes a characteristic proline residue 64 residues upstream to motif-1, which is 
typical for TE acting as cyclases (Roonsawang et al., 2007) (Figure 4-17). So, this TE 
domain of PKS/NRPS gene locus-1 is speculated to cyclize the linear putative 
lipopeptide by mediating a nucleophilic attack between the amino group introduced 
by the action of AMT1 on the fatty acid and the terminal carboxyl group. 
   G X S X G  D  G X H  
TE P 7 G H S F G 75 D 100 G D H 237 
CrpD P 7 G H S F G 75 D 100 G N H 244 
BA TE P 7 G H S F G 75 D 100 G D H 248 
MF TE P 7 G H S F G 75 N 100 G D H 244 
CC TE P 7 G H S F G 75 D 100 G D H 240 
Figure 4-17: Consensus sequences of the TE domain (highlighted in yellow) from the 
PKS/NRPS gene locus-1; CrpD from Nostoc sp. ATCC 53789 (Acc no-ABM21572.1); BA, TE 
from Burkholderia ambifera IOP40-10 (Acc no- ZP02892872.1); MF TE, Myxococcus fulvus 
HW-1 (Acc no- YP04668982.1); CC TE, Cyanotheca sp. CCY0110 (Acc no- ZP01728834.1). 
The catalytic active site residues are highlighted in green. The proline typical for the cyclase 
group of TE is highlighted in blue. Conserved sequence from the literature (Konz and 
Marahiel, 1999) is highlighted in bold. The numbers indicate the position of amino acids. 
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Putative structure encoded by hybrid gene locus-1 
Based on PKS/NRPS gene locus-1 sequence, the locus is predicted to encode a 
putative lipopeptide composed of β-amino fatty acid tail linked to a hexapeptide 
(Figure 4-18). The latter should consist of six amino acids including D-asparagine, D-
threonine, L-serine, D-ornithine, L-glycine and an unpredictable amino acid (Figure 
4-8B). Ornithine cyclodeaminase encoded by haur_1863 (Table 4-4) is expected to 
convert ornithine loaded on PCP7 to proline. Finally, the molecule is supposedly 
cyclised by an intramolecular attack of the β-amino group of the fatty acid side chain 
with the terminal carboxy group of L-glycine to form a lactam ring (Figure 4-18). 
Similar to the other lipopeptides like mycosubtilin, bacillomycin and iturin, the putative 
lipopeptide encoded by the hybrid gene locus-1 is also expected to possess 
antimicrobial activity (Duitman et al., 1999). 
(A) 
 
 
 
(B) 
 
 
Figure 4-18: PKS/NRPS gene locus-1 
(A) Putative PKS (red) and NRPS (blue) genes in PKS/NRPS gene locus-1. Brown, acyl-CoA 
synthetase; green, PKS/NRPS hybrid.   
(B)Predicted strcture of the putative lipopeptide encoded by PKS/NRPS gene locus-1. X,  
Unknown fatty acid side chain; R, Unknown amino acid. 
 4.1.4.1.2 PKS/NRPS gene locus-2 
The PKS/NRPS gene locus-2 with eleven NRPS and a single PKS module spanning 
from haur_1871- haur_1888 is 65.3 Kb in size (Table 4-5). The biosynthesis of the 
putative compound is most likely to start with the activation and loading of an unusual 
long chain starter unit by the action of AMP-dependent synthetase and ligase (Figure 
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SH
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SH
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4-19) (Haur_1884) to the ACPL encoded by haur_1873. The loaded starter is then 
proposed to condense with the malonyl- S-ACP1 linked to the partially reducing PKS 
module-1 in Haur_1873. In addition to Smith and Tsai (2007) model, the selection of 
malonyl-CoA by the AT1 domain is supported by the presence of the consensus 
motifs GQSVG and IAFH (Yadav et al., 2003) in the AT1 domain amino acid 
sequence (Figure 4-20). The PKS module-1 includes an internal MT1 domain (Table 
4-5). BLASTP of the MT1 encoded by haur_1873 showed 52% identity to KtzH (O-
MT) of Kutzneria sp. 744 (Fujimori et al., 2007). Therefore, the O-MT1 of haur_1873 
was presumed to methylate the hydroxyl group generated collectively by the action of 
KR1 and DH1 domains on the starter unit.  
Gene locus Modules Putative functions 
haur_1871  p-hydroxymandelate synthase 
haur_1872  Hypothetical protein 
haur_1873 Module-L 
Module-1 
ACPL 
KS1-AT1 –DH1-MT1-KR1-ACP1 
haur_1874 Module-2 C2-A2-PCP2-E2  
haur_1875 Module-3 C3-A3-PCP3-E3-C4’ 
haur_1876  Taurine catabolism dioxygenase (TfdA/TauD) 
haur_1877 Module-4 C4-A4-PCP4-E4 
haur_1878  C5’ 
haur_1879 Module-5 
Module-6 
C5-A5-PCP5 
C6-A6-PCP6 
haur_1880  Hypothetical 
haur_1881 Module-7 C7-A7-PCP7-C8’ 
haur_1882 Module-8 
Module-9 
Module-10 
Module-11 
Modue-12 
C8-A8-PCP8 
C9-A9-PCP9 
C10-A10-PCP10 
C11-A11-PCP11 
C12-A12-PCP12-TE1 
haur_1883  Phenylalanine/histidine ammonia-lyase 
haur_1884  AMP-dependant synthetase and ligase 
(AMP) 
haur_1885  TE2 
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haur_1886  Glycosyl transferase  
haur_1887  L-p-hydroxyphenylglycine (HPG) 
transaminase 
haur_1888  4-hydroxyphenylpyruvate dioxygenase 
Table 4-5: List of genes in PKS/NRPS gene locus-2 and their putative functions. Suffices 
indicate the respective modules. L, Loading module; ACP, Acyl Carrier Protein; KS, 
Ketosynthase; AT, Acyltransferase; DH, Dehydratase; MT, Methyltransferase; C, 
Condesation; A, Adenylation; PCP, Peptidyl Carrier Protein; E, Epimerization. The genes 
encoding the biosynthesis of HPG are highlighted in blue. 
 
 
Figure 4-19: Characteristic motifs of acyl-CoA synthetase in the AMP dependent synthetase 
and ligase encoding genes (highlighted in green) in PKS/NRPS gene loci-2, 3, 4 and 5 and in 
the NRPS gene locus-4 of H. aurantiacus DSM 785. The histidine residue is typical for long 
chain acyl-CoA synthetases and is highlighted in green. The numbers indicate the position of 
amino acids. Conserved sequences from the literature (Gulick, 2007) are highlighted in bold.  
 
 
  L A Y X X Y T S G S T G X P K G  H  Y G P T E  Y R T G D L  
           T           W X A   X K S     
Hybrid-2 P A A I V Y S S G T T G F P K G 170 H 206 Y G L T E 303 F H T G D L 380 
Hybrid-3 L A Y L Q F S S G S T G Q P R G 196 H 232 Y G L A E 342 L R T G D L 455 
Hybrid-4 P A A I V Y S S G T T G F P K G 171 H 207 Y G L T E 302 F H T G D L 380 
Hybrid-5 P A L F Q Y S S G S T G R P K K 175 H 211 Y G C T E 313 F F T G D L 390 
NRPS-4 L A F L Q Y T S G S T G Q P K G 204 H 240 Y G M A E 351 L R T G D L 441 
Motif 1 Motif 2 Motif 3 
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 (A)  AT domains                                                                                                                          (B) KS domains 
 
 
 
 
 
 
 
(C) ACP domains                        (D) KR domains                                                                       (E) DH domains 
                
       
 
 
 
Figure 4-20: Characteristic motifs in AT, KS, ACP, KR and DH domains of PKS modules extracted from PKS/NRPS gene loci- 2, 3 & 4 and the 
PKS gene locus-1 in H. aurantiacus DSM 785 (highlighted in yellow). Catalytically active site residues are highlighted in green. Consensus 
sequences from the literature (Yadav et al., 2003; Pawlki et al., 2007; Bachmann and Ravel, 2009) are highlighted in bold. * indicates the 
invariant residues Q/M/I/L/V/F/A/M, # indicates S/F/P, § indicates T/A/N/G/E/D/S and $ indicates N/S/H/Q. The numbers represent the position 
of amino acids. Suffices indicate the respective modules. 
  C    H     H   
Hybrid-2-KS1 C S G 173 H G T 308 G H T 345 
Hybrid-3-KS1 C S S 168 H G T 303 G H L 338 
Hybrid-4-KS1 C S G 172 H G T 307 G H S 346 
Hybrid-4-KS5 C S T 172 H G T 308 G H L 345 
PKS-KS  C S S 209 H G T 342 G H T 380 
  Q  Q  G H S * G  R    # H  §  $  V  
Hybrid-2-AT1 Q 11 Q 52 G Q S V G 82 R 105 I A F H 194 T 224 N 243 F 248 
Hybrid-3-AT1 Q 11 Q 63 G H S V G 93 R 116 M A Y H 195 T 225 Q 244 V 249 
Hybrid-4-AT1 G 11 Q 52 G H S L G 82 R 105 I A F H 194 T 224 N 243 F 248 
Hybrid-4-AT5 Q 14 L 65 G H S L G 95 R 118 V A A H 192 N 222 H 242 V 247 
PKS-AT  -  Q 44 G H S L G 74 R 97 H A F H 175 T 205 Q 223 V 228 
  G X G X X G X X X A  S  Y  N  
       A            
Hybrid-2-KR1 G L S G I G L E V A 17 S 151 Y 165 N 169 
Hybrid-3-KR1 G T G G V G A Q L A 15 S 134 Y 150 N 154 
Hybrid-4-KR1 G S G G L G L E I A 17 S 145 Y 159 N 163 
Hybrid-4-KR3 G L G G I G S Q F A 17 S 159 Y 173 N 177 
PKS-KR  G G K G I T A E S V 22 S 141 Y 155 N 159 
  G X X S   
Hybrid-2-ACPL G L S S I 32 
Hybrid-2-ACP1 G L D S I 32 
Hybrid-3-ACPL G A T S L 32 
Hybrid-3-ACP1 G L D S L 32 
Hybrid-4-ACPL Q I D S I 32 
Hybrid-4-ACP1 G L D S I 32 
Hybrid-4-ACP5 G G D S L 30 
  L X X H X X X G X X X X P  
Hybrid-2-DH1 L R D H Q V Q G V V V L P 46 
Hybrid-4-DH1 L A D H V V Q E Q V L L P 46 
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Amino acid sequences of the eleven NRPS A domains (Table 4-5), i.e A2-A12 from 
PKS/NRPS gene locus-2 include ten conserved core motifs (Figure 4-22A). The 
Stachelhaus code extracted from these core motifs was used to predict the substrate 
of the respective A domains. Except for A6, A10 and A12, the Stachelhaus code of all 
other A domains were at least 70% identical with of those known substrates (Figure 
4-22B). The latter are highly likely to activate the predicted substrates. 
The Stachelhaus code extracted from the A2 domain of the PKS/NRPS gene locus-2 
suggested that it activates the non-proteinogenic amino acid 4-hydroxyphenylglycine 
(HPG). The PKS/NRPS gene locus-2 includes the entire set of genes, haur_1871, 
haur_1887 and haur_1888 (Table 4-5) encoding p-hydroxymandelate synthase, p-
hydroxyphenylglycine transaminase and 4-hydroxyphenylpyruvate dioxygenase, 
respectively, required for the synthesis of HPG (Figure 4-21) (Kastner et al., 2012). 
This unusual amino acid is also one of the building blocks of bioactive compounds 
like vancomycin, in which this amino acid plays an important role for its biological 
function (Hubbard et al., 2000).  
 
 
Figure 4-21: Biosynthesis of p-hydroxyphenylglycine (HPG). 
 
 
 
 
Primary 
metabolism Haur_1871 Haur_1888 Haur_1887 
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p-
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L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A2 Y S Y A E L 52 F K A G G L F L P L D 102 L A Y M I Y T S G T T G T P K A 181 F D I F 218 V L Y G P T E 318 
A3 L S Y G E L 51 L K A G A A Y V P L D 101 L V Y L I Y T S G S T G R P K A 181 F D A S 218 N A Y G P T E 308 
A4 L S Y A E L 51 L K A G G A Y V P L D 101 L M Y I I Y T S G S T G Q P K G 181 A D L G 218 N H Y G P T E 315 
A5 L T Y Q E L 52 L K A G A A Y L P I D 102 L A Y I I Y T S G S T G K P K G 181 A D L G 218 N H Y G P T E 315 
A6 L S Y A E L 51 L K A G A G Y V P L D 101 P V Y T I Y T S G S T G T P K G 181 F D F G 218 N G Y G P T E 314 
A7 L S Y H A L 51 L K A G A A Y A P V D 101 L A Y V M Y T S G S T G R P K G 181 F D A S 217 N G Y G P T E 312 
A8 L S Y H A L 51 L K A G A A Y A P V D 101 L A Y V M Y T S G S T G R P K G 181 F D A S 217 N G Y G P T E 315 
A9 L S Y A E L 45 L K A G G A Y V P L D 95 L A Y M I Y T S G S T G K P K G 181 F D V S 218 N L Y G P T E 315 
A10 W T Y A Q M 50 L K A G G A Y L P L D 100 L A Y V I Y T S G S T G V P K G 181 F D I S 218 N M Y G P T E 311 
A11 L S Y G A L 45 M K A G G A Y V P L D 95 L A Y M I Y T S G S T G T P K G 181 F D V S 218 N L Y G P T E 315 
A12 W S Y A E L 50 I K A G A A Y L P L D 100 L A Y V I Y T S G S T G V P K G 181 F D I S 218 N M Y G P T E 311 
 
 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
A2 G E L Y I G G A G V S R G Y L 378 Y R T G D L 403 G R I D Q Q V K I R G F R I E L G E I E 436 L P E Y M L P 490 N G K V D R 510 
A3 G E L Y I A G P G L A W G Y L 377 Y R S G D L 396 G R V D H Q V K I R G F R I E T G E I E 429 L P E H M L P 483 N G K L D R 503 
A4 G E L Y V G G A A L A R G Y W 378 Y R T G D V 408 G R A D D Q V K I R G F R I E L G E I E 441 L P D Y M V P 495 N G K L D R 515 
A5 G E L Y I G G A G V A R G Y L 378 Y R S G D V 408 G R S D D Q V K I R G Y R V E L G E I S 441 Q Q G I F A E 497 N R H M T V 515 
A6 G E L C V A G P S L S Q G Y L 387 Y R T G D V 406 G R I D H Q V K V R G Y R I E L G E I E 439 L P G Y M L P 489 N G K I N R 509 
A7 G E L Y L G G A G L A R G Y L 383 Y R S G D L 403 G R R D Q Q V K V R G Y R I E L E E I V 436 V P S Y M L P 487 N G K V D R 507 
A8 G E L Y L G G A G L A R G Y L 383 Y R S G D L 403 G R R D Q Q V K V R G Y R I E L E E I V 436 V P S Y M L P 487 N G K V D R 507 
A9 G E L Y I G G L Q V G R G Y Y 375 Y R T G D L 405 G R I D H Q V K V R G L R I E L G E I E 438 L P E F M L P 491 N G K L D R 511 
A10 G E L Y I G G S G I A R G Y L 367 Y R T G D L 397 G R I D H Q V K V R G F R I E L G E I E 430 L P E Y M L P 483 N G K V D R 503 
A11 G E V Y I G G V Q V G R G Y H 375 Y R T G D V 405 G R I D H Q V K L R G L R I E L G E I E 438 L P E Y M L P 491 N G K V D R 511 
A12 G E L Y I G G S G I A R G Y L 367 Y R T G D L 397 G R I D H Q V K V R G F R I E L G E I E 430 L P E Y M L P 483 N G K V D R 503 
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Figure 4-22: PKS/NRPS gene locus-2 A domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in 
yellow) from PKS/NRPS gene locus-2. The 10 core motif sequences as reported in the 
literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the 
amino acid positions in the respective sequences. Suffices indicate the respective modules. 
(B) The table lists the Stachelhaus codes extracted from the sequences of PKS/NRPS gene 
locus-2 A domains and their putative substrates. HPG, 4-hydroxyphenylglycine. The asterisk 
indicates the unknown amino acid. 
The NRPS modules of the PKS/NRPS gene locus-2 contain supposedly superfluous 
C domains (Table 4-5). Aligning the amino acid sequences of all C domains (Figure 
4-23A), i.e C2-C12, C4’, C5’ and C8’ from the hybrid gene locus-2 revealed that C4, C5 
and C8’ did not posses the consensus histidine motif in their active sites (Bergendahl 
et al., 2002; Roche et al., 2008). Therefore, these C domains are presumed to be 
inactive. However, these inactive C domains were either succeeded or preceeded by 
an active C domain, i.e C4’, C5’ and C8 (Table 4-5). Thus, all the NRPS modules of the 
PKS/NRPS gene locus-2 are proposed to be active in the biosynthesis (Figure 4-19, 
Figure 4-23, Figure 4-24).  
The E2, E3 and E4 domains of the PKS/NRPS gene locus-2, include the seven 
conserved motifs (Figure 4-23B) (Konz  and Marahiel, 1999). Therefore, these E 
domains were presumed to convert the L-HPG-S-PCP2, L-Phe-S-PCP3 and L-Asn-S-
PCP4 into D-HPG-S-PCP2, D-Phe-S-PCP3 and D-Asn-S-PCP4. 
Gene locus A domain Stachelhaus code Predicted substrates 
haur_1874 A2 DIFHFGLIIK HPG 
haur_1875 A3 DAFTIAAVWK Phenylalanine 
haur_1877 A4 DLTKIGHVGK Asparagine 
haur_1879 A5 DLTKVGHVG* Aspartate 
haur_1879 A6 DFFHHGGVNK Unknown 
haur_1881 A7 DAFWLGGTFK Valine 
haur_1882 A8 DAFWLGGTFK Valine 
haur_1882 A9   DVWHISLVDK 
 
Serine 
haur_1882 A10 DITQIGMVYK Unknown 
haur_1882 A11 DVWHLSLVDK Serine 
haur_1882 A12 DIVQIGMVYK Unknown 
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 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C2 C F A Q E R L W L M 16 R H E I L R T T F 61 L H H I V S D D W S 144 
C3 S P L Q Q G L L F H 16 R H A A L R T V F 61 N H H L L L D G W S 145 
C4' T P T Q Q G M L F H 16 Q H T I L R S C F 61 Q H H I L L D G W C 145 
C4 S P Q Q Q H V W A L 21 R Y E I L R T T F 65 V P T L C A D N L S 143 
C5 S P Q Q K Q L W S L 21 R Y E I L R T Q F 65 L P A L T A D L T T 141 
C5' S P M Q K G M L F H 16 R H S V L R T A F 61 R H H L L L D G W S 145 
C6 S F T Q E R Y W I L 16 R H A I L R T T F 61 M H H I I T D D W S 144 
C7 S F A Q E R L W F L 16 R H A S F R T T F 62 C H H I I S D G W S 148 
C8' T S A Q Q R V W F F 16 R H E I L R A S F 61 I Q H S I T D A W S 144 
C8 S F A Q E R L W F L 16 R H A S F R T T F 62 C H H I I S D G W S 148 
C9 S F A Q E R L W F L 16 R H S S L R T T F 62 L H H S I T D G W S 141 
C10 S F A Q E R L W F L 16 R H A S L R T S F 62 L H H T I T D G W S 141 
C11 S F A Q E R L W F L 16 R H A S L R T T F 62 L H H T I T D G Q S 141 
C12 S F A Q E R L W F L 16 R H A S L R T T F 62 L H H T I T D G Q S 141 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C2 V W Q - R Q R 184 I G C F I N M L V L R 298 N A E V P F E 330 
C3 Y R D Y I A W 180 V G L F I N T I P V C 298 Y H Y T G L N 330 
C4' Y R E Y I A W 156 L G L F I N T L P V R 298 Y E Y T P V A 330 
C4 E W Q - H E L 178 L G L F A K A V P L A 292 W Q E S F H W 331 
C5 E W L - N D T 162 L G L F A K H V P F F 279 W Q E Y W A W 328 
C5' Y G E Y I A W 186 V G L F I N T L P L R 301 Y E Y S S L V 333 
C6 H W Q - R Q W 185 I G F F L N T L P L R 299 H Q D L P F E 331 
C7 V W Q - R Q R 189 I G F L V N T W T L R 302 H R D L P F E 334 
C8' A W Q - A A W 186 L G F F I N T L V L R 299 Q Q D L P L E 331 
C8 V W Q - R Q R 189 I G F L V N T W T L R 302 H R D L P F E 334 
C9 L W Q - R A V 182 I G F F A N T L V V R 295 Q Q E L P F E 327 
C10 V W Q - R A V 182 I G F F A N T L V V R 295 H Q E L P F E 327 
C11 V W Q - R A V 182 I G F F A N T L V V R 295 H Q E L P F E 327 
C12 V W Q - R A V 182 I G F F A N T L V V R 295 H Q E L P F E 327 
 P I Q X W F  H H X I S D G W S  D X L L X A X G  E G H G R E  
               V                   
E5 P I Q Q W F 14 H H L V F D G I S 142 E V L L T A L A 256 E S H G R A 285 
E6 P I Q Q W F 14 H H L I F D G V S 143 D I L L T A L A 259 E S H G R E 282 
E7 P I Q H W F 14 H H L A I D T V S 142 D A L L A A L T 259 E G H G R E 282 
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(C) PCP domains 
 D X F F X L G G H S L  
         D  I  
PCP2 D N F F E L G G D S I 30 
PCP3 D N F F E L G G D S I 30 
PCP4 N N F F E L G G D S I 30 
PCP5 D K F F D L G G H S L 30 
PCP6 D N F F H I G G H S L 30 
PCP7 T N F F Q V G G H S L 30 
PCP8 T N F F Q V G G H S L 30 
PCP9 S N F F Q L G G H S L 30 
PCP10 A H F F Q L G G H S L 30 
PCP11 A H F F Q L G G H S L 30 
PCP12 Q N F F E L G G H S M 30 
Figure 4-23: Characteristic motifs in C (A), E (B) and PCP (C) domains (highlighted in 
yellow) from the NRPS modules of PKS/NRPS gene locus-2. The catalytically active site 
residues are highlighted in green. Consensus sequences from the literature (Konz and 
Marahiel, 1999) are highlighted in bold. The numbers indicate the position of amino acids. 
Suffices indicate the respective modules. The inactive domains are highlighted in grey. 
The locus harbors two TE domains (Table 4-5) i.e TE1 and TE2. The TE1 encoded on 
haur_1874 contains the catalytic triad S-89/D-116/H-264 required for activity.  In 
addition, TE1 includes a glycine residue at position 27, typical for the hydrolase type 
of TEs (Figure 4-24) (Roongsawang et al., 2007). The TE2 of uncertain function on 
haur_1885 contains S-89/S-116/H-264. As per the surfactin synthetase model, the D-
116 of the TE domain was required for the activity (Bruner et al., 2002). But in TE2 
domain amino acid sequence, serine instead of aspartate (Figure 4-24) raises 
question about the activity and role of this TE domain in the biosynthesis. 
Interestingly the TE2 domain amino acid sequence from the PKS/NRPS gene loci-3, 
4 and 5 of H. auaratiacus DSM 785 also harbors the serine amino acid instead of 
aspartate (Figure 4-24).  
 R T V G W F T X X Y P Y P F E  P X X G X G Y G  F N Y L G Q  
            V                   R  
E5 R T I G W F T S L Y P V I L D 307 P E Y G L S Y G 337 F N Y L G Q 356 
E6 R T I G W F T A I A P L R L T 305 P Q H G V G Y G 335 F N Y L G Q 357 
E7 R T V G W F T S R F P V L L Q 305 P Q R G I G Y G 335 F N Y L G T 364 
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Figure 4-24: Consensus sequences of the TE domains (highlighted in yellow) from the 
PKS/NRPS gene loci-2, 4 and 5 and the NRPS gene loci-1, 3 and 4. The catalytic active site 
residues are highlighted in green. The glycine typical for the hydrolases group of TE is 
highlighted in blue. The putative inactive TE domain is highlighted in grey. The consensus 
sequence in the TE2 domains is highlighted in pink. Conserved sequence from the literature 
(Konz and Marahiel, 1999) is highlighted in bold. The numbers indicate the position of amino 
acids. Suffices indicate the number of TE domains. 
In addition to the PKS and NRPS genes, the PKS/NRPS gene locus-2 harbors a 
gene encoding for a glycosyltransferase (Table 4-5). This glycosyltransferase is likely 
to be involved in the addition of a sugar moiety to the lipopeptide resulting in a 
putative glycolipopeptide (Figure 4-25). Since the sugar moiety and the starter unit 
cannot be predicted from the sequences, the expected molecular mass of the 
biosynthetic product cannot be calculated. Nevertheless, HPG as an unusual building 
block could used to trace this metabolite in a H. aurantiacus DSM 785 culture.  
(A) 
 
 
 
 
 
 
 
    G X S X G  D  G X H  
Hybrid-2-TE1 G 11 G W S F G 75 D 100 G D H 232 
Hybrid-4-TE1 G 11 G W S M G 75 D 100 G T H 235 
Hybrid-5-TE1 G 11 G W S F G 75 D 100 G T H 233 
NRPS-1-TE G 11 G W S L G 75 D 100 G D H 231 
NRPS-3-TE G 11 G W S F G 74 D 99 G D H 224 
NRPS-5-TE G 11 G H C V G 76 G 101 H A G 220 
Hybrid-2-TE2 G 27 G H S M G 92 S 117 G G H 224 
Hybrid-4-TE2 G 11 G H S M G 77 S 102 G D H 208 
Hybrid-5-TE2 G 60 G H S L G 125 S 150 G D H 257 
haur_1884   haur_1873                haur_1874           haur_1875                  haur_1877  haur_1878     haur_1879                 haur_1881 
 
haur_1884   haur_1873                haur_1874           haur_1875                  haur_1877  haur_1878     haur_1879                 haur_1881 
C8 A8 PCP8
SH
C9 A9 PCP9
SH
C10 A10 PCP10
SH
C11 A11 PCP11
SH
TE1C12 A12 PCP12
SH
TE2
haur_1882 
 
haur_1882 
haur_1885 
 
haur_1885 
ACL KS1
SH
ACPL ACP1
SH
C2 A2 PCP2
SH
E2 C3 A3 PCP3
SH
E3 C4 A4 PCP4
SH
E4C4'AT1
DH1
MT1
KR1
C5' C5 A5 PCP5
SH
C6 A6 PCP6
SH
C7 A7 PCP7
SH
C8'
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(B) 
 
 
 
Figure 4-25: PKS/NRPS gene locus-2 
(A) Putative PKS (red) and NRPS (blue) genes in PKS/NRPS gene locus-2. Brown-acyl-CoA 
synthetase; grey- accessory genes.   
(B) Predicted strcture of the putative glycosylated lipopeptide encoded by PKS/NRPS gene 
locus-2. Glycosyl group to be added and the position of glycosylation is unknown. X- 
Unknown fatty acid side chain; R1, R2 and R3-Unknown amino acid.  
4.1.4.1.3 PKS/NRPS gene locus-3 
The PKS/NRPS gene locus-3 is only 12.3 Kb in size and contains PKS and NRPS 
genes in a single ORF (Table 4-6). The biosynthesis is likely to commence with the 
loading of a long chain unusual starter unit on to the ACPL by the AMP-dependent 
synthetase and ligase encoded by haur_2008 ( Figure 4-19). The substrate of the 
AT1 domain could not be predicted from the observed consensus motif (Figure 
4-20A). The substrate of A2 domain could not predicted. Altogether, the substrates for 
both the PKS and NRPS modules of the PKS/NRPS gene locus-3 remain obscure. 
However, from the sequences all the domains i.e KS, AT, ACP, C, A, PCP in the 
PKS/NRPS gene locus-3 are active in the biosynthesis of the putative compound 
(Figure 4-20, Figure 4-26). The PKS/NRPS gene locus-3 lacks in a TE domain, 
instead the gene locus terminates with a C domain, i.e C3. It is evident from the 
sequence alignment that this terminal C domain could be functional. Therefore, the 
PKS/NRPS gene locus-3 is speculated to function in conjunction with one of the 
other loci, i.e is as such not a complete biosynthetic gene cluster. 
Gene locus Modules Putative functions 
Haur_2008 Module-L 
Module-1 
Module-2 
AMP-ACPL 
KS1-AT1-KR1-ACP1 
C2-A2-PCP2-C3 
Table 4-6: List of genes in PKS/NRPS gene locus-3 and their putative functions. Suffices 
indicate the respective modules. L, Loading module; AMP, AMP dependent synthetase and 
ligase; ACP, Acyl Carrier Protein; KS, Ketosynthase; AT, Acyltransferase; C, Condesation; A, 
Adenylation; PCP, Peptidyl Carrier Protein.  
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
H
N
N
H
COOH
O
O
O
O
O
O
O
O
O
O
OR1 R2 R3
COOH OH OH
NH2
O
OH
X
Result 
93 
 
(A) C domains 
 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C2 A P A Q V S - F Y V 47 R H P M L R A Q F 85 L H H S I A D G W S 168 
C3 T F A E Q R G F M L 71 R H Q M L R V R I 109 A H H I I G D G W S 195 
 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C2 F E H Y T E H 203 V G C C A D H L P L L 326 H S N I S A L 359 
C3 F Q D Y V K L 230 F G C F A T A L P I R 346 Q H A L A P T 379 
(B) A domain 
 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  
               V              S        
A2 L T Y A Q L 46 L W A G V P W L G L N 96 L A Y V I F T S G S T G R P K G 181 
 
 F D X S  N X Y G P T E  G E L X I X G X G L A R G Y L  Y R T G D L  
                           K          
A2 F D A A 218 N H Y G P T E 324 G E L Y I G G S G L A A G Y L 386 Y R T G D L 414 
 
 
(C) PCP domain 
 
 
Figure 4-26: Characteristic motifs in C (A) , A (B), PCP (C) domains of PKS/NRPS gene 
locus-3 (highlighted in yellow). The catalytically active residues are highlighted in green. 
Conserved sequences from the literature (Konz and Marahiel, 1999) are highlighted in bold. 
The numbers indicate the position of amino acids. Suffices indicate the respective modules. 
 
 G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
                           I      L    
A2 G R V D E Q I K L R G Y R I E P A E I E 446 L P P Q M I P 500 S G K I D R 519 
 D X F F X L G G H S L  
         D  I  
PCP2 D N F F D L G G H S L 30 
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(A)                                                                                      (B) 
 
 
Figure 4-27: PKS/NRPS gene locus-3.  
(A) Putative PKS and NRPS hybrid gene along with acyl-CoA synthetase (green) in 
PKS/NRPS gene locus-3.   
(B) Predicted strcture of the putative lipopeptide encoded by PKS/NRPS gene locus-3. X, 
Unknown fatty acid side chain; R’, Unknown PKS extender unit; Y, H/CH3/OH; R, Unknown 
amino acid. 
4.1.4.1.4 PKS/NRPS gene locus-4 
The PKS/NRPS gene locus-4 having a size of 34 Kb (Table 4-7) is contemplated to 
commence the biosynthesis with loading of an unusual long chain starter unit on to 
the ACPL , Haur_2412 by the trans acting AMP-dependent synthetase and ligase, 
Haur_2407 (Figure-4.19). The biosynthesis includes two PKS and three NRPS 
modules. Due to the deviations in the conserved The AT domains, i.e AT1 and AT5 of 
the PKS/NRPS gene locus-4 include the consensus sequence GHSLG (Figure 
4-20A). The other consensus motif IAFH in AT1 and VAAH in AT5 showed that these 
AT domains activate either malonyl or methylmalonyl-CoA. Sequence alignment of 
the PKS modules of the PKS/NRPS gene locus-4 showed that all the domains 
constituting the PKS region are active (Figure 4-20). 
Gene locus Modules Putative functions 
Haur_2406  Phenylalanine/Histidine ammonia-lyase 
Haur_2407  AMP-dependant synthetase and ligase 
Haur_2408  Glycosyltransferase 
Haur_2409  ABC 2 type transporter 
Haur_2410  ABC transporter related proteins 
Haur_2411  Hypothetical protein 
Haur_2412 Module-L 
Module-1 
ACPL 
KS1-AT1-DH1-KR1-ACP1 
Haur_2413 Module-2 C2-A2-PCP2-C3 
Haur_2414 Module-3 A3’-A3-KR3-PCP3 
X R'
Y
H
N
R
COOH
O
OH
haur_2008 
 
haur_2008 ACL
SH
ACPL KS1 AT1 ACP1
SH
KR1
C2 A2 PCP2
SH
C2
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Haur_2415 Module-4 C4-A4-PCP4 
Haur_2416 Module-5 KS5-AT5-PCP5-TE1 
Haur_2417  TE2 
Haur_2418  Glycosyltransferase 
Haur_2419  O-methyltransferase 
Table 4-7: List of genes in PKS/NRPS gene locus-4 and their putative functions. Suffices 
indicate the respective modules. L, Loading module; ACP, Acyl Carrier Protein; KS, 
Ketosynthase; AT, Acyltransferase; DH, Dehydratase; C, Condesation; A, Adenylation; PCP, 
Peptidyl Carrier Protein; TE, thioesterase. 
The NRPS region of the PKS/NRPS gene locus-4 includes four A domains (Table 
4-7), i.e A2-A4, and A3’. The NRPS module-3 contains tandem A domains, i.e A3 and 
A3’. The amino acid sequences encoding the A3’ domain deviates from the conserved 
motifs required for the binding of ATP (Figure 4-28A). Therefore, the A3’ domain is 
presumed to be inactive. The substrate specificities of the other A domains from the 
hybrid gene locus-4 are (Table 4-7) shown in the Figure 4-28B. The NRPS module-3 
also includes an active KR3 domain. The unusual presence of KR3 domain in the 
NRPS module-3 is expected to reduce the substrate loaded on the PCP3 domain. But 
the Stachelhaus code was 80% identical with that of genes encoding for A domains 
activating α-hydroxy-isocaproic acid (Figure 4-28B). Further processing of α-hydroxy-
isocaproic acid is required for the incorporation of this extender unit into the putative 
product. The active KR3 domain may be expected to remain inert or act on the starter 
unit of the biosynthetic pathway. The C domains, i.e C2, C3, and C4 of the PKS/NRPS 
gene locus-4 contain the six conserved motifs and the active site residues necessary 
for their activity (Figure 4-28A). Sequence alignment of the PCP domains, i.e PCP2-
PCP4 showed the serine residue required for the binding of PPant arm by the action 
of PPTase (Figure 4-29B). 
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 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
A2 G E L Y V A G A G V F A G - F 341 Y Q T R Y L 369 G S L D S T I E L A A T P I L L Q E V E 400 L D C Q L A N 456 D G Q L D R 476 
A3' G R L Q I Q G P T I T A G Y Y 475 - - - - - D 496 G R E K D V I I I N G I N Y H N H E I E 527 I G I N P S Y 593 I G K I Q R 613 
A3 G E L Y V G G A G L A R G Y W 383 Y K T G D L 409 G R R D N Q V K I R G F R I E L G E I Q 442 L P E Y M V P 499 N G K I D Y 518 
A4 G E I Y V G G V G V A R G Y L 368 Y R T G D L 396 G R I D Q Q I K L R G H R I E L G E I S 429 - - - S Q A P 486 K Q K L P A 505 
 
Gene locus A domain Stachelhaus code Predicted substrates 
haur_2413 A2 DFWNIGMVHK Threonine 
haur_2414 A3 GIFWLGASG* α-OH-isocaproic acid 
haur_2415 A4 GDASTIAAVC* Tyrosine 
Figure 4-28: PKS/NRPS gene locus-4 A domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in yellow) from PKS/NRPS gene locus-4. The ten core 
motif sequences as reported in the literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the amino acid positions in 
the respective sequences. The inactive A3’ domain is highlighted in grey. Suffices indicate the respective module.
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A2 L S Y A E L 52 L K A G G A Y L P I D 102 L A Y M I Y T S G S T G T P K G 181 F D F S 219 N M Y G I T E 321 
A3' V S Y H E L 36 L L L G A R Y A L L S 86 L I G L S L A S N P S G L I E A 158 - D F S 194 N Y Y G F P A 282 
A3 Q S Y A A L 104 M L G G F T A V P L A 154 S A L L L F T S G S T G L P K G 244 G G I V 283 P A Y G M S E 390 
A4 L S Y H E L 51 L K S G G A Y I P L D 101 L A Y I V Y T S G S T G Q P K G 181 F D A A 219 N A Y G P S E 309 
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(B) The table lists the Stachelhaus codes extracted from the sequences of PKS/NRPS gene 
locus-4 A domains and their putative substrates. The asterisk indicates the unknown amino 
acid. 
 
 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C1 Y R E H V A W 188 V G Y Y V N P V L I N 299 H Q A Y P F D 332 
C2 Y R D F V A Q 209 I G V H L N M L P F R 323 Y R Q M P L A 357 
C3' Y G D Y A C W 173 I G F F I N Q L V L R 289 H Q H V P F D 322 
C3 Y I D A A E W 167 Y A E L A N A Q G L F 273 Q Q L A D L A 306 
C4 Y H E F V R L 181 L G L F I N S I P L R 292 H R R Y P T A 326 
 
 (B) 
 
 
Figure 4-29: PKS/NRPS gene locus-4 C and PCP domain characteristic motifs. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS C domains (highlighted in 
yellow) from PKS/NRPS gene locus-4. The six core motif sequences as reported in the 
literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the 
amino acid positions in the respective sequences. Suffices indicate the respective modules  
(B) CLUSTALW alignment of the conserved core motif of NRPS PCP domains (highlighted in 
yellow) from PKS/NRPS gene locus-4. The core motif sequence as reported in the literature 
(Konz and Marahiel, 1999) is highlighted in bold. The PPant attaching serine is highlighted in 
green.  
The PKS/NRPS gene locus-4 terminates with tandem TE domains (Table 4-7), i.e 
TE1 and TE2. The TE1 domain contains the catalytic triad S-89/D-116/H-264 required 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C1 S F G E Q A L W A L 28 R H A A L R T N F 74 Q H - T V V D L Q S 151 
C2 A R M Q A G V I F H 43 R H A V L R T S F 89 F H D T I F D G W S 172 
C3' S L A Q Q R L W L V 15 R H E V L R T S I 61 L H H I I A D G W S 136 
C3 S P Q Q T H T W L V 18 R H E A L R T R F 64 L A A L V G D A T S 132 
C4 A K L Q G G M I F H 15 R H P A L R T S F 61 F H H A V I D G W S 144 
 D X F F X L G G H S L  
         D  I  
PCP2 D N F F D L G G H S L 30 
PCP3 D N F F A L G G H S L 30 
PCP4 A N F F D L G G N S L 30 
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for activity (Figure 4-24). As described in PKS/NRPS gene locus-2, the TE2 domain 
contains serine instead of aspartate in the catalytic triad, i.e S-89/S-116/H-264 
(Figure 4-24). This exchange of serine residue instead of aspartate at position 116 is 
significant concerning the role of the second TE domain, i.e TE2 in the biosynthesis. 
In addition to the PKS and NRPS genes, the PKS/NRPS gene locus-4 includes two 
genes haur_2408 and haur_2418 encoding for a glycosyltransferase for glycosylating 
the lipopeptide (Table 4-7). The PKS/NRPS gene locus-4 contains also a O-MT 
(haur_2419) for methylating a hydroxyl group of the intermediate (Table 4-7). But the 
exact position of O-methylation and glycosylation remains elusive. 
The putative glycosylated lipopeptide biosynthesized by enzymes encoded by this 
hybrid gene locus-4 comprises of threonine and tyrosine in the peptide core (Figure 
4-29). In addition the processing steps required for the incorporation of α-hydroxy 
isocaproic remains unclear. 
 
 
 
 
Figure 4-30: Putative PKS (red) and NRPS (blue) genes in PKS/NRPS gene locus-4 along 
with their respective predicted substrates. Brown, acyl-CoA synthetase. Inactive domain is 
highlighted in grey. X, Unknown fatty acid; Y, H/CH3.  Glycosylating groups and the positions 
of glycosylation is unknown. Inactive domains are highlighted in grey. 
4.1.4.1.5 PKS/NRPS gene locus-5 
The PKS/NRPS gene locus-5 spanning over 109 Kb is the biggest of all the 
biosynthetic gene loci (Table 4-8) identified from H. aurantiacus DSM 785. The locus 
comprises 16 PKS and seven NRPS modules. Biosynthesis is speculated to 
commence with the loading of an unknown long chain starter unit on to ACPL by the 
AMP-dependent synthetase and ligase, Haur_3958 (Figure 4-19). Among the 16 
PKS modules two are completely reducing modules, whereas the others are partially 
reducing modules with only KR domain.  
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Gene locus Modules Putative functions 
haur_3958 Module-L AMP-PCPL 
haur_3959 Module-1 KS1-AT1-DH1-ER1-KR1-ACP1 
haur_3960 Module-2 KS2-AT2-DH2-ER2-KR2-ACP2 
haur_3961 Module-3 
Module-4 
KS3-AT3-KR3-ACP3 
KS4-AT4-KR4-ACP4 
haur_3962 Module-5 KS5-AT5-KR5-ACP5 
haur_3963 Module-6 
Module-7 
KS6-AT6-KR6-ACP6 
KS7-AT7-KR7-ACP7 
haur_3964 Module-8 
Module-9 
KS8-AT8-KR8-ACP8 
KS9-AT9-KR9-ACP9 
haur_3965 Module-10 
Module-11 
Module-12 
KS10-AT10-KR10-ACP10 
KS11-AT11-KR11-ACP11 
KS12-AT12-KR12-ACP12 
haur_3966 Module-13 
Module-14 
KS13-AT13-KR13-ACP13 
KS14-AT14-KR14-ACP14 
haur_3967 Module-15 
Module-16 
KS15-AT15-KR15-ACP15 
KS16-AT16-KR16-ACP16 
haur_3968  3-hydroxyacyl CoA dehydrogenase 
haur_3969  Hypothetical protein 
haur_3970  Acyl-CoA dehydrogenase 
haur_3971  Phosphatase  
haur_3972 Module-17 C17-A17-PCP17 
haur_3973 Module-18 
Module-19 
Module-20 
Module-21 
Module-22 
Module-23 
A18-PCP18 
C19-A19-PCP19 
C20-A20-PCP20 
C21’-C21-A21-PCP21 
C22-A22-PCP22 
C23-A23-PCP23-TE1 
haur_3974  TE2 
Table 4-8: List of genes in PKS/NRPS gene locus-5 and their putative functions. Suffices 
indicate the respective modules. L, Loading module; ACP, Acyl Carrier Protein; KS, 
Ketosynthase; AT, Acyltransferase; DH, Dehydratase; ER, Enoylreductase; C, Condesation; 
A, Adenylation; PCP, Peptidyl Carrier Protein; TE-Thioesterase.  
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Alignment of DH1 domain showed variation in the catalytically active residues, G-41 
and P-46 (Figure 4-31D). Therefore, DH1 domain is presumed to be inactive. Due to 
inactive DH1 domain, ER1 with the conserved motif G-G-V-G-X-A-A-X-Q-A-A (Pawlik 
et al., 2007) is proposed to be inert. Other than this, all the other domains of the PKS 
modules, i.e AT, KS, ACP, KR, DH contain the consensus motifs required for their 
activity (Figure 4-31). Since the AT domains includes a different combination of 
consensus motifs than reported, the exact substrates could not be predicted. 
However, the gene locus comprises the genes haur_3968, haur_3970 and 
haur_3971 encoding for 3-hydroxyacyl CoA dehydrogenase, acyl-CoA 
dehydrogenase and a phosphotase required for the synthesis of hydroxymalonyl-
CoA (Table 4-8) (Figure 4-4). Henceforth, it is expected that one or more of the AT 
domains of the hybrid gene locus-5 might activate hydroxymalonyl-CoA. 
(A) AT domains 
 Q  Q  G H S * G  R    # H  §  $  V  
AT1 Q 8 Q 58 G H S M G 89 R 112 V A S H 190 T 221 N 241 V 246 
AT2 Q 8 Q 59 G H S M G 90 R 113 V A S H 191 T 222 N 242 V 247 
AT3 L 31 Q 80 G Y S L G 111 R 134 H A F H 208 N 239 H 259 V 264 
AT4 P 36 Q 85 G Y S L G 116 R 139 H A F H 213 N 244 H 264 V 269 
AT5 N 35 Q 84 G Y S L G 115 R 138 H A F H 212 N 243 H 263 V 268 
AT6 C 30 Q 80 G Y S V G 111 R 134 H A F H 208 N 239 H 259 V 264 
AT7 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
AT8 R 29 Q 79 G Y S V G 110 R 133 H A F H 207 N 238 H 258 V 263 
AT9 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
AT10 Q 29 Q 79 G Y S L G 110 R 133 H A F H 207 N 238 H 258 V 263 
AT11 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
AT12 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
AT13 Q 29 Q 81 G Y S L G 112 R 135 H A F H 207 N 238 H 258 V 263 
AT14 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
AT15 Q 29 Q 79 G Y S L G 110 R 133 H A F H 207 N 238 H 258 V 263 
AT16 C 31 Q 81 G Y S V G 112 R 135 H A F H 209 N 240 H 260 V 265 
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 (B) KS domains                                     (C) KR domains 
 
 
 
(D) DH domains                                                       (E) ER domains 
 
 
 (F) ACP domains 
 
  
 
 
 
 
 
 
Figure 4-31: Characteristic motifs in AT (A), KS (B), KR (C), DH (D), ER (E) and ACP (F) 
domains of PKS modules extracted from PKS/NRPS gene locus- 5 (highlighted in yellow). 
 G X G X X G X X X A  S  Y  N  
      A            
KR1 G L G G V G L T V V 17 S 66 Y 146 N 151 
KR2 G L G G L G I A V A 17 S 66 Y 146 N 151 
KR3 G L G D I G L I L A 17 S 156 Y 166 N 171 
KR4 G L G G I G L A L A 17 S 152 Y 164 N 168 
KR5 G L G G I G L A L A 17 S 153 Y 165 N 169 
KR6 G L G G V G L V L A 17 S 156 Y 166 N 171 
KR7 G L G G I A L G L A 17 S 153 Y 165 N 169 
KR8 G L G G V G L V L A 17 S 156 Y 166 N 171 
KR9 G L G G I A L G L A 17 S 153 Y 165 N 169 
KR10 G L G G V G L V L A 17 S 156 Y 166 N 171 
KR11 G L G G I G T A I A 17 S 156 Y 166 N 171 
KR12 G L G G I A L G L A 17 S 153 Y 165 N 169 
KR13 G L G G V G L V L A 17 S 156 Y 166 N 171 
KR14 G L G G I A L G L A 17 S 153 Y 165 N 169 
KR15 G L G G V G L I L A 17 S 156 Y 166 N 171 
KR16 G L G G I A L G L A 17 S 153 Y 165 N 169 
 C    H     H   
KS1 C S S 174 H G S 342 G H L 347 
KS2 C S S 174 H G T 308 G H L 347 
KS3 C S S 177 H G S 311 G H L 350 
KS4 C S T 175 H G T 300 G H L 349 
KS5 C S T 175 H G T 300 G H L 349 
KS6 C S T 175 H G T 300 G H L 349 
KS7 C S T 174 H G T 299 G H L 348 
KS8 C S T 173 H G T 298 G H L 347 
KS9 C S T 174 H G T 299 G H L 348 
KS10 C S T 175 H G T 300 G H L 349 
KS11 C S T 174 H G T 299 G H L 348 
KS12 C S T 174 H G T 299 G H L 348 
KS13 C S T 175 H G T 300 G H L 349 
KS14 C S T 174 H G T 299 G H L 348 
KS15 C S T 175 H G T 300 G H L 349 
KS16 C S T 174 H G T 299 G H L 348 
 L X X H X X X G X X X X P  
DH1 L A E H Q V Q D I V V L S 46 
DH2 L S D H C V E G M V V V P 46 
 G G V G X A A X Q X A  
ER1 G G V G L A A I Q L A 151 
ER2 G G V G L A A I Q I A 152 
 G X X S   
ACPL G L D S A 32 
ACP1 G F D S L 32 
ACP2 G L D S L 32 
ACP3 G G N S L 30 
ACP4 G G N S L 30 
ACP5 G G N S L 30 
ACP6 G G N S L 30 
ACP7 G G N S L 30 
ACP8 G G N S L 30 
ACP9 G G N S L 30 
ACP10 G G N S L 30 
ACP11 G G N S L 30 
ACP12 G G N S L 30 
ACP13 G G N S L 30 
ACP14 G G N S L 30 
ACP15 G G N S L 30 
ACP16 G G N S L 30 
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Catalytically active residues are highlighted in green. Consensus sequences from the 
literature (Yadav et al., 2003; Zhang et al., 2006; Bachmann and Ravel., 2009; Pawlik et al., 
2007) are highlighted in bold. * indicates the invariant residues Q/M/I/L/V/F/A/M, # indicates 
S/F/P, § indicates T/A/N/G/E/D/S and $ indicates N/S/H/Q. The numbers represents the 
position of amino acids. Suffices indicate the respective modules. 
The PKS/NRPS gene locus-5 includes seven NRPS modules (Table 4-8). Of these, 
module-18 lacks a C domain, whereas module-22 has supposedly functional tandem 
C domains, i.e C22’ and C22. According to bioinformatic analysis, NRPS module-18 
with active A18 and PCP18 domains, has however no C18 domain, and thus is 
anticipated to be skipped during biosynthesis. The role of tandem C domains C22’ and 
C22 in the NRPS module-22, remains obscure. Sequence alignment of all the 
domains of the NRPS modules, i.e C, A, PCP showed the presence of conserved 
motifs required for their activity (Figure 4-32, Figure 4-33). From the sequences of the 
A domains from the hybrid gene locus-5 the putative substrates activated by the 
respective A domains were identified (Figure 4-32B). 
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 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A17 L T Y G E L 52 L K A G A A Y V P L D 103 P A Y V I Y T S G S T G Q P K G 181 F D V C 219 N S Y G V T E 361 
A18 V T Y W Q L 49 L K A G G A Y L P L D 100 L A Y V I Y T S G S T G R P K G 181 F D A A 218 N N Y G P T E 347 
A19 L T Y A E L 54 L K A G G A Y V P L D 105 L A Y I I Y T S G S T G R P K G 181 F D I S 218 N F Y G P S E 344 
A20 L T Y A E L 54 L K A G G A Y V P L D 105 L A Y I I Y T S G S T G R P K G 181 F D I S 218 N F Y G P S E 344 
A21 L T Y A E L 54 L K A G G A Y V P L D 105 L A Y I I Y T S G S T G R P K G 181 F D I S 218 N F Y G P S E 344 
A22 L L Y R D I 36 L K S G G A F A L V N 87 A A C L V Q T D G A A G T R R L 165 T G D A 202 N L Y G A A E 338 
A23 L T Y R E L 51 V I A G G A Y V P L D 102 L A Y M I Y T S G S T G R P K G 181 F D L T 218 N E Y G P T E 353 
 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
A17 G E L Y L G G S R L A L G Y W 382 Y R T G D A 412 G R I D Q Q V K L H G V R I E L G E I E 445 L P E H M V P 498 N G K I D R 518 
A18 G E L Y V G G V G L A R Y Y L 370 Y R T G D R 400 G R I D F Q V K V R G F R I E L G E I E 433 L P E Y M V P 488 N G K I D R 508 
A19 G E L Y L G G A G V S R G Y F 367 Y R T G D R 397 G R M D R Q V K L R G F R I E L G E V E 430 L P E Y M V P 485 S G K L D R 505 
A20 G E L Y L G G A G V S R G Y F 367 Y R T G D R 397 G R M D R Q V K L R G F R I E L G E V E 430 L P E Y M V P 485 S G K L D R 505 
A21 G E L Y L G G A G V S R G Y F 367 Y R T G D R 397 G R M D R Q V K L R G F R I E L G E V E 430 L P E Y M V P 485 S G K L D R 505 
A22 G E L Y L G G A G V S R G Y F 360 Y R T G D R 390 G R V E Q Q V K L R G F R I E L G E V E 423 L P E Y M V P 478 S G K L D R 498 
A23 G E L Y I G G A G V G R G Y H 376 Y K T G D L 406 G R V D H Q V K V R G F R I E L E E I E 439 L P A Y M A P 494 N G K V D R 514 
Motif-2 Motif-3 
 
Motif -3 
Motif-4 
 
Motif- 4 
Motif-1 
 
Motif- 1 
Motif-5 
 
Motif -5 
(A) 
 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A2 Y S Y A E L 52 F K A G G L F L P L D 102 L A Y M I Y T S G T T G T P K A 181 F D I F 218 V L Y G P T E 318 
A3 L S Y G E L 51 L K A G A A Y V P L D 101 L V Y L I Y T S G S T G R P K A 181 F D A S 218 N A Y G P T E 308 
A4 L S Y A E L 51 L K A G G A Y V P L D 101 L M Y I I Y T S G S T G Q P K G 181 A D L G 218 N H Y G P T E 315 
A5 L T Y Q E L 52 L K A G A A Y L P I D 102 L A Y I I Y T S G S T G K P K G 181 A D L G 218 N H Y G P T E 315 
A6 L S Y A E L 51 L K A G A G Y V P L D 101 P V Y T I Y T S G S T G T P K G 181 F D F G 218 N G Y G P T E 314 
A7 L S Y H A L 51 L K A G A A Y A P V D 101 L A Y V M Y T S G S T G R P K G 181 F D A S 217 N G Y G P T E 312 
A8 L S Y H A L 51 L K A G A A Y A P V D 101 L A Y V M Y T S G S T G R P K G 181 F D A S 217 N G Y G P T E 315 
A9 L S Y A E L 45 L K A G G A Y V P L D 95 L A Y M I Y T S G S T G K P K G 181 F D V S 218 N L Y G P T E 315 
A10 W T Y A Q M 50 L K A G G A Y L P L D 100 L A Y V I Y T S G S T G V P K G 181 F D I S 218 N M Y G P T E 311 
A11 L S Y G A L 45 M K A G G A Y V P L D 95 L A Y M I Y T S G S T G T P K G 181 F D V S 218 N L Y G P T E 315 
A12 W S Y A E L 50 I K A G A A Y L P L D 100 L A Y V I Y T S G S T G V P K G 181 F D I S 218 N M Y G P T E 311 
 (A) 
Motif-6 Motif-7 Motif-10 Motif-8 Motif-9 
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(B) 
Gene locus A domain Stachelhaus code Predicted substrate 
haur_3972 A17 DVGEIGSIDK Ornithine 
haur_3973 A18 DAWFLGNVVK Leucine 
haur_3973 A19 DIFNNAFTYK Alanine 
haur_3973 A20 DIFNNAFTYK Alanine 
haur_3973 A21 DIFNNAFTYK Alanine 
haur_3973 A22 GDWRLALLDK Unknown 
haur_3973 A23 DLTKVGEVGK Asparagine 
Figure 4-32: PKS/NRPS gene locus-5 A domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in 
yellow) from PKS/NRPS gene locus-5. The ten core motif sequences as reported in the 
literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the 
amino acid positions in the respective sequences. Suffices indicate the respective modules.  
(B) The table lists the Stachelhaus codes extracted from the sequences of PKS/NRPS gene 
locus-5 A domains and their putative substrates 
 (A) C domains 
 
 
 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C17 S F S Q E R L W F L 16 R H E I L R T S F 61 L H H I A Y D E W S 146 
C19 S F A Q E R L W F L 16 R H A P L R S T F 61 I H H I I F D G W S 144 
C20 S F A Q E R L W F L 16 R H A P L R S T F 61 I H H I I F D G W S 144 
C21’ S V D Q E R F W F V 16 R H E S L R A F F 61 L H H S V F D G W S 144 
C21‘ S F A Q E R L W F L 16 R H E I L R T T F 61 I H H I V F D G W S 144 
C22 S F A Q E R L W F L 16 R H E S L R T T F 61 L H H S I S D G W S 144 
C23 S F A Q E R L W F L 16 R H E S L R T T F 61 L H H S I S D G W S 144 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C17 Y G D Y A Y W 182 I G F F V N S L P L R 301 H Q D V P I E 333 
C19 Y A D Y A R W 180 I G M F V N T L A L R 299 H Q D L P F E 331 
C20 Y A D Y A R W 180 I G M F V N T L A L R 299 H Q D L P F E 331 
C21’ Y A D Y A A W 183 I G L F I N S L P L R 302 H Q N I P L T 334 
C21‘ Y A D Y A R W 183 I G M F V N T L A L R 302 H Q D L P F E 334 
C22 Y A D Y A L W 183 I G M F V N T L A L R 302 H Q D V P F E 334 
C23 Y A D Y A L W 183 I G M F V N T L A L R 302 H Q D V P F E 334 
Motif-2 Motif-3 Motif-1 
Motif-4 Motif-5 Motif-6 
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(B) PCP domains 
 D X F F X L G G H S L  
         D  I  
PCP17 D N F F E L G G H S L 30 
PCP18 S N F F D L G G H S L 30 
PCP19 S N F F D L G G H S L 32 
PCP20 S N F F D L G G H S L 32 
PCP21‘ S N F F A L G G H S L 32 
PCP21 S N F F A L G G H S L 32 
PCP22 Q N F F D L G G H S L 30 
Figure 4-33: PKS/NRPS gene locus-5 C and PCP domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS C domains (highlighted in 
yellow) from PKS/NRPS gene locus-5. The six core motif sequences as reported in the 
literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the 
amino acid positions in the respective sequences.  Suffices indicate the respective modules. 
(B) CLUSTALW alignment of the conserved core motif of NRPS PCP domains (highlighted in 
yellow) from PKS/NRPS gene locus-5. The core motif sequence as reported in the literature 
(Konz and Marahiel, 1999) is highlighted in bold. The PPant attaching serine is highlighted in 
green color.  
From the sequences, the PKS/NRPS gene locus-5 is predicted to encode the 
biosynthetic enzymes for a lipopeptide (Figure 4-34). The peptide core of the putative 
compound comprises eight amino acids including L-ornithine, L-leucine, three times 
L-alanine and L-asparagine (Figure 4-33B). One of the A domain Stachelhaus codes 
showed only 50% homology to that of L-serine. Therefore, this domain is suspected 
to activate some other substrate. Considering the polyketide backbone, the 
conserved residues allowing for the prediction of substrate selectivity remain 
obscure. Since, biosynthetic genes encoding for the formation of hydroxymalonyl-
CoA were identified for at least one of the PKS modules, this is expected to load this 
unit. Nevertheless, it would be interesting to isolate the compound because of the 
unusual motifs in the AT domains. 
(A) 
 
 
 
haur_3964 haur_3963 haur_3962 haur_3961 haur_3960 haur_3959 haur_3958 
ACL KS1
SH
ACPL
AT1
DH1
KR1
ACP1
SH
KS3 AT3
KR3
ACP3
SH
ER1
KS2
AT2
DH2
KR2
ACP2
SH
ER2
KS4 AT4
KR4
ACP4
SH
KS5 AT5
KR5
ACP5
SH
KS6 AT6
KR6
ACP6
SH
KS7 AT7
KR7
ACP7
SH
KS8 AT8
KR8
ACP8
SH
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(B) 
 
 
Figure 4-34: PKS/NRPS gene locus-5. 
(A) Putative PKS (red) and NRPS (blue) genes in PKS/NRPS gene locus-5. Brown-acyl-CoA 
synthetase.   
(B)Predicted strcture of the putative lipopeptide encoded by PKS/NRPS gene locus-5. X- 
Unknown fatty acid side chain; P1-16-Unknown PKS extender units; R-Unknown amino acid. 
4.1.4.1.6 NRPS gene locus-1 
The NRPS gene locus-1 comprising 8.6 Kb is rather a small biosynthetic gene locus 
with only three NRPS modules, including the loading module (Table 4-9). The amino 
acid sequence of the C2 domain is very short and consequently the conserved active 
motifs could not be identified from the sequence (Figure 4-37A). Moreover, the A2 
domain lacks in the core motifs-6 to10 (Figure 4-37A). Therefore, the second NRPS 
module is speculated to be skipped during the biosynthesis of the dipeptide. 
Sequence alignment of the A domains showed that the AL domain activates 
glutamine and the A1 domain activates HPG (Figure 4-37B). The condensed 
dipeptide is then most likely to be transferred to the PCP3 which would subsequently 
released by the action of the TE domain of haur_1573 (Figure 4-35). 
Gene locus Modules Putative functions 
haur_1574 Module-L 
Module-1 
AL-PCPL 
C1-A1-PCP1 
haur_1572 Module-2 C2 -A2 
X P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 N
H
H
N
N
H
H
N
N
H
H
N
OH OH OH OH OH OH OH OH OH OH OH OH OH OH OH O
O
O
O
O
O
R
OH
O
NH2
NH2O
haur_3964 haur_3967 haur_3966 haur_3965 
KS9 AT9
KR9
ACP9
SH
KS10 AT10
KR10
ACP10
SH
KS11 AT11
KR11
ACP11
SH
KS12 AT12
KR12
ACP12
SH
KS13 AT13
KR13
ACP13
SH
KS14 AT14
KR14
ACP14
SH
KS15 AT15
KR15
ACP15
SH
KS16 AT16
KR16
ACP16
SH
haur_3974 haur_3973 haur_3972 
C17 A17 PCP17
SH
A18 PCP18
SH
C19 A19 PCP19
SH
C20 A20 PCP20
SH
C21 C21' A21 PCP21
SH
C22 A22 PCP22
SH
C23 A23 PCP23
SH
TE1 TE2
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haur_1573 PCP2-TE 
Table 4-9: List of genes in NRPS gene locus-1 and their putative functions. L, Loading 
module; A, Adenylation; C, Condensation; PCP, Peptidyl Carrier Protein; TE, Thioesterase.  
(A)                    (B) 
 
 
 
 
Figure 4-35: NRPS gene locus-1. 
(A) Putative NRPS (blue) genes in NRPS gene locus-1. Inactive domains are highlighted in 
grey. 
(B)Predicted strcture of the putative dipeptide encoded by NRPS gene locus-1. 
(A) C domains 
 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C1 S T M Q E R V W F L 22 R H E I L R T T F 60 E H H F I H D G W S 144 
 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C1 Y A D F A V W 179 L G M F V N T V V L R 298 H L D V L I E 331 
 
 (B) PCP domains 
 
 
Figure 4-36: Characteristic motifs in C (A) and PCP (B) domains of NRPS gene locus-1 
(highlighted in yellow). The catalytically active site residues are highlighted in green. 
Conserved sequences from the literature (Konz and Marahiel, 1999) are highlighted in bold. 
The numbers indicate the position of amino acids. Suffices indicate the respective modules. 
 D X F F X L G G H S L  
         D  I  
PCPL D D F F D L G G H S L 30 
PCP1 A N F F E L G G H S L 30 
PCP2 A N F F E L G G H S L 30 
haur_1572 haur_1574 haur_1573 
Motif-6 Motif-5 Motif-4 
Motif-3 Motif-2 Motif-1 
H2N
H
N
OH
O
O
NH2O
OH
AL PCPL
SH
C1 A1 PCP1
SH
C2 A2 PCP2
SH
TE
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 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
AL G E L Y I G G M G L A R G Y Q 374 Y K T G D R 404 D R I D Q Q I K L R G Y R I E L G E I Q 437 L P R Y M L P 493 N G K L D R 513 
A1 G D I Y I A G I G L A L G Y I 377 Y R S G D R 407 G R S D R Q V K I R G M R I E L N E I R 440 L P L A M Q P 496 N D K L D W 516 
A2                                                            
 
 (B)  
 
 
Figure 4-37: NRPS gene locus-1 A domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in yellow) from NRPS gene locus-1. The ten core motif 
sequences as reported in the literature (Konz and Marahiel, 1999) are highlighted in bold. Sufices indicate the respective modules. The numbers 
represent the amino acid positions in the respective sequences.  
(B) The table lists the Stachelhaus codes extracted from the sequences of NRPS gene locus-1 A domains and their putative substrates. 
 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
AL L T Y A Q L 50 L K A G A A Y L P I D 102 L A Y V I Y T S G S S G Q P K G 181 F D A S 218 N L Y G P T E 315 
A1 I S Y S R L 55 L K L G A A Y V P L D 107 C A Y G L F T S G S T G Q P K G 181 F D V S 218 N G Y G P T E 317 
A2 L T Y Q A L 48 L R L G A I Y V P I D 100 V L Y S I Y T S G S T G V P K G 181 F D L T 218 N T Y G P T E 319 
Gene locus A domain Stachelhaus code Predicted substrates 
haur_1574 AL DAWQFGLIDK Glutamine 
haur_1574 A1 DVYYLGGICK HPG 
Motif-10 Motif-9 Motif-8 Motif-7 Motif-6 
(A)  
Motif-2 Motif-3 Motif-4 Motif-1 Motif-5 
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4.1.4.1.7 NRPS gene locus-2 
NRPS gene locus-2 of 14 Kb size is homologous to the myxochelin biosynthetic gene 
cluster. The locus includes genes, i.e encoding isochorismate synthase (haur_1802), 
isochorismatase (haur_1804) and 2,3-dihydro-2,3-dihydroxybenzoate 
dehydrogenase (haur_1800) required for the synthesis of 2,3- dihydroxybenzoic acid 
(DHBA) (Table 4-10) (Figure 4-38A). These regions are also bordered by genes 
encoding for iron transport and utilization proteins. Therefore, it is anticipated that this 
gene locus encodes for a siderophore. Based on the Stachelhaus code extracted 
from the core motifs of the A domain amino acid sequence, the A domain is expected 
to activate lysine (Figure 4-39). This activation is consistent with that during 
myxochelin biosynthesis. Comparing the biosynthetic gene cluster for myxochelin 
from M. xanthus DK1622 with NRPS gene locus-2, that latter was identified to 
encode for myxochelin A biosynthesis (Figure 4-38). Myxochelin A and B are the 
siderophores with two units of 2,3-dihydroxybenzoic acid (DHBA) condensed with the 
amino acid lysine. Till date, the myxochelin siderophore is known only from 
Myxobacteria (Gaitatzis et al., 2001; Silakowski et al., 2000). Sequence alignments of 
the NRPS C, A, PCP and R domains showed that all the domains are active and 
likely to participate in the biosynthesis of myxochelin A (Figure 4-38, Figure 4-39, 
Figure 4-40, Figure 4-41). 
Gene locus Putative functions 
Haur_1800 2,3-dihydro-DHBA dehydrogenase 
Haur_1801 DAHP synthase 
Haur_1802 Isochorismate synthase 
Haur_1803 DHBA-AMP ligase 
Haur_1804 Isochorismatase 
Haur_1805 C-A-PCP-R 
Haur_1806 Periplasmic binding protein 
Haur_1807 Transport system permease 
Haur_1808 Transport system permease 
Haur_1809 ABC transporter 
Table 4-10: List of genes in NRPS gene locus-2, DHBA, 2,3-dihydroxybenzoic acid; DAHP, 
3-deoxy-D-arabinoheptulosonate 7-phosphate. 
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 (A) 
 
 
 
 
(B) M. xanthus DK1622 
 
    H. aurantiacus DSM 785 
 
(C)  
 
 
 
Figure 4-38: Myxochelin in H. aurantiacus. 
(A) 2,3-dihydroxybenzoic acid (DHBA) biosynthetic pathway from Stigmatella aurantiaca 
Sg15. The gene haur_1802 represents isochorismate synthase, haur_1804 for 
Isochorismatase and Haur_1800 2,3-dihydro-DHBA dehydrogenase. 
(B) Myxochelin biosynthetic gene cluster from M. xanthus DK1622 and H. aurantiacus DSM 
785. Red, NRPS gene; green, aminotransferase; grey, iron transport and utilization proteins, 
others, genes for the biosynthesis and loading of DHBA. 
(C) Proposed myxochelin biosynthetic pathway in H. aurantiacus DSM 785. Due to the 
absence of aminotransferase gene (highlighted in green) in (B) the final product of the 
pathway in H. aurantiacus DSM 785 is expected to be myxochelin A. AMP, DHBA AMP 
dependent synthetase and ligase; IC, Isochorismate synthase; ArCP, Aryl Carrier Protein; C, 
Condensation; A, Adenylation; PCP, Peptidyl Carrier Protein; R, Reductase. The two arrows 
indicate the iterative usage of DHBA.  
 
 
haur_1805 haur_1804 haur_1803 
Myxochelin A 
C A PCP
S
R
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O
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2,3-dihydro-2,3-
DHBA 
COOH
O COOH
COOH
OH
O COOH
COOH
OH
COOH
OH
OH
CH2 CH2
OH
OH
Results 
111 
 
 
Figure 4-39: Characteristic core motifs of A domains (highlighted in yellow) from the NRPS 
gene locus-2 in H. aurantiacus DSM 785, MxcG-Myxococcus xanthus DK1622 (Acc no-
NC_008095.1). Conserved sequences from the literature are highlighted in bold. The 
numbers indicate the position of amino acids. 
(A) C domains 
 
 (B) PCP domains 
  D X F F X L G G H S L  
          D  I  
NRPS-2-PCP A D F F G L G G Q S L 30 
MxcG-PCP D D F F D L G G Q S L 30 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  
               V              S        
NRPS-2 L S Y A E L 63 L C C G A A Y L P L D 113 P A Y I M Y T S G S T G E P K G 181 
MxcG L T Y A A L 55 L F S G A G Y L P V D 105 L A Y V I Y T S G S T G Q P N G 181 
 
 
 
 
 F D X S  N X Y G P T E  G E L X I X G X G L A R G Y L  Y R T G D L  
                           K          
NRPS-
2 F D A S 218 N T Y G P T E 319 G D L Y L L G N G L A T G Y Y 378 Y R T G D R 406 
MxcG F D A S 218 N T Y G P T E 319 G E L H L L G G A L A R G Y L 384 Y R T G D K 412 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
                           I      L    
NRPS-2 G R S D D E F K I S G Q R V T P A E I E 437 L P A A V I P 493 A G K I D R 512 
MxcG G R V D D E F K I S G H R I D P S E V E 444 L P A P M V P 500 T G K L D R 519 
 S X A Q X R L W X L  R H E X L R T X F  M H H  I S D G W S  
       M Y                      V   
NRPS-2 S A A Q H G I W L G 16 E A A T L H L R F 61 A H H I A L D G Y S 121 
MxcG S A A Q H G I W V G 16 E A E A L H A R F 61 A H H I A L D G F G 122 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
NRPS-2 T L D R E F W 192 P C M A M N I V P L C 290 H G R Y R Y E 323 
MxcG A A D H A F W 193 P C M A M N I V P L R 290 H L R Y R Y E 323 
Motif-4 Motif-5 Motif-6 
Motif-3 Motif-2 Motif-1 
Motif-3 Motif-2 Motif-1 
Motif-10 Motif-9 Motif-8 
Motif-7 Motif-6 Motif-5 Motif-4 
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Figure 4-40: Characteristic motifs in the C (A) and PCP (B) domains (highlighted in yellow) 
identified from the NRPS gene locus-2 in H. aurantiacus DSM 785. MxcG is from M. xanthus 
DK1622 (Acc no-NC_008095.1). The catalytically active residues are highlighted in green. 
The PPant attaching serine in PCP domain is highlighted in green. The conserved residues 
from the literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers indicate 
the position of amino acids. 
 
 
 
 
 
Figure 4-41: Conserved motifs in the R domain (highlighted in yellow) from the NRPS gene 
loci-2 and 4 in H. aurantiacus DSM 785, MxcG-R-R domain from Myxococcus xanthus 
DK1622 (Acc no-NC_008095.1). Conserved residues from the literature (Konz and Marahiel, 
1999) are highlighted in yellow. The numbers indicate the position of amino acids. 
4.1.4.1.8 NRPS gene locus-3    
The NRPS gene locus-3, spanning 16 Kb comprises five NRPS modules including 
the loading module (Table 4-11). The module-1 without A1 domain is anticipated 
either to be skipped in the biosynthesis or involved making use of adjacent A 
domains. The substrate specificities of the A domains are listed in Figure 4-43B. 
Since the substrates encoding Stachelhaus code for A3 and A4 was only 50% 
identical to that known for serine it is expected that these A domains activate some 
other amino acids. The other A domains, i.e AL and A2 was predicted to activate 
alanine and threonine respectively. From the random location of the initiation, 
elongation and the termination modules in the NRPS gene locus-5, the biosynthesis 
is likely to stutter between the modules. The TE domain contains the catalytic triad S-
89/D-166/H-264 required for its function (Figure 4-24). The NRPS gene locus-3 
 V L L T G A T G Y L G  V X X X V R A  G D L  
  F V   V N  F                
NRPS-2 V L L T G A T G F V G 36 V I C V V R A 57 G D L 92 
MxcG V V L T G A T G F V G 38 V V C L V R A 59 S D L 94 
NRPS-4 I L L T G A T G F L G 37 I Y C V V R A 58 G D L 93 
 V Y P Y X X L R X P N V X X T  G Y X X S K W X X E  R P G  
          L                      
NRPS-2 V R E Y S S L R A V N V N A T 138 G Y S Q S K W V A E 193 R L G 212 
MxcG V R E Y G S L Q A V N V R G T 140 G Y Q Q S K W I A E 196 R L G 215 
NRPS-4 A H S Y A Q L K A S N V Q A T 139 G Y A Q T K W V A E 196 R P G 215 
Motif-5 
Motif-2 Motif-3 Motif-1 
Motif-6 Motif-4 
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includes the superfluous PCP3’ domain. Sequences of the PCP3’ domain showed that 
it is functional (Figure 4-44B). Therefore, this domain might function in conjunction 
with any of the other loci, most likely with the PKS/NRPS gene locus-3 terminating 
with a C domain synthesizing a tetrapeptide (Figure 4-42) or just transfers the 
building blocks between the adjacenet modules. However, it is interesting to isolate 
the compound and look for the biosynthesis of the latter. 
Gene locus Modules Putative functions 
haur_2089 Module-4 C4-A4-PCP4-TE 
haur_2090 Module-L 
Module-1 
AL-PCPL 
C1-PCP1 
haur_2091 Module-2 C2-A2-PCP2 
haur_2092 Module-3 PCP3’-E3’-C3-A3-PCP3 
Table 4-11: List of genes in NRPS gene locus-3 and their putative functions. L, Loading 
module; A, Adenylation; C, Condensation; PCP, Peptidyl Carrier Protein; E-Epimerization; 
TE, Thioesterase. 
(A) 
 
 
(B) 
 
Figure 4-42: NRPS gene locus-3. 
(A) Putative NRPS (blue) genes in NRPS gene locus-3.  
(B)Predicted strcture of the putative tetrapeptide encoded by NRPS gene locus-3 R1,2-
Unknown amino acid. 
haur_2092 haur_2091 haur_2090 haur_2089 
AL PCPL
SH
C4 A4 PCP4
SH
TE C1 PCP1
SH
C2 A2 PCP2
SH
PCP3'
SH
E3 C3 A3 PCP3
SH
H2N
H
N
N
H
H
N
OH
R1
R2O
O
O
O
OH
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T 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
AL L T F A D L 31 L K A G A T Y L P L D 80 P A Y I I Y T S G S T G Q P K G 156 F D L S 193 N L Y G P T E 330 
A2 I S Y Q Q L 57 L K A G A A Y L P L D 106 L A Y I I Y T S G S T G Q P K G 181 F D F S 218 N M Y G I T E 319 
A3 W S Y F D L 62 L Q L G A V Y L P I D 111 L A Y V L F T S G S T G T P K G 181 F D I S 218 N A Y G P A E 319 
A4 Y S Y Q A L 49 F Y A G 
A 
A Y L P L D 
98 
L A Y T L F T S G S T G T P K G 181 F D 
I 
S 218 N A Y G 
P 
A E 319 
 
 
                              
 
 
 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
AL G E L F I A G L G V A Q G Y L 343 Y K T G D L 372 G R N D Q Q V K I R G F R I E L G E I E 405 V P S Y M L P 457 N G K L D R 477 
A2 G E I Y V G G A G L A R G Y L 382 Y R S G D L 410 G R S D Q Q V K L R G F R I E L G E L E 443 L P H Y L Q P 495 N G K R D Y 515 
A3 G E L Y I A G I A V G W G Y L 382 Y R T G D L 410 G R S D Q Q V K I R G F R I E L G E I E 443 L P H Y L Q P 495 N G K L D R 515 
A4 G E L Y I G G V G V G R G Y L 382 Y R T G D L 410 G R A D Q Q V K V R G Y R I E L G E I E 443 L P S Y M L P 492 N G K L D R 512 
Gene locus A domain Stachelhaus code Predicted substrate 
haur_2090 AL DLFNNALTYK Alanine 
haur_2091 A2 DFWNIGMVHK Threonine 
haur_2092 A3 DIWELTADDK Unknown 
haur_2089 A4 DIWELTADDK Ünknown 
Motif-3 
(A) 
Motif-2 Motif-4 Motif-1 Motif-5 
(B) 
Motif-6 Motif-7 Motif-10 Motif-8 Motif-9 
Results 
115 
 
Figure 4-43: NRPS gene locus-3 A domains. 
(A)- CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in 
yellow) from NRPS gene locus-3. The ten core motif sequences as reported in the literature 
(Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the amino acid 
positions in the respective sequences. Suffices indicate the respective modules.  
(B) The table lists the Stachelhaus codes extracted from the sequences of NRPS gene 
locus-3 A domains and their putative substrates. 
(A) C domains 
 
 
 
 
 
 
Figure 4-44: NRPS gene locus-3 C and PCP domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS C domains (highlighted in 
yellow) from NRPS gene locus-3. The six core motif sequences as reported in the literature 
(Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the amino acid 
positions in the respective sequences. Suffices indicate the respective modules. 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C1 S F G Q Q R L W F A 16 R H E M L R S S I 60 I H H S I I D A W S 131 
C2 S F A Q Q R L W F L 16 R H T I L R S H V 61 Q H H W I S D G W S 141 
C3 S S L Q Q G I L F H 16 H Y R M L R T A F 61 N H H L I I D G W S 143 
C4 S F A Q E R L W F I 16 R H E S L R T S F 61 L H H A I F D G W S 154 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C1 Y L D F V A W 168 V G F F I N I L P L R 287 H Q A L P F E 320 
C2 Y R D L A V W 178 I G C F I N S L V L R 294 H Q E L P F E 327 
C3 Y Q R Y I Q W 180 V G M F V N T L P T R 296 Y E A S S L I 329 
C4 Y A D F S Y W 191 I G F F V N M L L L R 310 H Q D L P F E 343 
 D X F F X L G G H S L  
         D  I  
PCPL S N F L Q L G G H S L 30 
PCP1 A D F F R M G G H S L 30 
PCP2 Q N F F E V G G N S L 30 
PCP3' D N F F Q L G G D S I 30 
PCP3 Q N F F E L G G H S L 30 
PCP4 A N F F S S G G H S L 30 
(B) PCP domains 
 
Motif- 2 Motif -3 
Motif- 5 
Motif- 1 Motif -5 
Motif- 4 Motif- 6 
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(B) CLUSTALW alignment of the conserved core motif of NRPS PCP domains (highlighted in 
yellow) from NRPS gene locus-3. The core motif sequence as reported in the literature (Konz 
and Marahiel, 1999) is highlighted in bold. The PPant attaching serine residue is highlighted 
in green.  
4.1.4.1.9 NRPS gene locus-4 
The NRPS gene locus has a size of 18.5 Kb and includes four NRPS modules, 
terminating with a functional R4 domain (Table 4-12). The biosynthesis related to this 
gene locus begins with the loading of a long chain unknown starter unit on to the 
ACPL by the AMP-dependent synthetase and ligase (Figure 4-19) encoded by 
haur_2108. The NRPS module-4 contains tandem C domains, C3’ and C3 in two 
adjacent ORFs. Alignment of C domain amino acid sequence of NRPS gene locus-4 
showed deviations in the histidine active site motif in C1, C2 and C3 domain (Figure 
4-45A). Therefore, it is presumed that C1, C2 and C3domains are inactive. Hence, 
these inactive C domains, i.e C1 and C2 might hinder the module-1 and module-2 
from taking part in the biosynthesis of the peptide. However, module-3 is expected to 
resumes its activity by the action of C3’ domain. The rest of the NRPS domains and 
ACPL were identified to contain the respective conserved motifs (Figure 4-45, Figure 
4-46). The synthesized putative lipodipeptide is expected to be reductively released 
by the R4 domain (Figure 4-47). Downstream to the NRPS gene locus-4 is the mbtH-
like gene, haur_2109 which was already reported to be involved in the biosynthesis 
of non-ribosomal peptides (Boll et al., 2011, Felnagle et al., 2010). 
  Gene locus Modules Putative functions 
haur_2109  MbtH-like protein 
haur_2108 Module-L 
Module-1 
Module-2 
AMP-ACPL 
C1-A1-PCP1 
C2-A2-PCP2 
haur_2107 Module-3 
 
Module-4 
C3’ 
haur_2106 C3-A3-PCP3 
C4-A4 
haur_2105  Taurine catabolism 
dioxygenase (TauD/TfdA) 
haur_2104 Module-4 PCP4-R4 
Table 4-12: List of genes in NRPS gene locus-4 and their putative functions. L, Loading 
module; AMP, AMP-dependent synthetase and ligase; ACP, Acyl Carrier Protein; C, 
Condensation, A-Adenylation, PCP-Peptidyl Carrier Protein, R-Reductase. 
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(A) C domains 
 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
C1 S F G E Q A L W A L 28 R H A A L R T N F 74 Q H - T V V D L Q S 151 
C2 A R M Q A G V I F H 43 R H A V L R T S F 89 F H D T I F D G W S 172 
C3' S L A Q Q R L W L V 15 R H E V L R T S I 61 L H H I I A D G W S 136 
C3 S P Q Q T H T W L V 18 R H E A L R T R F 64 L A A L V G D A T S 132 
C4 A K L Q G G M I F H 15 R H P A L R T S F 61 F H H A V I D G W S 144 
 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
C1 Y R E H V A W 188 V G Y Y V N P V L I N 299 H Q A Y P F D 332 
C2 Y R D F V A Q 209 I G V H L N M L P F R 323 Y R Q M P L A 357 
C3' Y G D Y A C W 173 I G F F I N Q L V L R 289 H Q H V P F D 322 
C3 Y I D A A E W 167 Y A E L A N A Q G L F 273 Q Q L A D L A 306 
C4 Y H E F V R L 181 L G L F I N S I P L R 292 H R R Y P T A 326 
 
(B) PCP domains and ACP domain 
 D  F F X X G X X S   
PCP1 D D F F A L G G H S L 30 
PCP2 D N F F D L G G D S I 30 
PCP3 D N F F A L G G N S I 30 
PCP4 D N F F A L G G D S I 30 
ACPL L P I Q Q L G L D S L 30 
Figure 4-45: NRPS gene locus-4 C and PCP domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS C domains (highlighted in 
yellow) from NRPS gene locus-4. The six core motif sequences as reported in the literature 
(Konz and Marahiel, 1999) are highlighted in bold. The numbers represent the amino acid 
positions in the respective sequences. Suffices indicate the respective modules. The inactive 
domains are highlighted in grey. 
(B) CLUSTALW alignment of the conserved core motif of NRPS PCP domains (highlighted in 
yellow) from NRPS gene locus-4. The core motif sequence as reported in the literature (Konz 
and Marahiel, 1999) is highlighted in bold. The PPant attaching serine residue is highlighted 
in green.  
Motif- 3 Motif- 2 Motif- 1 
Motif- 4 Motif- 5 Motif- 6 
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 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  F D X S  N X Y G P T E  
               V              S                     
A1 L T F A D L 31 L K A G A T Y L P L D 80 P A Y I I Y T S G S T G Q P K G 156 F D L S 193 N L Y G P T E 330 
A2 I S Y Q Q L 57 L K A G A A Y L P L D 106 L A Y I I Y T S G S T G Q P K G 181 F D F S 218 N M Y G I T E 319 
A3 W S Y F D L 62 L Q L G A V Y L P I D 111 L A Y V L F T S G S T G T P K G 181 F D I S 218 N A Y G P A E 319 
A4 Y S Y Q A L 49 F Y A G A A Y L P L D 98 L A Y T L F T S G S T G T P K G 181 F D I S 218 N A Y G P A E 319 
 
 G E L X I X G X G L A R G Y L  Y R T G D L  G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
              K                                    I      L    
A1 G E L F I A G L G V A Q G Y L 343 Y K T G D L 372 G R N D Q Q V K I R G F R I E L G E I E 405 V P S Y M L P 457 N G K L D R 477 
A2 G E I Y V G G A G L A R G Y L 382 Y R S G D L 410 G R S D Q Q V K L R G F R I E L G E L E 443 L P H Y L Q P 495 N G K R D Y 515 
A3 G E L Y I A G I A V G W G Y L 382 Y R T G D L 410 G R S D Q Q V K I R G F R I E L G E I E 443 L P H Y L Q P 495 N G K L D R 515 
A4 G E L Y I G G V G V G R G Y L 382 Y R T G D L 410 G R A D Q Q V K V R G Y R I E L G E I E 443 L P S Y M L P 492 N G K L D R 512 
 
Gene locus A domain Stachelhaus code Predicted substrates 
haur_2108 A1 DFWNIGMVH Threonine 
haur_2108 A2 DILQLGLIWK Glycine 
haur_2106 A3 DLTKVGEVGK Asparagine 
haur_2106 A4 DSALVAEVW Unknown 
(A) 
Motif-2 Motif-3 Motif-4 Motif-1 Motif-5 
Motif-6 Motif-7 Motif-10 Motif-8 Motif-9 
(B) 
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Figure 4-46: NRPS gene locus-4 A domains. 
(A) CLUSTALW alignment of the conserved core motifs of NRPS A domains (highlighted in 
yellow) from NRPS gene locus-4. The ten core motif sequences as reported in the literature 
(Konz and Marahiel,1999) are highlighted in bold. The numbers represent the amino acid 
positions in the respective sequences. Suffices indicate the respective modules. 
(B) The table lists the Stachelhaus codes extracted from the sequences of NRPS gene locus-4 A 
domains and their putative substrates. 
(A) 
 
(B) 
 
 
Figure 4-47: NRPS gene locus-4. 
(A) Putative NRPS (blue) genes in NRPS gene locus-4. Green, accessory gene. Inactive 
domains are highlighted in grey.  
(B)Predicted strcture of the putative dipeptide encoded by NRPS gene locus-4. X, Unknown fatty 
acid side chain; R, Unknown amino acid. 
4.1.4.1.10 NRPS gene locus-5 
The NRPS gene locus-5 with 9.5 Kb is rather small with only two NRPS modules. The 
conserved motifs required for the activity of the NRPS domains were identified by 
aligning the sequences (Figure 4-49). The AL domain was predicted to activate tyrosine, 
whereas the A1 domain may to activate asparagine resulting in a dipeptide (Figure 4-48). 
Sequences of the TE domain from module-1 lacks the catalytic triad S-89/D-116/H-264 
required for its function (Figure 4-24). Hence the TE domain of the NRPS gene locus-4 
is proposed to be inactive. The underlying mechanism in releasing the dipeptide remains 
unclear. In between the NRPS modules is the gene haur_3128 encoding a 
glycosyltransferase for glycosylating the synthesized dipeptide (Table 4-13). 
haur_2104 haur_2106 haur_2107 haur_2108 
ACL
SH
ACPL C1 A1 PCP1
SH
C2 A2 PCP2
SH
C3' C3 A3 PCP3
SH
C4 A4 PCP4
SH
R4
X N
H
H
N CHO
R
H2N
O
O
O
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Downstream to the NRPS genes is haur_3130 encoding for PPTase, which is necessary 
for priming the biosynthetic enzymes.  
Gene locus Modules Putative functions 
haur_3127 Module-L AL-PCPL 
haur_3128  Glycosyltransferases 
haur_3129 Module-1 C1-A1-PCP1-TE 
haur_3130  Phosphopantetheinyltransferase 
Table 4-13: List of genes in NRPS gene locus-5. L, Loading module; A, Adenylation; PCP, 
Peptidyl Carrier Protein; C, Condensation; TE, Thioesterase. 
(A)                      (B) 
 
 
 
Figure 4-48: NRPS gene locus-5. 
(A) Putative NRPS (blue) genes in NRPS gene locus-5.  
(B)Predicted strcture of the putative dipeptide encoded by NRPS gene locus-5.  
(A) C domain 
 
 S X A Q X R L W X L  R H E X L R T X F  M H H X I S D G W S  
       M Y                      V   
NRPS-5 S F A Q Q R L W F L 17 R H E V L R S T I 55 I H H I A C D G W S 139 
 
 Y X D F A V W  V G X F V N T L Q X R  N Q D Y P F E  
    Y     I       Q A    H        
NRPS-5 Y A D F A V W 174 I G F F V N T L P I R 293 H Q D M P L E 326 
(B) PCP domains 
 
 
 
 
 D  F F X X G X X S   
PCPL D D F F D AL G G H S L 30 
PCP1 D N F F D L G G E S L 30 
haur_3129 haur_3127 
Motif-6 
Motif-2 Motif-3 
Motif-5 Motif-4 
Motif-1 
AL PCPL
SH
C1 A1 PCP1
SH
TE
H2N
H
N
OH
OH
NH2
OO
O
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(C) A domains 
 
 L S Y X E L  L K A G X A Y L P I D  L A Y X X Y T S G T T G X P K G  
               V              S        
AL L S Y A E F 26 W K A G A V Y L P L D 76 L A Y I I Y T S G S T G K P K G 154 
A1 L S Y A E L 51 L K A G A A Y V P I D 101 L M Y V L F T S G S T G R P K G 181 
 
 F D X S  N X Y G P T E  G E L X I X G X G L A R G Y L  Y R T G D L  
                           K          
AL F D A S 193 N A Y G P T E 282 G E L L V S S V G L A H G Y L 340 Y R T G D L 370 
A1 A D L G 220 N H Y G P T E 316 G E L Y V G G A G V G R G Y I 378 Y R S G D L 408 
 
 G R X D X Q V K I R G X R I E L G E I E  L P X Y M V P  N G K V D R  
                           I      L    
AL G R I D H Q I K H R G Y R I D P G E I E 401 L P K Y M V P 456 N G K L D L 476 
A1 G R I D L Q V K I R G Y R V E L S E I E 439 L P D Y M V P 494 N G K I E R 514 
Figure 4-49: Characteristic motifs in C (A), PCP (B) and A (C) domains of NRPS gene locus-5 
(highlighted in yellow). The catalytically active residues are highlighted in green. The conserved 
residues from the literature (Konz and Marahiel, 1999) are highlighted in bold. The numbers 
indicate the position of amino acids. Suffices indicate the respective modules.   
4.1.4.1.11 PKS gene locus 
With the predominant occurrence of NRPS and PKS/NRPS mixed gene loci, only one 
PKS gene locus was identified from the H. aurantiacus DSM 785 genome sequence 
(Table 4-3). This PKS gene locus comprises KS, AT and KR domains but an ACP 
domain required for the binding of the substrate is missing. Albeit the sequence 
alignment of KS, AT, and KR domains showed the conserved motifs and catalytically 
active residues (Figure 4-20), a missing ACP domain (Table 4-14) is contemplated to 
render this PKS gene locus inactive. 
Gene locus Putative functions 
haur_0866 KS-AT-KR 
Table 4-14: PKS gene locus of H. aurantiacus DSM 785 
Motif-7 Motif-6 
Motif-10 Motif-9 Motif-8 
Motif-5 Motif-4 
Motif-3 Motif-2 Motif-1 
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4.2 Chemical screening of H. aurantiacus DSM 785 
The computational analysis of the H. aurantiacus DSM 785 genome sequence gave an 
insight into the biosynthetic potential of this strain (section-4.1.4). Since siphonazole is 
the only known metabolite from a bacterium of the genus Herpetosiphon (Figure 4-50), 
isolation and structural elucidation of the products of the above described cryptic 
biosynthetic pathways (Table 4-3) would be of great interest. 
 
 
Figure 4-50: Structure of siphonazole derivatives isolated from Herpetosiphon sp. 
To investigate this, H. aurantiacus DSM 785 was cultivated in CY, MD1+G and HP74 
medium as described in the section-3.2.4 (Figure 4-51). The culture was then 
centrifuged, and both the cell pellet and supernatant were analyzed further for the 
presence of secondary metabolites. The supernatant was extracted ethyl acetate, and 
this extract was fractionated by NP-VLC using dicholormethane, ethyl acetate, acetone 
and methanol as eluents. In parallel, the cell mass was extracted with methanol and 
fractionated in NP-VLC using dicholormethane, ethyl acetate, acetone and methanol. 
LC-MS and NMR analysis of the extracts showed molecular masses and NMR spectral 
features corresponding to the diketopiperazines cyclo(L-Pro-L-Tyr), cyclo(L-Pro-L-Val), 
cyclo(L-Hyp-L-Leu) and the indole derivative indol-3-yl-acetaldoxime (Figure-4.52). 
These diketopiperazines and the indole derivative were already reported to be by-
products contained in the culture medium (Mitscher et al., 1967). Besides these 
compounds no trace of secondary metabolites could be identified from LC-MS and NMR 
analysis. 
 
 
 
R = H/CH3 
H3CO
OR
N
O
O
N
O
H
N
O
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(A)                                                                                          (B) 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Figure 4-51: Swarm of strain H. aurantiacus DSM 785 on VY/2 agar (A) and the bacterium in 
CY medium (B). 
 
 
 
 
 
 
                             
 
Figure 4-52: Structures of diketopiperazines and an indole derivative identified from H. 
aurantiacus DSM 785 culture extracts. 
4.3 Exploring the genome based biosynthetic potential of H. aurantiacus DSM 785 
The initial chemical screening of H. aurantiacus DSM 785 (section-4.2) did not revealed 
the products of the cryptic biosynthetic pathways analysed by our genome mining 
studies (Table 4-3). Thus, as a next step the expression of the cryptic biosynthetic genes 
was investigated under defined cultivation conditions.  
 
Indol-3-yl-acetaldoxime 
Cyclo(L-Pro-L-Tyr) Cyclo(L-Pro-L-Val) Cyclo(L-Hyp-L-Leu) 
OH
N
NH
O
O
N
NH
O
O
N
NH
O
O
OH
N
H
N
OH
25X 
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4.3.1 Expression analysis for the PKS/NRPS gene locus-1 
In the first step towards the identification of the putative lipopeptide encoded by 
PKS/NRPS gene locus-1 (section-4.1.4.1), the expression of PKS and NRPS genes was 
analysed at the transcriptional level. Total RNA was isolated from H. aurantiacus DSM 
785, cultivated in CY and additionally in MD1+G medium for seven days. The isolated 
RNA was reverse transcribed using the forward primers of the primer pairs P1, P2 and P3 
designed from the PKS and NRPS sequences of the putative lipopeptide biosynthetic 
gene locus (Figure 4-53A). Since the PKS and NRPS genes (haur_1858, haur_1859, 
haur_1860 and haur_1861) are overlapping, the primer pairs, P2 and P3 were designed 
in such a way, that they span between the adjacent ORFs. The primer pair P1 was from 
the PKS/NRPS hybrid module, haur_1857 (Figure 4-53A). The synthesized cDNA was 
then PCR amplified by the respective primer pairs P1, P2 and P3. Agarose gel 
electrophoresis of the amplified PCR product showed bands of the appropriate size only 
for the cDNA synthesized from the RNA isolated from H. aurantiacus DSM 785 
cultivated in CY medium (Figure 4-53B). Sequencing of the amplicons confirmed the 
expression of the PKS/NRPS gene locus-1 in CY medium. 
(A) 
 
 
                                                                                                                              
Figure 4-53: RT-PCR of PKS/NRPS gene locus-1. 
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(A) RT-PCR primer pairs, P1, P2 and P3 designed specific for PKS and NRPS regions of 
PKS/NRPS gene locus-1. Red, PKS and NRPS genes in PKS/NRPS gene locus-1; black, ORFs. 
(B) Agarose gel electrophoresis of RT-PCR product amplified with the respective gene specific 
primers. Lane M, marker; Lane 1, RT-PCR positive control; Lane 2, 5 and 7,PCR amplified RNA 
using primer pairs P1, P2 and P3 respectively; Lane 3, RT-PCR product using primer pair P1 RNA 
(3µl); Lane 4, RT-PCR product using primer pair P1, RNA (7µl); Lane 6, RT-PCR product using 
primer pair P2, RNA (3µl); Lane 8, RT-PCR product using primer pair P3, RNA (3µl).   
4.3.2 Expression analysis of PKS/NRPS gene locus-2 
The PKS/NRPS gene locus-2 with a PKS and eleven NRPS modules includes the genes 
encoding for the biosynthesis of HPG (Table 4-5). As mentioned in the section 4.1.4.2, 
one of the A domains, i.e A2 was predicted to activate HPG (Figure 4-22B).   Hubbard et 
al., 2012 described the biosynthesis of HPG by 4-hydroxyphenylpyruvate dioxygenase, 
p-hydroxymandelate synthase and aminotransferase. Kastner et al., 2012 reported the 
respective candidate genes haur_1888, haur_1871, haur_1887 in H. aurantiacus DSM 
785 responsible for the biosynthesis of HPG (Figure 4-21). Therefore, the expression of 
these genes was analyzed in H. aurantiacus 785 cultivated in CY and MD1+G medium 
for three, five and seven days. Since haur_1887 and haur_1888 were overlapping, the 
primer pair P4 was designed for both ORFs. The primer pair P5 was designed for the 
gene haur_1871 (Figure 4-54A). The isolated RNA from the bacterium grown in CY 
medium was reverse transcribed and PCR amplified using the respective primer pairs. 
Agarose gel electrophoresis of the PCR amplified cDNA using the primer pair, P5 
showed a band of appropriate size from the RNA isolated after 2, 3 and 5 days (Figure 
4-54B). But no band was observed from the RNA isolated after 7 days. Sequencing of 
the amplicons showed that haur_1887 encoding for p-hydroxymandelate transaminase 
and haur_1888 for p-hydroxyphenylpyruvate dioxygenase were expressing till day 5 but 
not any more days. cDNA synthesized from the primer designed from haur_1871 didn’t 
show any PCR product in the agarose gel (Figure 4-54B). This confirmed that 
haur_1871 encoding for p-hydroxymandelate synthase is not expressing in CY medium. 
This is the key enzyme in converting p-hydroxyphenylpyruvate to p-hydroxymandelate 
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(Figure 4-55). These results demonstrated that HPG biosynthesis is seized because 
haur_1871 is not expressed. 
 (A) 
 
(B) 
 
                                                              
Figure 4-54: RT-PCR of PKS/NRPS gene locus-2. 
(A) RT-PCR primer pairs, P4 and P5 designed specific for HPG biosynthetic genes within 
PKS/NRPS gene locus-2. Red- PKS/NRPS gene locus-2; black, ORFs. 
(B) Agarose gel electrophoresis of RT-PCR product amplified with the respective gene specific 
primers. Lane M-marker; Lane 1, PCR of H. aurantiacus DSM 785 genomic DNA using house 
keeping gene specific primers P6 (haur_0866); Lane 2, RT-PCR product using house keeping 
gene specific primers P6 (positive control); Lane 3, 4 and 5, RT-PCR product using primer pair 
P4 and RNA isolated after 2, 5 and 7 days, respectively; Lane 6, 7, 8 and 9,  RT-PCR product 
using primer pair P5 and RNA isolated after 2, 3, 5 and 7 days, respectively.  
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Figure 4-55: Metabolism of p-hydroxyphenylpyruvate. HPPD, p-hydroxyphenylpyruvate 
dioxygenase; HPG, p-hydroxyphenylglycine. 
4.3.3 Expression analysis of NRPS gene locus-3 
NRPS gene locus-3 with five NRPS modules is organised in five ORFs (Table 4-11). 
The locus haur_2089, which is a part of the NRPS gene locus-3, carries an NRPS 
module with a TE domain for releasing the synthesized peptide from the enzyme 
assembly (Table 4-11). The primer pair P7 was designed for this termination module 
encoding region (Figure 4-56A). In addition, another primer pair, P8 was designed for 
haur_2091 (Figure 4-56A), which is considered to encode an enzyme which performs 
the second elongation step in the biosynthesis of the putative peptide. The RNA isolated 
from H. aurantiacus DSM 785 cultured in CY and MD1+G medium for 7 days was 
reverse transcribed using primer pairs P7 and P8. PCR of the synthesized cDNAs using 
both the primer pairs did not show any bands (Figure 4-56B). The inability of amplifying 
cDNAs using the respective primers showed that the NRPS gene locus-3 is not 
expressing in CY medium. 
4.3.4 Expression analysis of NRPS gene locus-4 
NRPS gene locus-4 with NRPS genes organised in four ORFs was described in section-
4.1.4.9, to encode for a putative lipodipeptide (Figure 4-47). For the expression analysis 
a single primer pair P9 was designed for the intiation module encoding gene, haur_2108. 
cDNA was synthesized from the RNA isolated from H. aurantiacus DSM 785 cultivated 
in CY and MD1+G medium. PCR of the reverse transcribed product was done using the 
designed gene specific primer pairs P9. Agarose gel electrophoresis of the PCR product 
showed band of the expected size of 730 bp in the cDNA synthesized from the RNA 
isolated from H. aurantiacus DSM 785 in CY medium (Figure 4-56B). Sequencing of the 
amplicons confirmed the expression of the gene in CY medium. Therefore, it is expected 
that the NRPS gene locus-4 expresses in CY medium.  
(A)       
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Figure 4-56: RT-PCR of NRPS gene locus-4. 
(A) RT-PCR primer pairs, P7 and P8 designed specific for NRPS gene, haur_2089 and 
haur_2091. Red, NRPS genes of NRPS gene locus-3; black, ORFs. 
(B) Agarose gel electrophoresis of RT-PCR product amplified with the respective gene specific 
primers. Lane M, marker (Promega, 1 Kb DNA ladder); Lane 1, primer pair of NRPS gene locus-
4 and RNA from H. aurantiacus DSM 785 in MD1+G medium; Lane 2- 3, primer pairs P7 and P8 
of NRPS gene locus-3 and RNA from H. aurantiacus DSM 785 in MD1+G medium; Lane 4- 
primer pair P9 of NRPS gene locus-4 and RNA from H. aurantiacus DSM 785 in CY medium; 
Lane 5-6, primer pairs P7 and P8 of NRPS gene locus-3 and RNA from H. aurantiacus DSM 785 
in CY medium. 
4.3.5 Strategies to uncover H. aurantiacus DSM 785 secondary metabolites, 
focussing on the product of PKS/NRPS gene locus-1 
Examining the expression of cryptic biosynthetic genes, PKS/NRPS gene loci-1 and 2, 
NRPS gene loci 3 and 4, showed that CY medium is the preferred culture medium for 
the expression of PKS/NRPS gene locus-1 and NRPS gene locus 4. Therefore, H. 
aurantiacus was cultivated in CY medium as described in section-2.1. However, the 
preliminary chemical screening of such H. aurantiacus culture had not resulted in any 
secondary metabolites (Section-3.2). Therefore, different extraction methodologies were 
adopted. Also, the CY medium was supplemented with additives in order to probably 
enhance the biosynthesis of secondary metabolites in H. aurantiacus.  
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The focus was put on PKS/NRPS gene locus-1, which was described in section- to 
encode for a putative lipopeptide (Figure 4-18). It was regarded as an advantage, that a 
lipopeptide is expected to posses’ anti-microbial activity. The PKS and NRPS genes of 
PKS/NRPS gene locus-1 could be analysed with some certainty concerning the modules 
and their function (Section-4.1.4.1).  
4.3.5.1 Extraction methods  
There were reports (Akhihiro et al., 1991; Liu et al., 2008) claiming the isolation of 
lipopeptides from both, the broth and cell mass. Hence, the supernatant and cell pellet 
obtained from the H. aurantiacus cultivated in CY medium were extracted further for the 
isolation of secondary metabolites (Figure 4-57). The extraction procedures were guided 
by LC-MS analysis of the extracts.  
 
 
 
 
 
 
Figure 4-57: Extraction scheme for H. aurantiacus culture 
Supernatant extract and its chemical analysis 
First, the H. aurantiacus culture supernatant was extracted with butanol. The butanol 
extract was mixed with water and adjusted to pH-2 using HCl. This suspension was then 
allowed to separate and the organic phase was collected. The collected organic phase 
was washed with water to get rid of polar impurities. The washed organic phase was 
further fractionated using NP-VLC using dichloromethane, dichloromethane:acetone 
(1:1), acetone, acetone:methanol (1:1) and methanol as eluent to obtain five fractions. 
(Liu et al., 2008) 
 
H. aurantiacus DSM 785 in CY medium for 7 days 
Aqueous phase Organic phase 
Supernatant Cell  mass 
(Ohno et al., 1995; Borders et al., 2004) 
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In addition to the above method, the butanol extract was evaporated under vacuum and 
subsequently are fractionated by NP-VLC using dichloromethane, 
dichloromethane:acetone (1:1), acetone, acetone:methanol (1:1) and methanol as 
eluents. 
In a further experiment, precipitation of the lipopeptides was attempted. As in the 
isolation of surfactin (Ohno et al., 1995), the H. aurantiacus culture supernatant was 
adjusted to pH-2 using HCl. The mixture was incubated overnight at 4°C to allow any 
lipopeptides to precipitate. The precipitate was then collected by centrifuging. 
Precipitated material was in very low amount. It was extracted with methanol and 
evaporated under vacuum. 
 LC-MS and NMR analysis of all above mentioned extracts and fractions showed 
molecular masses and NMR spectral features corresponding to diketopiperazines and 
the indole derivative described in section-4.2. 
Cell mass extract and its chemical analysis 
The cell pellet obtained from H. aurantiacus in CY medium (4 L) was lyophilized and 
suspended in a methanol and dichloromethane (2:1) mixture. The suspension was then 
centrifuged and the supernatant collected. The collected supernatant was evaporated 
under vacuum. This crude methanol extract was fractionated by NP-VLC using 
dichloromethane, ethyl acetate, acetone and methanol as eluents. LC-MS analysis of 
this extract showed an interesting molecular mass of approximately 774 Da (Compound-
1). HR-MS of this crude methanol extract using a RP C-18 column and 
acetonitrile/water/formic acid as mobile phase showed that the exact mass of 
compound-1 as 772.9128 Da (Figure-8.3). Therefore, the crude methanol extract was 
further purified in RP-18 so as to isolate the putative compound-1. 12 fractions were 
collected using gradient elution starting from 50:50 (methanol:water) to 100% methanol. 
LC-MS analysis of the 12 fractions showed the presence of compound-1 in the fraction-
8. Since fraction-8 comprised only 3 mg and still was a mixture, the cultivation was 
scaled up to 40 L. 
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The resulted crude methanol was fractionated by NP-VLC as described above.  RP-
HPLC of the NP-VLC methanol fraction using C8 column with acetonitrile/water (7:3) 
resulted in 6 fractions. LC-MS analysis of the RP-HPLC fractions showed that the 
compound-1 was distributed throughout all the fractions. In addition to compound-1 with 
a mass of 774 Da, another compound-2 with a molecular mass approximately 745 Da 
was also identified in all the fractions(Figure-8.2). Therefore, all RP-HPLC fractions 
composed of the molecular masses 774 Da and 745 Da were pooled again and it was 
decided to first to get rid of impurities that prevent the purification of compounds-1 and 2.  
To get rid of any polar impurities, the extract was fractionated further using RP-VLC and 
different water and methanol mixture (9:1, 3:1, 1:1, 1:3, 0:1) as eluents. LC-MS analysis 
of the fractions showed that the RP-VLC fraction obtained with 100% methanol 
contained compounds-1 and -2. The methanol fraction was separated further using size 
exclusion chromatography on sephadex LH-20.  14 fractions were collected and 
analyzed by LC-MS, and fractions 6-9 were identified to include the compounds-1 and -
2.  
NMR analysis of the pooled fractions obtained from size exclusion chromatography 
showed that they contain large amounts of lipids. Therefore, the extract was liquid-liquid 
partitioned between chloroform and methanol:water (7:3) to remove lipids. But, LC-MS 
analysis of the both phases showed that the chloroform phase contained compounds-1 
and -2. RP-HPLC of the chloroform extract was not successful in purifying compounds-1 
and -2. Nevertheless, the extract was fractionated in SPE columns by gradient elution 
starting from dichloromethane and methanol (9:1, 8:2, 7:3 6:4, 5:5, 4:6, 3:7, 2:8, 1:9) to 
100% methanol. LC-MS analysis of the fractions showed that the compounds 1 and -2 
co-eluted in fraction 4 with (6:4) dichloromethane and methanol (Figure-8.2). The 
amount of the fraction-4 obtained from the above stages of purification was 1 mg. The 
amount was too low to proceed with further purifications. Therefore, the structure of 
compounds-1 and -2 could not be elucidated in detail (Figure-8.1).  
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Compounds-1 and -2 have a characteristic UV absorption maximum at 376 nm and 354 
nm respectively. In the LC-MS chromatogram, compounds-1 and -2 were found to co-
elute with UV absorption at 362 nm (Figure-8.2).  
4.3.5.2 Modification of cultivation methods to facilitate the biosynthesis of 
secondary metabolites by H. aurantiacus 
It was decided to change the cultivation media composition in order to increase the 
amounts of compounds-1 and -2 and possibly the isolation of the putative lipopeptide 
and other secondary metabolites. 
Effect of HPG on the metabolic profile of H. aurantiacus DSM 785 
As per the NRPS predictor tool, the A3 domain of PKS/NRPS gene locus-1 is expected 
to activate HPG (Figure 4-8B). Moreover, A2 of PKS/NRPS gene locus-2 and A1 of 
NRPS gene locus-1 was predicted to activate HPG (Figure 4-22B). Expression of 
PKS/NRPS gene locus-1 in CY medium and the failure of HPG biosynthetic genes to 
express in CY medium were used to refine the cultivation strategies to isolate the 
putative lipopeptide.  
In the first attempt, 3 days old H. aurantiacus DSM 785 culture cultivated in 3 L CY 
medium was supplemented with 1mM of tyrosine. Tyrosine, the precursor of HPG, is 
anticipated to induce the expression of HPG biosynthetic genes. Since, HPG is expected 
to be one of the building blocks of the putative lipopeptide the expression of the HPG 
biosynthetic genes is considered to increase the production of the putative lipopeptide 
as well. At the same time, H. aurantiacus DSM 785 was cultivated in 3 L of CY medium 
supplemented with 3mM of L-HPG. The supernatant and cell mass were extracted from 
the cultures using the procedures described in the section-4.4.1. LCMS and NMR 
spectra of the extracts were similar to that of the extracts isolated from CY medium 
without tyrosine and HPG. Thus, the supplementation of tyrosine or HPG into CY 
medium didn’t influence the secondary metabolic profile of H. aurantiacus DSM 785. 
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Bacteriolysis and the metabolic profile of H. aurantiacus DSM 785 
Lysis of dead E. coli cells by H. aurantiacus DSM 785 similar to myxobacteria was 
reported earlier (Trick and Lingens, 1984). Therefore, cultivation of H. aurantiacus DSM 
785 in the presence of dead E. coli cells is speculated to bring some metabolic changes 
in H. aurantiacus DSM 785. This is in turn is expected to reflect in the metabolic profile 
of H. aurantiacus DSM 785 as well. Therefore, 10 ml of dead E. coli suspension 
prepared according to the section-3.2.4 was added to 1.5 L of 3 days old H. aurantiacus 
DSM 785 in CY medium. The supernatant and cell mass were extracted as described in 
the section-4.4.1. In contrary to expected, no difference in the metabolic profile was 
observed in H. aurantiacus DSM 785 cultivated along with dead E. coli suspension in CY 
medium.  
From gene expression studies using RT-PCR and the growth behaviour, CY medium 
was opted as the better medium to cultivate H. aurantiacus DSM 785. To extract the 
biosynthetic potential of H. aurantiacus DSM 785, the strain was cultivated in CY 
medium along with additives including tyrosine, L-HPG and the dead E. coli suspension. 
Moreover, different extraction methods were followed for the above cultivation 
conditions. Albeit, two compounds-1 and 2 were identified in the extract neither of the 
compounds were in good amounts to proceed further. None of the other metabolites 
encoded by the PKS and/or NRPS genes of H. aurantiacus DSM 785 were also isolated. 
4.4 Biochemical characterization of A domains in PKS/NRPS gene locus-1 
PKS/NRPS gene locus-1 comprises six A domains responsible for selecting amino acids 
for the putative lipopeptide (Table 4-4). As mentioned in section-4.4.1.1, the putative 
substrates activated by all A domains except for the A2 domain, were anticipated from 
their amino acid sequences (Figure 4-8B). In order to verify these deductions the A 
domains were biochemically characterized. Moreover, using this approach it was 
attempted to identify the substrate of the A2 domain. For the characterization, 
overexpressed A domain proteins were assayed using γ-18O4- ATP pyrophosphate 
exchange assay in the presence of predicted and other substrates (Phelan et al., 2009). 
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4.4.1 Heterologous expression and purification of the A3 domain 
To initiate the biosynthesis of the full length N-terminal His6-tagged A3 domain protein, 
2.3 Kb of the nucleotide sequence encoding for the A3 domain was  first PCR amplified 
using pfu DNA polymerase from the isolated H. aurantiacus DSM 785 genomic DNA. 
The amplicon with appropriate restriction sites was then cloned into the pET-28a 
expression vector. For the overexpression, the generated construct pLN-A3 was 
transformed into the E. coli BL21 cells. The recombinant E. coli BL21-pLN-A3 cells were 
then cultivated in LB medium with kanamycin till an OD600 of 0.5 was reached. The 
culture was then induced with different concentrations of IPTG to enable the expression 
of the His6-tagged A3 domain protein and incubated further at different temperatures for 
varying time period. However, the protein did not express in the above conditions tested. 
Owing to the codon usage bias between E. coli and H. aurantiacus DSM 785, the 
plasmid pLN-A3 was transformed into Rosetta (DE3) pLysS cells. Rosetta (DE3) pLysS 
facilitates the expression of genes that contain the codons rarely used in E. coli. The 
cultivation of Rosetta-pLNA3 cells in LB medium with kanamycin till OD600 of 0.5 followed 
by the induction with different concentrations of IPTG and incubation at 37°C showed 
the expression of a 63.6 kDa His6-tagged A3 protein in the insoluble fraction (Figure 
4-58A). The protein was then successfully expressed in the soluble fraction from the 
cells induced with 0.5 mM IPTG and post-induction incubation at 16°C for 16 hrs. Due to 
the low level of expression the protein was extracted from 1L LB medium for the 
adenylation assay. 
The expressed protein was then purified via affinity chromatography using gravity flow 
Ni-NTA resin (Figure 4-58B). The purified protein fractions were then desalted and 
exchanged in Tris buffer pH-7.5 using PD-10 desalting column. The protein fractions 
were further concentrated using 10 kD cut-off Amicon centrifugal concentrator.   
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(A)                                                                                   (B)                 
 
                                    
Figure 4-58: Heterologous expression and purification of His6-A3 protein.  
(A) SDS-PAGE (11%) of protein extracts from Rosetta (DE3) pLysS-pLNA3 at 37°C. Lane 1-
Control (IF); Lane 2, 3 and 4- 1mM IPTG, 0.5mM IPTG and 0.25mM IPTG (IF); Lane 5, 6 and 7-
0.25 mM IPTG, 0.5mM IPTG and 1mM IPTG (SF); Lane 8-Control (SF). IF-Insoluble fraction, 
SF-Soluble fraction. M- marker. 
(C) SDS-PAGE (11%) of Ni-NTA elution fractions (E1-E4) containing His6-tagged A3 protein.  
4.4.1.1 Adenylation assay with A3 domain 
Bioinformatic analysis of A3 protein sequences showed that A3 domain of haur_1858 
should preferentially activate the amino acid, L-asparagine. To support the bioinformatic 
prediction, the heterologously expressed A3 domain protein was analysed using γ -
18O4-
ATP pyrophosphate exchange assay in the presence of L-asparagine. In addition to L-
asparagine other amino acids showing similar physiochemical properties like L-
aspartate, L-glutamine and L-glutamate and other diverse amino acids like L-histidine 
and L-cysteine were also tested. MALDI-TOF MS of the assay mixture showed 
activation of all the tested amino acids without any substantial difference (Figure 4-59). 
To improve the function of the A3 domain protein, the assay was carried out at 30°C for 
30 min. This was done because H. aurantiacus DSM 785 grows well at 30°C. Analysis 
of the assay mixtures showed that at this temperature the A3 domain protein was 
inactive. Since the A3 domain protein was eluted along with some background proteins, 
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the influence of these background proteins on unspecific activation of substrates by His-
tagged A3 domain protein was examined. Thus, the assay was done with proteins 
extracted from the uninduced culture. But none of the amino acids tested were activated. 
Therefore, it is most likely that indeed the A3 domain protein is responsible for the 
unspecific activation.   
 
Figure 4-59: γ -18O4-ATP pyrophosphate exchange assay with His6-tagged A3 protein. Black bar 
indicates activity of A3 domain with the predicted substrate (Asn). Grey bars indicate activity of A3 
domain with other substrates used in the assay.   
4.4.2 Heterologous expression, purification of A4 and A5 domains 
The bimodular locus haur_1859, which is a part of PKS/NRPS gene locus-1, has two A 
domains, i.e A4 and A5 (Table 4-3). In order to assess the activity of these A domains, 
the nucleotide sequences encoding for the A4 and A5 domains were cloned into the 
pET28 expression vector  to generate the constructs pLNA4 and pLNA5. The expression 
of N-terminus His6-tagged A4 and A5 domain proteins was achieved using the same 
procedure as that described for pLNA3 with 0.5 mM IPTG and a post-induction 
incubation at 16°C for 18 hrs. The purification of the A4 and A5 domain proteins in their 
native form from the soluble fraction was carried out using gravity flow Ni-NTA resin. 
SDS-PAGE of the protein fractions followed by the Coomassie blue staining and 
destaining showed a band of 49.7 kDa and 48.7 kDa size in consistent with the 
predicted molecular weight of the His6-tagged A4 and A5 proteins, respectively. The 
purified protein fractions were then desalted and concentrated (Figure 4-60).     
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Figure 4-60: Heterologous expression and purification of His6-A4 and His6-A5 proteins.  
(A) SDS-PAGE (12%) of Ni-NTA elution fractions (E1-E4) containing His6-tagged A4 protein. M-
marker. 
(B) SDS-PAGE (11%) of Ni-NTA elution fractions (E1-E2) containing His6-tagged A5 protein.  
4.4.2.1 Adenylation assay with A4 and A5 domains 
The Stachelhaus code for the A4 and A5 domains were congruent with that for L-
threonine and L-serine, respectively (Figure 4-8B). Since serine and threonine differ only 
in a methylene group, the expressed A4 and A5 domain proteins were examined in the 
presence of L-serine and L-threonine using the γ 18O4-ATP pyrophosphate exchange 
assay. In addition other amino acids including L-alanine, L-histidine, L-cysteine and L-
HPG were also assayed. But again, as in the case of A3 domain both the A4 and A5 
domain proteins were highly promiscuous (Figure 4-61). 
 
 
 
 
 
          M       E1         E2         E3         E4                                   M     E1            E2 
His6-A5 
48.7 kDa 
His6-A4 
49.7 kDa 
30 
 
60 
50 
40
 
 
kDa 
30 
 
60 
50 
40
 
 
kDa 
Results 
138 
 
(A)                                                                 (B) 
                                  
Figure 4-61: (A) γ-18O4-ATP pyrophosphate exchange assay with His6-tagged A4 protein. Black 
bar indicates activity of A4 domain with the predicted substrate (Thr). Grey bars indicate activity 
of A4 domain with other substrates used in the assay. 
(B) γ-18O4-ATP pyrophosphate exchange assay with His6-tagged A5 protein. Black bar indicates 
activity of A5 domain with the predicted substrate (Ser). Grey bars indicate activity of A5 domain 
with other substrates used in the assay.   
Although the tested A domains, i.e A3, A4 and A5 were functional they were unspecific. 
These results demonstrated that discrete A domain proteins of PKS/NRPS gene locus-1 
of H. aurantiacus DSM 785 were either indeed unspecific or a larger protein is required 
to gain specific activity. 
4.4.3 Heterologous expression with A3-PCP3 didomain 
Marshall et al., 2002 reported the significance of interdomain interactions between trans 
acting A and PCP domains in recognizing their substrates. Therefore, it is expected that 
the respective PCP domains might improve the in vitro behaviour of A3, A4 and A5 
domain proteins. To generate N-terminus His6-tagged A3-PCP3 didomain protein, the 
encoding nucleotide sequences were cloned into the pET28a expression vector resulting 
in the construct pLNA3-PCP3. For the expression and purification of the A3-PCP3 
didomain protein the same procedure as that for the discrete A3 domain was followed, 
except that after induction with IPTG the culture was incubated at 18°C for 24 hrs. 
Coomassie blue staining and destaining of the SDS-PAGE from the eluted protein 
fractions showed a band of 75.9 kDa, corresponding with the expected molecular weight 
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of the N-terminus His6-tagged A3-PCP3 didomain protein. The heterologously expressed 
protein was then purified using gravity flow Ni-NTA resin (Figure 4-62). The eluate was 
desalted and concentrated. 
 
 
Figure 4-62: Heterologous expression and purification of His6-A3-PCP3. 
SDS-PAGE (11%) of Ni-NTA elution fractions (E1-E4) containing His6-tagged A3-PCP3 protein.  
M-Marker. 
4.4.3.1 Adenylation assay with A3-PCP3 didomain 
The γ-18O4-ATP pyrophosphate exchange assay of the concentrated A3-PCP3 didomain 
protein was done with the same set of amino acids as for the A3 domain alone; L-
asparagine, L-aspartate, L-glutamine, L-glutamate, L- histidine and L-cysteine. L-
asparagine was highly activated but other amino amino acids were also equally 
activated (Figure 4-63). This showed that the PCP domain did not influence the activity 
of the A3 domain. 
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Figure 4-63: γ-18O4-ATP pyrophosphate exchange assay with His6-tagged A3-PCP3 protein. 
Black bar indicates activity of A3 domain with the predicted substrate (Asn). Grey bars indicate 
activity of A3 domain with other substrates used in the assay.   
4.4.3.2 Heterologous expression of the PPTase Haur_3130 
In a further attempt a mass spectral characterization of the loaded amino acids was 
tried. For this a PPTase was needed. To identify the covalently loaded substrates, the 
expressed A-PCP didomains needed to be incubated with PPTase. PPTase is the 
primary enzyme for converting the PCP domain to active holo form. This in turn renders 
the PCP domain to bind the adenylated subtrates. The H. aurantiacus DSM 785 genome 
sequence encoding a PPTase at the locus haur_3130 for priming the PCP domains of 
NRPS megasynthases.  
To generate a full length N-terminal His-tagged PPTase, haur_3130 was cloned in 
pET28a to generate the construct pLNPPT. The construct was then transformed in to 
the expression host BL21 (DE3) pLysS. 30 kDa of the His-tagged PPTase was then 
successfully expressed in of LB medium with 0.5mM IPTG and post-induction incubation 
at 16°C for 16 hrs (Figure 4-64). The N-terminal his-tagged PPTase was purified using 
gravity flow Ni-NTA resin. The purified protein was then desalted and concentrated 
further. 
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Figure 4-64: Heterologous expression and purification of His6-tagged PPT. 
SDS-PAGE (11%) of Ni-NTA purified fractions containing His6-tagged PPT. PPT, 
phosphopantetheinyltransferase; M, marker; FT, flow through; W, wash fraction; E1-E4, elution 
fractions. 
4.4.3.3 Phosphopantetheinylation of A3-PCP3 didomain  
Heterologously expressed A3-PCP3 didomain was incubated with Haur_3130 and amino 
acid substrates, in order to analyze the loading of specific substrates onto the PCP3 
domain. For the beginning, native SDS-PAGE of the assay mixtures including A3-
PCP3(apo), A3-PCP3(holo) and A3-PCP3(holo) incubated with amino acid substrates 
showed bands at 75.9 kDa corresponding to the A3-PCP3 didomain and 30 KDa for 
Haur_3130. The mass difference between the A3-PCP3(apo) and A3-PCP3(holo) with 
and without the substrate loading is too small to be identified from the SDS-PAGE. The 
in-gel digestion of the 75.9 kDa band and subsequent analysis using MALDI TOF/TOF 
(Section-3.5.8.2) was expected to reveal the mass difference and protein sequence as 
well. The peptide fingerprints showed the presence of catalytically active serine for the 
loading of phosphopantetheine arm in one of the fragment of molecular weight 3346.82 
Da. But, shift in the molecular mass to 3686.92 Da.corresponding to the A-PCP(holo) 
was not observed and obviously loading of the amino acids was also not observed.   
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4.4.4 Heterologous expression of the A2-PCP2 didomain 
The A2-PCP2-didomain was cloned into expression vector pET28a to generate the 
construct pLNA2-PCP2. The expression of N-terminus His-tagged A2-PCP2 protein was 
tried in Rosetta (DE3) pLysS with different concentrations of IPTG and with different post 
induction times and temperatures. But the protein was only identified in the insoluble 
fraction.  
Since the formation of insoluble aggregates could be minimized at low temperatures, 
protein expression was done at temperatures lower than 16°C using Arctic cells. Arctic 
competent cells express chaperones for assisting protein folding at lower temperatures. 
Since the plasmid carrying the genes encoding for chaperones contains a gentamycin 
resistance cassette, the transformed clones were selected on the LB agar plates with 
kanamycin and gentamycin. The genetically modified Arctic-pLNA2-PCP2 was then 
cultivated in LB medium till OD600 of 0.5 was reached. The culture was then induced with 
0.5mM IPTG and incubated at 11°C for additional 24 hrs. SDS-PAGE of the Ni-NTA 
purified soluble fractions showed a band of 116 kDa consistent to the molecular weight 
of A2-PCP2 protein (Figure 4-65). The protein was desalted and concentrated before 
proceeding with γ-18O4-ATP pyrophosphate exchange assay. 
 
 
Figure 4-65: Heterologous expression and purification of His6-A2-PCP2. 
SDS-PAGE (10%) of Ni-NTA elution fractions (E1-E3) containing His6-tagged A2-PCP2 protein. 
M-Marker. 
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4.4.4.1 Adenylation assay with A2-PCP2 didomain  
From the sequence of the A2 domain the substrate activated by the latter could not yet 
be predicted. Therefore, A2-PCP2 protein was assayed with a broad range of amino 
acids. Similar to the previous experiments the A2-PCP2 didomain protein was highly 
unspecific and adenylated virtually all amino acids (Figure 4-66).  
 
Figure 4-66: γ-18O4-ATP pyrophosphate exchange assay with His6-tagged A2-PCP2 protein. 
Black bar indicates activity of A2 domain with the predicted substrate (HPG). Grey bars indicate 
activity of A2-PCP2 domain with other substrates used in the assay.   
4.4.5 Coexpression of mbtH-like protein and A3 domain  
The mbtH-like protein is approximately 71 amino acids long and is often encoded in 
NRPS biosynthetic gene cluster. There are reports claiming the involvement of mbt-H 
proteins in the adenylation of substrates and regulating the production of non-ribosomal 
peptides. However, the exact role of mbtH-like proteins is not yet known (Boll et al., 
2011; Felnagle et al., 2010). In order to study whether such mbtH-like proteins influence 
the adenylating proteins A2, A3 and A4  of PKS/NRPS gene locus-1, the H. aurantiacus 
DSM 785 genome was scanned for the presence of mbtH-like genes. In total two mbtH-
like genes were identified at the locus haur_0026 and haur_2109, being located at 
around 2 Mb and 45 Kb upstream and downstream to PKS/NRPS gene cluster-1, 
respectively. Because of the relative proximity, the locus haur_2109 was chosen for 
coexpression with the adenylating proteins (A2, A3 and A4) of PKS/NRPS gene locus-1. 
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For the coexpression, initially the mbtH-like gene was cloned into the pCDFDuet vector 
resulting in the construct pLN-mbtH. The coexpression vector pCDFDuet was chosen 
because of its compatibility with the pET28a expression vector.  
The pLNA3 and pLN-mbtH constructs were transformed into Rosetta (DE3) pLysS 
expression host. The coexpression of mbtH and A3 domain proteins was attained by the 
same procedure followed for the expression of discrete A3 domain proteins, except 
streptomycin was added in addition to kanamycin. SDS-PAGE of the purified protein 
fractions showed 63.6 kDa band corresponding to the size of the A3 domain protein 
(Figure 4-67). Additionally another band of 8 kDa consistent with the size of mbtH 
protein (Figure 4-67) was also identified agreeing with the fact that A domain and mbtH 
proteins elute together during purification. 
 
 
Figure 4-67: Heterologous expression and purification of His6-A3-mbtH. 
SDS-PAGE (12%) of Ni-NTA elution fractions (E1-E4) containing His6-tagged A3 and mbtH 
proteins. M, Marker. 
4.4.5.1 Adenylation assay with mbtH-A3 domain 
The γ-18O4-ATP pyrophosphate exchange assay was done for the expressed mbtH-A3 
domain protein in the presence of amino acids used for testing discrete A3 domain. The 
assay showed higher activation for L-asparagine whereas the other amino acids L-
aspartate, L-glutamine, L-cysteine and L-histidine showed very low activation. The other 
amino acid L-glutamate didn’t show any activation. The experiment was repeated again 
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using L-asparagine along with another set of amino acids, L-threonine, L-tyrosine, L-
tryptophan and L-serine. Except L-serine all the other amino acids didn’t show any 
activation (Figure 4-68A). However the activation of L-serine was low when compared to 
that of L-asparagine. Thus, the earlier experiments with mbtH-A3 domain protein showed 
that L-asparagine was the substrate for A3 domain of PKS/NRPS gene locus-1 (Figure 
4-68A). But later on, the experiments with same amino acids showed unspecific 
activation (Figure 4-68B).  
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Figure 4-68: (A), (B): γ-18O4-ATP pyrophosphate exchange assay with His6-tagged A3-mbtH 
protein. Black bar indicates activity of A3 domain with the predicted substrate (Asn). Grey bars 
indicate activity of A3 domain with other substrates used for the assay.   
4.4.6 Coexpression of mbtH-like and A4 domain 
As described in the coexpression of mbtH and A3 domain protein, pLNmbtH and pLNA4 
was cloned and expressed in Rosetta (DE3) pLysS expression host. 49.7 kDa of A4 
domain protein and 8 kDa of mbtH-like protein were co-eluted during purification using 
gravity flow Ni-NTA resin (Figure 4-69).  
 
 
 
Figure 4-69: Heterologous expression and purification of His6-A3-mbtH. 
SDS-PAGE (12%) of Ni-NTA elution fractions (E1-E5) containing His6-tagged A4 and mbtH 
proteins. M, Marker. 
4.4.6.1 Adenylation assay of mbtH-A4 domain  
 The γ-18O4-ATP pyrophosphate exchange assay was done for the desalted and 
concentrated mbtH-A4 domain protein with amino acids L-serine, L-threonine, L-
cysteine, L-histidine, L-alanine. MALDI-TOF MS analysis of the incubated assay mixture 
showed activation for L-threonine, whereas the other amino acids tested were not 
activated (Figure 4-70A). The experiment was repeated with L-threonine along with 
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additional amino acids L-phenylalanine, L-HPG, L-asparagine, L-glutamine and L-lysine. 
The assay again showed activation only for L-threonine as expected among the amino 
acids tested (Figure 4-70A). But, later the γ-18O4-ATP pyrophosphate exchange assay 
with the same set of amino acids L-serine, L-threonine, L-cysteine, L-histidine and L-
valine showed unspecific activation (Figure 4-70B).    
(A)        
 
 
Figure 4-70: (A), (B) γ-18O4-ATP pyrophosphate exchange assay of His6-tagged A4-mbtH 
proteins. Black bar indicates activity of A4 domain with the predicted substrate (Thr). Grey bars 
indicate activity of A4 domain with other substrates used for the assay.   
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4.4.7 Coexpression and adenylation assay of mbtH-like and A5 domain 
Coexpression of mbtH-like (pLNmbtH) and A5 domain protein (pLNA5) was done in 
Rosetta (DE3) pLysS expression host using the same procedure as described in 
section-3.5.5.1. 48.7 kDa of A5 domain protein and 8 kDa of mbtHe protein were co-
eluted during purification using gravity flow Ni-NTA resin (Figure 4-71A). The purified 
protein was then tested for its adenylation activity using the amino acids L-serine, L-
threonine, L-alanine, L-histidine, L-cysteine and L-HPG. MALDI-TOF of the incubated 
assay mixtures showed the unspecific activation of A5 domains (Figure 4-71). 
(A)                                                                                  (B) 
                                           
Figure 4-71: γ-18O4-ATP pyrophosphate exchange assay with heterologously expressed and 
purified His6-A5-mbtH. 
(A) SDS-PAGE (12%) of Ni-NTA elution fractions (E1-E3) containing His6-tagged A5 and mbtH 
proteins. M, Marker. 
 (B) γ-18O4-ATP pyrophosphate exchange assay of His6-tagged A5-mbtH protein. Black bar 
indicates activity of A5 domain with the predicted substrate (Ser). Grey bars indicate activity of A5 
domain with other substrates used for the assay.   
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5. Discussion 
Nature is an exquisite resource for structurally diverse molecules. These molecules 
often exhibit an impressive range of biological properties, which are of pharmacological 
importance. Since 1981, 41% of clinically approved drugs were either obtained, or 
inspired by molecules from nature’s treasure trove. Of them, 27.4% are being 
administered as anti-infective (bacterial, fungal, parasitic and viral) drugs and 24.4% are 
being used for cancer therapies (Newman and Cragg, 2012). Despite the development 
of natural product based drugs, the existence of untapped organisms in unusual natural 
habitats and lately especially plentiful genome sequences have made it apparent, that 
there is a wide range of molecules yet to be determined (Lefevre et al., 2008). The 
deeper understanding of biosynthetic enzymes has revolutionized the discovery of 
molecules starting from genes, and offers a unique opportunity for the development of 
novel pharmaceuticals. For instance, the broad spectrum anti-tumor agent TLN-4601 
(ECO-4601), which is currently in phase II clinical trial (McAlpine et al., 2008) was 
predicted from the genome of the soil Micromonospora sp. 046Eco-11, and successively 
isolated (Bachmann et al., 2004). Almost at the same time TLN-4601 (ECO-4601) was 
also discovered from the marine Micromonospora sp. DPJ12 (Charan et al., 2004).   
5.1 Genomes and secondary metabolites of gliding bacteria 
The developments in genome-guided discovery and isolation of new compounds is not 
limited to well studied taxa, but also applicable to the as yet unexplored. In this study we 
investigated gliding bacterial genomes with a size bigger than 5 Mb, because a genome 
size bigger than 5 Mb is a typical indicator for the presence of PKS and NRPS genes 
(Donadio et al., 2007). Subsequently, 33% of the gliding bacterial genomes available 
through Genbank were recognized by us to harbour PKS and NRPS genes. The striking 
feature in this is the large number of PKS and NRPS genes identified, which vastly 
exceeds the number of metabolites isolated from the respective bacteria (Figure 5-1). 
Reflected by the above, this study sheds light into the latent biosynthetic potential of 
gliding bacteria, especially from the overlooked genera, as judged from the genomes of 
Myxococcus fulvus HW-1, Haliangium ochraceum DSM14365, Isophaera pallida ATCC 
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43644, Paedobacter heparinus DSM 2366, Chitinophaga pinensis DSM 2588  and 
Herpetosiphon aurantiacus DSM 785. 
(A)                                                                    (B) 
 
Figure 5-1: Gliding bacterial genomes and their secondary metabolites. 
(A) Distribution of gliding bacterial genomes other than cyanobacteria with respect to their size. 
The percentage of genomes bigger than 5 Mb is subdivided based on the presence of PKS and 
NRPS genes. 
(B) Number of PKS and NRPS genes encoded in gliding bacterial genomes. The red bars 
represent the genome encoded biosynthetic potential. Blue bars indicate the number of 
metabolites known from the strains at the time of genome sequencing.   
The halotolerant M. fulvus HW-1 has 75.17% identical protein coding sequences to 
those of M. xanthus DK1622 (Li et al., 2011) and was expected to have similar 
biosynthetic abilities. But since the isolation of this strain (Li et al., 2002; Li et al., 2011) 
no metabolites were reported yet. During our computational screening of the M. fulvus 
HW-1 genome, we identified 17 PKS and/or NRPS gene loci including the putative 
DKxanthenes and the myxochelin A gene clusters. Since M. fulvus HW-1 should be 
closely related to their terrestrial counterparts (Li et al., 2011), we suggest that at least 
one of the M. fulvus HW-1 cryptic gene clusters encode biosynthetic enzymes for typical 
M. fulvus metabolites (Nett and König, 2007).  
With the onset of isolating marine myxobacterial strains, the accessibility of the Ha. 
ochraceum DSM14365 genome affords a possibility to study genes involved in their 
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secondary metabolism (Ivanova et al., 2010). Only 3% of the genome was found to be 
involved in the biosynthesis of non-ribosomal peptides and polyketides. Nevertheless, 
the unusual ecological niche is expected to give rise to the biosynthesis of structurally 
intriguing compounds. Haliangicin, the antifungal compound isolated from Ha. 
ochraceum DSM14365 (Kundim et al., 2003; Fudou et al., 2001) is an example for this. 
In our study we rationalized the biosynthetic gene cluster for haliangicin in Ha. 
ochraceum (Section-3.1.1.2.1). However, isotope labeled feeding analysis coupled, 
either with gene inactivation, or heterologous expression studies are essential for 
complete validation and identification of the haliangicin biosynthetic pathway. The 
presence of a methylated myxochelin A biosynthetic pathway in the Ha. ochraceum 
genome shows on the other side that marine myxobacterial strains are closely related to 
their terrestrial counterparts. 
In the smaller genomes of I. pallida ATCC 43644 (5.5 Mb) and Pa. heparinus DSM 2366 
(5.2 MB) one PKS and a hybrid PKS/NRPS gene loci were found, respectively. 
However, the number of putative PKS and NRPS genes identified is not high, when 
compared to other genera. 
The percentage of PKS and NRPS genes identified from Ch. pinensis DSM 2588 (2.9%) 
is comparable to that from Ha. ochraceum DSM 14365. But the size of each of the gene 
loci is exceptionally big, limiting the number to a single PKS, NRPS and a mixed 
PKS/NRPS gene locus. The PKS gene locus was already described to involve in the 
biosynthesis of elansolid B1 and D (Teta et al., 2010). 
At the initial phase of our project only a few genomes of gliding bacteria were publicly 
accessible. Of them, the H. aurantiacus DSM 785 genome was promising because of its 
size (6 Mb) and lineage. Our detailed bioinformatic analysis of this genome witnessed 
the presence of 11 PKS and/or NRPS orphan gene loci. Genes to structure prediction of 
each of these gene loci unfolded the putative structurally most unusual metabolites 
encoded by the biosynthetic gene cluster. Although no siderophores have yet been 
isolated from Herpetosiphon spp., the identity of one of the mixed PKS/NRPS cluster 
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with the myxochelin biosynthetic gene cluster, strongly suggests that the resulting 
siderophore will be myxochelin A.  
5.2 Secondary metabolites of H. aurantiacus DSM 785 
The predictions made from the PKS and NRPS genes of the hitherto unexplored H. 
aurantiacus DSM 785, has prompted us to investigate the associated secondary 
metabolites of this bacterium. As a consequence of either low, or unexpressed PKS and 
NRPS genes, however no secondary metabolites were detected from the culture 
extracts. Therefore, some biosynthetic pathways, i.e. PKS/NRPS gene locus-1, -2 and 
NRPS gene locus-3 and -4 were examined concerning their expression in the applied 
cultivation conditions.   
RT-PCR analysis of the cryptic biosynthetic gene loci demonstrated the expression of 
PKS/NRPS gene locus-1 and NRPS gene locus-4 in casitone-yeast (CY) based 
medium. LC-MS analysis of lyophilised cell extract obtained from CY medium has 
provided us evidence for the presence of compound-1 and -2. The few micrograms of 
compound-1 and -2, that are obtained made it possible to perform MS analysis, but this 
was not sufficient for complete structure determination. According to our structure 
prediction studies, PKS/NRPS gene locus-1 and NRPS gene locus-4 were determined 
to encode for a lipohexapeptide and a lipodipeptide, respectively. Since the long chain 
fatty acid likely to be incorporated by the acyl-CoA synthetase, and the putative 
substrates activated by some of the A domains could not be predicted with accuracy, the 
exact molecular mass of the compounds encoded by these gene loci could not be 
determined. Nevertheless, the putative lipohexapeptide and lipodipeptide were 
anticipated to have a molecular mass different from that of compound-1 and -2, 
respectively. So, it has become apparent that although the expression of PKS/NRPS 
gene locus-1 and NRPS gene locus-4 is ensured, no trace of these lipopeptides could 
be identified in LC-MS. A reason for this could be that the lipopeptides are produced in 
amounts too low to be detected.  
A possibility to increase the production of the desired metabolites by H. aurantiacus 
DSM 785 would be to alter the cultivation parameters and/or the genetic manipulation of 
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the bacterium. In this context, it is interesting to note that manipulation of transcriptional 
regulators has been successful in the up-regulation of the expression of secondary 
metabolite genes. In So. cellulosum So ce 56, overexpression of the positive regulator 
chiR has increased the production of chivosazol (Rachid et al., 2007), whereas 
inactivation of the negative regulator ntcA has enhanced the production of both 
chivosazol and etnangien (Rachid et al., 2009). With the genome sequence of H. 
aurantiacus DSM 785 in hand, it is possible to identify transcriptional regulators. But the 
crucial factor is establishing H. aurantiacus DSM 785 amenable for genetic 
manipulation. In our laboratory many different strategies were tried to transform 
Herpetosiphon sp. (Ph.D T. Hoever, 2012), but all rendered unsuccessful. 
Heterologous expression of entire cryptic biosynthetic gene loci is the promising 
alternate route for the production of the corresponding molecules. Since a universal host 
for heterologous expression is not yet available, the rate-limiting step in this would be 
the development of a functional genetic system for the expression of H. aurantiacus 
biosynthetic genes. M. xanthus, a gliding myxobacteria has been proven successful in 
expressing a PKS gene cluster encoding for oxytetracycline from the actinomycete, 
Streptomyces rimosus (Stevens et al., 2010). Therefore, M. xanthus with a similar 
lifestyle as that of Herpetosiphon would be a challenging host for expressing H. 
aurantiacus biosynthetic genes. Other hosts including E. coli and pseudomonads, which 
has been successful in expressing genes from unrelated organisms (Wenzel and Müller, 
2005; Pfeifer et al., 2001) could also be used for the expression of H. aurantiacus 
biosynthetic genes. Additionally, the transfer of biosynthetic genes in a genetically 
tractable host would give the opportunity to manipulate these genes in such a way that 
unnatural compounds are generated. The polyketide and anticancer agent epothilone 
was heterologously expressed in M. xanthus and successively the gene cluster was 
modified to produce novel epothilone analogues (Tang et al., 2005). 
Inspite of the breakthroughs in analytical chemistry and molecular biology techniques, 
the isolation of metabolites encoded by cryptic biosynthetic genes still remains a 
challenge. Followed by sequencing of the myxobacterial genomes, Sg. aurantiaca 
DW4/3-1 and So. cellulosum So ce56, their genomes were found to have 9 cryptic gene 
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clusters (Schneiker et al., 2007; Ronning and Nierman, 2007). In the span of five years 
since the identification of these orphan gene clusters, the associated metabolites were 
not yet isolated. Also, in M. xanthus DK1622 six years after sequencing the genome with 
13 orphan gene clusters (Wenzel and Müller, 2009b), only one was verified to encode 
for a new class of compounds called myxoprincomide. The amount of myxoprincomide 
from M. xanthus DK1622 was hardly enough for structure determination. Ultimately, the 
myxoprincomide gene cluster which was luckily identified in another better producing M. 
xanthus strain was homologously overexpressed under the control of a constitutive 
promoter (Cortina et al., 2012).  
Continuing research in bioinformatics, analytical techniques, molecular biology and 
synthetic biology will hopefully soon facilitate genome-based discovery of novel 
compounds. For a big step forward, special microorganisms functioning as platforms for 
the expression of a wide range of genes are necessary. 
5.3 Biochemical characterization of adenylation (A) domains 
A domains are the crucial gatekeeper for the entry of building blocks into the 
construction pipeline of a nonribosomal peptide. Usually A domains exhibit a high 
degree of substrate specificity. However, A domains with relaxed substrate specificity 
were also observed thereby giving rise to analogues (Ueki et al., 2006). In this study, we 
attempted to characterize the A domains of PKS/NRPS gene locus-1, first by 
bioinformatic analysis and then by the classical γ-18O4- ATP pyrophosphate exchange 
assay. These methods have been proven accurate for identifying the specific substrate 
of an A domain (Phelan et al., 2009; Stachelhaus et al., 1999).  
Except the A2 domain, all other A domains, i.e A3, A4, A5, A7 and A8 of PKS/NRPS gene 
locus-1 were found to have a non-ribosomal code at least 90% identical to that of 
previously characterized A domains (Figure 5-2). It was thus considered most likely that 
these A domains activate the predicted substrates (Rottig et al., 2011), i.e A3, A4 and A5 
are suggested to activate L-asparagine, L-threonine and L-serine, respectively. 
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Figure 5-2: PKS/NRPS gene locus-1. 
(A) NRPS and PKS organization in PKS/NRPS gene locus-1. Putative PKS genes are in red, 
NRPS genes are blue, PKS/NRPS genes are green and acyl-CoA synthetase is in brown. 
(B) A domains of PKS/NRPS gene locus-1 and their substrate specificities. 
After heterologously expressing the respective proteins, adenylation assays were carried 
out in this study with the A3, A4 and A5 domain. However, in contrast to the expected 
results the proteins showed activation for almost all of the amino acids tested. Moreover, 
when the same experiment was repeated the results were inconsistent concerning the 
highly activated amino acid.  
It is not uncommon for the A domains with relaxed substrate specificity to behave in vivo 
contradictory to the computational predictions. For example, one of the A domains in 
LicC from lichenysin synthetase, activates not only L-isoleucine but also L-valine and L-
leucine (Konz et al., 1999). However, this A domain showed 100% identity to the 
Stachelhaus code for L-isoleucine. In case of xenematide synthase, the Stachelhaus 
codes for two of the A domains were 70% identical to that of L-phenylalanine. But in 
vivo, both these A domains activated L-phenylalanine and L-tyrosine thereby producing, 
xenematide A, B, C and D (Crawford et al., 2011). This clearly demonstrates that 
Gene locus A domain Stachelhaus code Predicted substrate 
haur_1857 A2 DIWELTADD* Unknown 
haur_1858 A3 DATKVGEVGK Asparagine 
haur_1859 A4 DFWNIGMVHK Threonine 
haur_1859 A5 DVWHFSLVDK Serine 
haur_1861 A7 DVGEIGSIDK Ornithine 
haur_1861 A8 DILQLGMVWK Glycine 
ACL KS1 AT1 ACP1
SH
AMT1 C2 A2 PCP2
SH
MT2 C3 A3 PCP3
SH
E3 C4 A4 PCP4
SH
E4 C5 A5 PCP5
SH
KS6 AT6
KR6
ACP6
SH
C7 A7 PCP7
SH
E7 C8 A8 PCP8
SH
TE
SH
ACPL
haur_1861 haur_1860 haur_1859 haur_1858
 haur_1856  
haur_1856 haur_1857 
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bioinformatics predictions must be viewed critically, and that the biochemistry of 
especially promiscuous A domains is not yet completely understood.  
For trans acting A and PCP domains also interdomain interactions have been stated to 
be important for A domain specificity (Marshall et al., 2002). So, we should not exclude 
the possibility that interdomain interactions might influence the activity of the A domains, 
i.e A3, A4 and A5 of PKS/NRPS gene locus-1. To account for possible interdomain 
interactions the A2 and A3 domain of PKS/NRPS gene locus-1 were heterologously 
expressed together with their PCP domain. But the adenylation assay with A3-PCP3 
again showed activation of all the tested amino acids at the same rate. The same was 
observed for the A2-PCP2 domain. Thus, it seems apparent that interdomain interactions 
between A and PCP domains of PKS/NRPS gene locus-1 do not play a role in the 
activity of these A domains. 
For the activity of some A domains a protein called MbtH is important (Felnagle et., 
2010; Wolpert et al., 2007), even though the exact function of this protein is not yet 
reported (Boll et al., 2011). Albeit no mbtH gene was found in proximity to PKS/NRPS 
gene locus-1, the H. aurantiacus DSM 785 genome contains two such genes at a distant 
position. The adenylation assay of the A domains, i.e A3 and A4 with the co-expressed 
mbtH-like proteins showed specific activation of the substrates consistent with the 
computational prediction. But these results were not reproducible. Moreover, the 
adenylation assay with A5-mbtH proteins showed again unspecific activation of amino 
acids.  
The results of the adenylation assays, showing unspecific action of the heterologously 
expressed A domains raised a lot of questions about the nature of these domains and 
the reliability of the γ-18O4-ATP pyrophosphate exchange assay. If these A domains 
were really promiscuous then we presume that H. aurantiacus would produce many 
analogues comprising different combinations of amino acids at a concentration hard to 
detect via MS. Nevertheless, A domains with such a broad substrate specificity were 
never observed to date and would be really tempting for further studies. Indeed the γ-
18O4-ATP pyrophosphate exchange assay of an A domain activating an amino acid at 
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higher frequency being not the actual substrate of the biosynthetic process was 
observed for corallopyronin. The PKS/NRPS corallopyronin cluster encodes a single A 
domain. This was expected to activate glycine in accordance with the in silico analysis 
and feeding studies. But, in the γ-18O4-ATP pyrophosphate exchange assay with the 
heterologously expressed corallopyronin A domain, L-threonine was activated 
approximately two times more than the expected L-glycine. Till date, corallopyronin 
analogues with L-threonine instead of glycine have not been reported (Erol et al., 2010). 
It is thus most likely that the γ-18O4-ATP pyrophosphate exchange assay is not really 
predictive for the here investigated system. Therefore, PKS/NRPS gene locus-1 A 
domains have to be analyzed for their substrates by assays other than the γ-18O4-ATP 
pyrophosphate exchange assay. 
In NRPS systems, A domains activate their respective substrates by adenylating them at 
the expense of ATP. This type of adenylation reaction is not only limited to NRPSs but 
occurs in a wide range of biological processes, including protein synthesis and 
degradation, DNA synthesis, coenzyme biosynthesis and lipid metabolism. Based on 
methods used to monitor these adenylation reactions, several non-radioactive assays 
have been developed to detect the kinetics of pyrophosphate release (McQuade et al., 
2009; Otten et al., 2007; Pavela-Vrancicet al., 1999). These non-radioactive assays 
were successful and can be readily used to distinguish the suitable substrate from other 
mis-adenylated intermediates. Analysis of PKS/NRPS gene locus-1 A domains of H. 
aurantiacus by these assays would probably give further information about the nature of 
these peculiar A domains. 
To conclude, genome sequences disclose the inherent biosynthetic potential of the 
respective bacteria. With many ongoing bacterial genome sequencing projects a 
multitude of biosynthetic pathways will be unveiled in the near future. Along with this, 
novel technologies will hopefully soon provide the possibility to express these genes 
heterologously and thus to exploit bacterial metabolomes. Concerning H. aurantiacus 
either the complete heterologous expression of the cryptic gene clusters, or the 
upregulation of these pathways in the producer strain would have to be attempted to 
access the encoded natural products.  
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6. Summary 
The need for new drug molecules necessitates different strategies, such as exploring 
untapped biological sources. Recently, numerous projects focussing bacterial genomes 
led to new biosynthetic pathways, being useful for drug-oriented natural product 
research.  
In this study, some of the publicly accessible genomes of gliding bacteria were analysed 
in silico using CLUSEAN, PKS/NRPS analysis and NRPS/PKS database for the 
presence of genes encoding polyketide synthases (PKS) and nonribosomal peptide 
synthetases (NRPS). Thus, among 16 completely sequenced genomes from Genbank, 
Myxococcus fulvus HW-1, Haliangium ochraceum DSM 14365, Chitinophaga pinensis 
DSM 2588, Isosphaera pallida ATCC 43644, Paedobacter heparinus DSM 2366 and 
Herpetosiphon aurantiacus DSM 785 were found to contain so called ‘cryptic’ gene 
clusters. Such cryptic gene clusters are defined to encode biosynthetic enzymes for 
hitherto unknown compounds. Deeper understanding regarding the genetic basis and 
structural enzymology of PKS and NRPS biosynthetic enzymes enable predictions 
concerning the putative structures encoded by these gene clusters. 
M. fulvus HW-1 and Ha. ochraceum DSM 14365 both belong to the chemically prolific 
myxobacteria. In M. fulvus HW-1 we identified 15 cryptic PKS and/or NRPS gene loci. 
Additionally, two gene loci in this bacterial genome were found to be identical to those of 
the known myxobacterial metabolites DKxanthenes and myxochelin A. Ha. ochraceum 
DSM 14365, the only marine myxobacterium to have its genome sequenced was found 
to contain 14 PKS and/or NRPS gene loci. Haliangicin, an antifungal compound has 
already been reported from this bacterium, but the encoding biosynthetic gene cluster is 
not yet annotated. As a part of this study by taking the haliangicin structure into account, 
a distinct PKS gene locus was putatively annotated to be associated with its 
biosynthesis. Again, one of the NRPS gene loci was detected to be homologous to that 
of the myxochelin A cluster. But, the presence of a methyltransferase encoding gene in 
proximity to the gene locus suggests that the encoded myxochelin A might be 
methylated. Ch. pinensis DSM 2588 from the phylum Bacteroidetes was already 
described to produce the polyketides elansolid B1 and D. Also, a cryptic NRPS gene 
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locus was reported to be present in the genome sequence.  During the current work an 
additional PKS/NRPS mixed gene locus of 88 Kb was identified from this genome 
sequence. I. pallida ATCC 43644 and Pa. heparinus DSM 2366 had been described to 
be non-producers of secondary metabolites. But, as a part of this study a PKS gene 
locus was recognized from I. pallida ATCC 43644, whereas a PKS/NRPS mixed gene 
locus was identified from Pa. heparinus DSM 2366. The genome of H. aurantiacus DSM 
785 from the phylum Chloroflexi was identified to putatively own the biosynthetic 
machineries capable of producing 11 metabolites, including the well known myxochelin 
A. Thus, from these in silico investigations M. fulvus HW-1, Ha. ochraceum DSM 14365 
and H. aurantiacus DSM785 were found to be promising candidates for the isolation of 
novel natural products.  
The second part of this study was focussed on H. aurantiacus DSM 785. First, using the 
CLUSEAN, PKS/NRPS analysis, NRPS/PKS database, BLAST, ‘NRPSpredictor’ and 
CLUSTALW tools, the putative structures encoded by the cryptic gene clusters of this 
bacterium were derived. Subsequently, the bacterium was cultivated and screened for 
the presence of metabolites, whose putative structure had been deciphered from the 
genome sequence. Since no distinct metabolites could be obtained, the expression of 
the cryptic gene clusters was studied using RT-PCR. This revealed the expression of 
PKS/NRPS gene locus-1 and NRPS gene locus-4 in Casitone-yeast based (CY) 
medium. Cultivation in CY medium and extraction of the lyophilised cell pellet revealed 
two compounds with molecular masses of 774 Da and 748 Da in LC-MS. These 
molecular masses of the identified compounds however were unexpected, and their 
biosynthetic origin could not be correlated with any of the cryptic gene clusters. Further 
modifications of the culture conditions and of extraction methods did not alter the 
metabolic profile of the bacterium. Therefore, to succeed in the production of the 
encoded secondary metabolites either the cryptic gene clusters have to be 
heterologously expressed or the regulatory genes controlling their expression have to be 
identified and manipulated. 
In the third part of this study we attempted to characterise the putative adenylation (A) 
domains of PKS/NRPS gene locus-1. A domains are one of the catalytically active 
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centres of NRPS and responsible for the selection and adenylation of a specific amino 
acid at the expense of ATP. Subsequently the adenylated amino acid is loaded on to the 
peptidyl carrier protein (PCP) domain of NRPS for the assembly of a nonribosomal 
peptide. PKS/NRPS gene locus-1 includes six A domains for the hexapeptide core of the 
putative lipopeptide. Bioinformatic analysis (NRPSpredictor) predicted the substrate of 
five of the six A domains, i.e A3, A4, A5, A7 and A8 to be asparagine, threonine, serine, 
ornithine and glycine, respectively. The A2 domain was unusual and possibly activates 
4-hydroxyphenylglycine. In order to assess the activity of these A domains 
biochemically, they were heterologously expressed and adenylation of the respective 
substrates in the presence of other amino acids was monitored using the γ-18O4-ATP 
pyrophosphate exchange assay. In the first set of experiments discrete A domains were 
expressed. Then A and PCP domains were expressed together in order to investigate 
the significance of interdomain interactions in selecting specific amino acids. In a third 
attempt, the A domains were co-expressed with MbtH proteins. The latter were found to 
be essential for the activity of some A domains. However, in the γ-18O4-ATP 
pyrophosphate exchange assay unspecific activation of several amino acids was 
observed with all these proteins. The outcome of these experiments was unexpected 
and does not allow to conclude on the structure of the encoded natural product.  
Mining bacterial genomes is beneficial in identifying the hidden biosynthetic potential of 
these species. However, despite the genetic potential the production of the respective 
secondary metabolites may prove to be difficult. Thus, technologies that enable the 
heterologous expression of complete biosynthetic gene clusters should be in the focus 
of future work. 
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8. Appendix 
Table 8-1: List of genomes analyzed from Genbank. Genomes that were analyzed in this study 
are highlighted in bold. The annotation of H. aurantiacus genome was based on Kiss et al., 
2011. 
Bacteria Genome (Mbp) 
Phylum: Chloroflexi 
Chloroflexus aurantiacus J-10-fl 5.3 
Herpetosiphon auranticaus DSM 785 6 
Chloroflexus sp. Y-400-fl 5.3 
Chloroflexus aggregans DSM 9485 4.7 
Phylum: Proteobacteria 
Myxococcus xanthus DK 1622 9.14 
Sorangium cellulosum So ce56  13 
Stigmatella  aurantiaca DW4/3-1 10.2 
Anaeromyxobacter dehalogenans 2CP-1-1  5 
Anaeromyxobacter sp. K 5 
Anaeromyxobacter sp. Fw109-5 5.3 
Haliangium ochraceum DSM 14365 9.4 
Myxococcus fulvus HW-1  
Phylum: Cyanobacteria 
Synechocystis sp. PCC 6803 3.6 
Trichodesmium erythraeum IMS101 7.8 
Anabaena variabilis ATCC 29413 6.4 
Nostoc azollae 0708 5.3 
Nostoc punctiforme PCC 73102 8.2 
Nostoc sp. PCC 7120 6.4 
Phylum: Firmicutes 
Heliobacterium modesticaldum Ice1 3 
Mycoplasma with 1.3 or less 
Phylum: Planctomycetes 
Isosphaera pallida ATCC 43644 5.5 
Phylum: Bacteroidetes 
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Cytophaga hutchinsonii ATCC 33406 4.4 
Capnocytophaga ochracea DSM 7271 2.6 
Flavobacterium johnsoniae UW101 6.1 
Flavobacterium psychrophilum JIP02/86 2.9 
Cellulophaga algicola DSM 14237 4.9 
Pedobacter heparinus DSM 2366 5.2 
Cytophaga fermentans DSM 9555 6.3 
Spirosoma linguale DSM 74 8.1 
Chitinophaga pinensis DSM 2588 9.1 
Phylum: Chlorobi 
Chloroherpeton thalassium ATCC 35110 3.3 
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Figure 8-1: 1H-NMR of fraction containing compound-1 and -2 in methanol-d4 
  
 
 
Figure 8-2: 13C-NMR of fraction containing compound-1 and -2 in methanol-d4  
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Figure-8.2: LC-MS of fraction containing compound-1 (747 Da) and -2 (773 Da)  
(A) Compound-1 (747 Da) in positive (+Q1) and negative (-Q1) mode with DAD spectral data 
 
 
 (B) Compound-2 (773 Da) in positive (+Q1) and negative (-Q1) mode with DAD spectral data 
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(C) Compound-1 (747 Da) and Compound-2 (773 Da) in positive (+Q1) and negative (-Q1) 
mode with DAD spectral data 
 
 
Figure-8.3: HR-MS data of crude extract containg compound with a molecular mass of 
772.2198 Da in the positive mode (A) and negative mode (B) 
 
(M+2H)/2 
(M+H) 
(M+HCOOH-H) 
(M-H) 
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Figure 8-3: Amino acid sequences of overexpressed proteins. His6- six histidine tagged. 
Sequences from the pET28-a+ expression vector are underlined and six histidine tag is 
highlighted in bold. 
His6-A3 
MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSGLVGRLEYNRDLFEPATIARLRDHFLR
LLGHALAQPTQPLAQISILSAAECQQLLVDWNQTQQPFPDQLGLQHLVAQQVQRTPNAPAMR
WNNQIICYTELEQRANQLAHLLLQRGVTQGSIVGVYATRCPEMIISLLAILKAGAAYLPLDPAYPA
ERLHYLVADSAASLIVQASHQALPTLVSTAETLDVVAEAETLASLPTTAPMVDFDPQQLAYVIYT
SGSTGKPKGVLIQHQGVVNYLHWAIHYYPFEQGAGAPLASSLAFDATITALWGPLCTGKTIDLLP
EQDELEVLAQRLSSEDYSVLKITPAHMEALSQLVAPDQIGSSKAFVIGGEALLQQHVAFWQTNA
PNLRLINEYGPTETVVGCVIYQAQAAPSEWAAVPIGRPIANTQLYVLDPAGLPVPIGVPGELYIAG
LGVGRGYHGRPELTAERFVRLEQLAGVQAELARCQQPQPAFERLYRSGDLVRYLPDGNLEYL
GRIDQQVKLHGFRIELGEIEATLASHPTVHAAVAMIREDRPGHKRLVAYVVAEPTANQDTSIVLT
HVAQQLPH 
His6-A4 
MGSSHHHHHHSSGLVPRGSHMSYAELDQRSNQVAHGLIAQGVTVGNLVGLCVERSLELVVGIL
AILKAGAAYVPLDPTYPRERLAFVQADAAIRHIVTQRHLRDVVQAEQCYLLDQPMDAYPTTPPS
VVCSTENPAYVIYTSGSTGNPKGVVVSHANVARLMLATNAWYQFNQHDVWTLFHSYAFDFSV
WELWGALLYGGHLVVVPYWVSRNPEAFHQLLRQQHVTVLNQTPSAFYQLIQADSLAEQRLALR
TVIFGGEALDLAQLAPWFARYGDQQPQLVNMYGITETTVHVTYRPIRLADLQAGLGSVIGCPIPD
LALAVLDAQGRQAGVGVAGELYVGGAGVAQGYLERPELNAQRFIQADASTPDLPSNSRWYRS
GDLVRYWPNGELEYLGRIDLQVKIRGFRIELGEIEAALSQHAAVQSAAVEFELRRQACGRTRAP
PPPPLRSGC 
His6-A5 
MGSSHHHHHHSSGLVPRGSHMSYAELDQRVTQLAASLQAHGVQVDDRVGVLMERSAQLVIAL
LAIVKAGAAYVPFDPAYPSERVLAMLADAAPRVVITDTPKLGQATIPVLLFDQAWQPNHSLSFNP
PIIHPLNAAYMIYTSGSTGKPKGVINSHQAIVNRLLWMQQRYQLTAADVVLQKTPYSFDVSVWE
FFWPLMTGAKLVVARPAGHLDRRYLAETIQAQKVTTIHFVPSMLSLFLEEPQAANCTSLRQVFC
SGEALSAETSARFCQTLNADLHNLYGPTEAAVDVSAWHYQPNAEPSVPIGRPIANTQLYILDAR
MQPVPVGVAGELLIGGLNLARGYAERPDLTAERFIPHPYASQAGARLYRTGDLARWRDDGAIE
YLGRNDFQIKVRGIRVELGEIEHQLSQHPAIAQIVVEFELRRQACGRTRAPPPPPLRSGC 
His6-A3-PCP3 
MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSGLVGRLEYNRDLFEPATIARLRDHFLR
LLGHALAQPTQPLAQISILSAAECQQLLVDWNQTQQPFPDQLGLQHLVAQQVQRTPNAPAMR
WNNQIICYTELEQRANQLAHLLLQRGVTQGSIVGVYATRCPEMIISLLAILKAGAAYLPLDPAYPA
ERLHYLVADSAASLIVQASHQALPTLVSTAETLDVVAEAETLASLPTTAPMVDFDPQQLAYVIYT
SGSTGKPKGVLIQHQGVVNYLHWAIHYYPFEQGAGAPLASSLAFDATITALWGPLCTGKTIDLLP
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EQDELEVLAQRLSSEDYSVLKITPAHMEALSQLVAPDQIGSSKAFVIGGEALLQQHVAFWQTNA
PNLRLINEYGPTETVVGCVIYQAQAAPSEWAAVPIGRPIANTQLYVLDPAGLPVPIGVPGELYIAG
LGVGRGYHGRPELTAERFVRLEQLAGVQAELARCQQPQPAFERLYRSGDLVRYLPDGNLEYL
GRIDQQVKLHGFRIELGEIEATLASHPTVHAAVAMIREDRPGHKRLVAYVVAEPTANQDTSIVLT
HVAQQLPHYMLPSVVIWLDSLPLTPNGKVDRQALPAPEINQTALDSAQTTPLDQYEAQLMAIWQ
RVLGLKAVDRHANFFSLGGDSILVMQVVGIARQHGLILTPRLLFQNQTIASLAQAI 
His6-A2-PCP2 
MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSMSYQALDQRANRLANYLQSLAISTNQV
VAILADRSCDFVSAVLGVFKAGAAYLPLDLEHPPRRLAQVLQQSQSRLVLVGEAWQATLAAALS
ILPSDQRPIIVLLEQAFNPELSSEAPTIQSQASDLAYVIYTSGSTGLPKGAMIEQRGMVNHLYAKII
DLQLTAADRVAQNARQSFDISVWQMLVALLVGAETQIYPDSIARDPEVLLSYAEQQATTILEIVPS
LLGAWLTIFPNRANDLPSFAQLRWLLLTGEALPPAACRDWFTWYPTIPLMNAYGPTECSDDVTH
YVVREAPAAHVVHMPIGRPVINTRLYILDGLLQPVPIGVIGELYVGGVGVGRGYLNDPERTQAVF
AADPFMAGGRWYRTGDLARYRSDGTIEYLGRIDHQVKVRGFRIELGEIEAALAQHQAVHQSIVT
ATPNAQGQLRLIAYVVSKAADQPAEQATSARLEQWDSVWADTYDQLSAGDHGTINTIGWNDSY
TRQPFSAEAMHEWSWVTVRNILAQQPSRILELGCGTGMLLLPLAPYCLSYRGHDIAAEVLAYVQ
QRLDQQIHDWPHVSLAQFPAHDFSNIAPHSVDTIVINSVAQYFPSIDYLVQVLAAGLEALVAGGR
IYLGDIRNLSLNPLLHASIQLFQAPNELAVEQIAQLAQQQHLRDQELVIDPSFFYALQQQYPQISHI
ELVLKRGRIHNELTRFRYDVVLHVQRPSLDLQPHWFDWQADGLSLSLVRQVLEQSQPDALGIA
NVPNSRLSEACGLWQALHVAEQPSTAGELKQALQPLALQGIDPEDWYNLHLNGRYRISVSLAQ
SGELGCYDVLFYATAKLADGGLPQQIQRLASPRKAWSAYANNPLQESQSLTQQFRQHLRQALP
DYMQPEAFVLLEQLPLTPNGKVDRRALAALEAPIQTTTYLAPRNPLEQQLASLFEQVLNLNQVG
VDQSFFELGGHSLTGTQLIGLIRSECHADLPLRTLFEAPTVGELALRVAAAQTEPSEIAKPTALKR
QRQRVNLNTAGFGQIAESNDGGAA 
MbtH 
MQTTDDDTTIYNVVINHEEQYSIWPAERENPLGWSNVGVSGNKQTCLDHIKAVWTDMRPLSLR
QALANQSA 
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Figure- 8.4: MALDI-TOF/TOF data of His6-A3-PCP3  (apo) protein. Peptide fragments observed 
in MALDI-TOF/TOF are highlighted in red. Catalytically active serine (highlighted as   ) for the 
loading of phosphopantetheine arm observed in the digested fragment  
[HANFFSLGGDSILVMQVVGIARQHGLILTPR] of molecular mass 3346.820 Da 
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Figure- 8.5: MALDI-TOF MS data of γ-18O4-ATP pyrophosphate exchange assay with His6-A3-mbtH showing specific activitytowards 
asparagine. The substrates tested and their activation by His6-A3-mbtH protein are indicated in the chromatogram. 
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Figure- 8.6: MALDI-TOF MS data of γ-18O4-ATP pyrophosphate exchange assay with His6-A3-mbtH showing  unspecific activity. The 
substrates tested and their activation by His6-A3-mbtH protein are indicated in the chromatogram. 
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